{
    "testId": 390370490,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 60,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 2,
    "testModeName": "Tutor",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 27,
    "correctToIncorrect": 1,
    "incorrectToCorrect": 6,
    "incorrectToIncorrect": 1,
    "timeInSeconds": 6277,
    "averageTimeSpentInSeconds": 157,
    "otherAverageTimeSpentInSeconds": 71,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 40,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 4254,
            "questionIndex": 4254,
            "questionText": "<p>A 39-year-old woman comes to the physician with a &#x22;pins and needles&#x22; sensation around her mouth for the last 2-3 weeks.&nbsp; She occasionally has similar sensations in her feet, along with muscle cramps, especially at the end of the day.&nbsp; Her past medical history is unremarkable, and she does not use tobacco, alcohol, or illicit drugs.&nbsp; Family history is not significant.&nbsp; Vital signs are normal, and examination is unremarkable.&nbsp; Laboratory findings results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"300\"><tbody><tr><td colspan=\"2\">Complete blood count</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Hemoglobin</td><td>13.2 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Leukocytes</td><td>6,300/&micro;L</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>140 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>4.0 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>100 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>24 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>10 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td width=\"30%\">0.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>100 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>6.5 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Phosphorus</td><td>5.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Total protein</td><td>7.0 g/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>4.0 g/dL</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s clinical features and laboratory findings are consistent with hypocalcemia caused by autoimmune primary hypoparathyroidism.&nbsp; Symptoms of hypocalcemia usually stem from neuromuscular irritability and manifest as perioral tingling and numbness, muscle cramps, tetany, carpopedal spasms, and seizures.&nbsp; Prolongation of the QT interval can also occur.&nbsp; If the hypocalcemia develops rapidly, as in surgical patients, the symptoms are typically more severe, even with modestly reduced serum calcium levels.&nbsp; However, chronic hypocalcemia may be asymptomatic even with markedly reduced serum calcium levels.</p><p>The causes of primary hypoparathyroidism include:</p><ol><li>Post-surgical (most common cause)</li><li>Autoimmune</li><li>Congenital absence or maldevelopment of the parathyroid glands (eg, DiGeorge syndrome)</li><li>Defective calcium-sensing receptor on the parathyroid glands</li><li>Non-autoimmune destruction of the parathyroid gland due to infiltrative diseases such as hemochromatosis, Wilson disease, and neck irradiation</li></ol><p>Post-surgical hypoparathyroidism can occur during thyroidectomy and sub-total parathyroidectomy (ie, removal of 3&frac12; parathyroid glands for parathyroid hyperplasia).&nbsp; Autoimmune hypoparathyroidism is the most common nonsurgical syndrome.</p><p><strong>(Choice A)</strong>&nbsp; Drugs such as phenytoin, carbamazepine, and rifampin cause vitamin D deficiency by inducing the P450 cytochrome system in the liver, which degrades vitamin D to inactive metabolites.&nbsp; This patient does not take any medications.</p><p><strong>(Choice C)</strong>&nbsp; The kidneys are responsible for converting 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D by the enzyme 1-alpha-hydroxylase.&nbsp; Impaired 1-alpha-hydroxylation occurs with chronic kidney disease, which can lead to hyperphosphatemia, hypocalcemia, and secondary hyperparathyroidism.&nbsp; However, this patient&#39;s renal function appears normal.</p><p><strong>(Choice D)</strong>&nbsp; Serum phosphorus is usually low in vitamin D deficiency.</p><p><strong>(Choice E)</strong>&nbsp; Insufficient calcium intake induces the secretion of parathyroid hormone, causing secondary hyperparathyroidism.&nbsp; High parathyroid hormone levels have the following major effects on <a href=\"629\">calcium homeostasis:</a> increase in bone resorption with release of calcium into the circulation; increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D in the kidneys, which stimulates gut calcium absorption; and increased renal phosphate loss resulting in <strong>hypophosphatemia</strong>.</p><p><strong>(Choice F)</strong>&nbsp; Precipitation of calcium with phosphate in the peripheral tissues can cause hypocalcemia, which can occur in renal failure, rhabdomyolysis, and phosphate administration.&nbsp; Hypocalcemia often also occurs in acute pancreatitis (due to precipitation of calcium soaps in the abdominal cavity) or in diffuse osteoblastic metastases (eg, prostate and breast cancer).&nbsp; This patient exhibits no signs or clinical features suggestive of these possible causes of hypocalcemia.</p><p><strong>Educational objective:</strong><br>Hypoparathyroidism (parathyroid hormone deficiency) is characterized by hypocalcemia and hyperphosphatemia in the presence of normal renal function.&nbsp; Causes of hypoparathyroidism include post-surgical, autoimmune and non-autoimmune parathyroid destruction, and defective calcium-sensing receptor.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2731,
            "topic": "Hypocalcemia",
            "titleId": 2731,
            "title": "Hypocalcemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Conversion of vitamin D to inactive metabolites",
                    "choiceNumber": 1,
                    "correctTaken": 871,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Decreased secretion of parathyroid hormone",
                    "choiceNumber": 2,
                    "correctTaken": 96338,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired 1-hydroxylation of vitamin D",
                    "choiceNumber": 3,
                    "correctTaken": 8888,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inadequate availability of vitamin D",
                    "choiceNumber": 4,
                    "correctTaken": 13774,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inadequate calcium intake",
                    "choiceNumber": 5,
                    "correctTaken": 9091,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Precipitation of calcium in soft tissues",
                    "choiceNumber": 6,
                    "correctTaken": 2561,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1279,1507,true,-1,1*646,1031,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "490",
                    "mediaDataId": 0,
                    "title": "Parathyroid disorders: hyperparathyroidism and hypoparathyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22863393",
                    "mediaDataId": 0,
                    "title": "Hypoparathyroidism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22863393",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 185,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 131523,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 655,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 20300,
            "questionIndex": 21799,
            "questionText": "<p>A 24-year-old man comes to the office for evaluation of progressive enlargement of the breasts for 2 years.&nbsp; He reports normal early morning erections and has had no headaches, breast pain or discharge, or fatigue.&nbsp; The patient does not use alcohol or recreational drugs.&nbsp; Blood pressure is 110/70 mm Hg and pulse is 88/min.&nbsp; BMI is 35 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination of the breasts shows soft tissue enlargement without clearly defined, palpable borders or nodules.&nbsp; There is no tenderness, discharge, nipple retraction, or skin dimpling.&nbsp; The remainder of the physical examination is unremarkable.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"61001\" src=\"https://www.uworld.com/media/L91549.jpg\"  ></p><p>This patient has diffuse enlargement of the breasts without pain, tenderness, nodules, or skin dimpling.&nbsp; In light of the chronicity, underlying obesity, and lack of hypogonadal (eg, loss of erections) and pituitary (eg, headache) symptoms, this most likely represents <strong>pseudogynecomastia</strong> (also called lipomastia).</p><p>Pseudogynecomastia is characterized by <strong>excessive deposition of fat</strong> in the breast, which commonly extends into the axilla and skin folds <strong>without a distinct margin</strong>.&nbsp; In contrast, in true gynecomastia (ie, enlargement of the glandular breast tissue), the margin of firm glandular tissue is often palpable and the breast may be tender.&nbsp; The diagnosis is usually apparent on clinical findings (ie, body habitus, palpation).&nbsp; Management includes <strong>weight loss</strong>, which is usually adequate.&nbsp; Liposuction or surgical reduction can be considered, but risks include scarring, asymmetry, and poor cosmetic results.</p><p><strong>(Choice A)</strong>&nbsp; Breast imaging (eg, mammogram, ultrasound) should be considered to exclude malignancy in patients with eccentric, asymmetric, or nodular breast findings.&nbsp; This patient has no signs of malignancy and imaging is not needed.</p><p><strong>(Choice B)</strong>&nbsp; Hormonal testing (eg, testosterone, estradiol, LH, hCG, prolactin) is indicated for evaluation of patients with true gynecomastia who do not have a known underlying cause (eg, cirrhosis).&nbsp; Biochemical testing is not needed for those with pseudogynecomastia.</p><p><strong>(Choice C)</strong>&nbsp; Testicular ultrasound to evaluate for gonadal malignancy is indicated for patients with a palpable scrotal mass or elevated beta-hCG level.&nbsp; In general, endocrinologic imaging studies are done only when the biochemical evaluation has detected a significant abnormality.</p><p><strong>(Choice D)</strong>&nbsp; Tamoxifen is a selective estrogen receptor modulator that is used to treat gynecomastia and is also sometimes used for prevention of gynecomastia in patients receiving antiandrogen therapy for prostate cancer.&nbsp; It is not beneficial in pseudogynecomastia.</p><p><strong>Educational objective:</strong><br>Pseudogynecomastia is characterized by chronic, excessive deposition of fat in the breast without a distinct margin, typically in patients with obesity.&nbsp; In true gynecomastia (ie, enlargement of the glandular breast tissue), the margin of firm glandular tissue is often palpable and the breast may be tender.&nbsp; The diagnosis is based on clinical findings.&nbsp; Management includes weight loss.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 6943,
            "topic": "Gynecomastia",
            "titleId": 6943,
            "title": "Gynecomastia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Obtain breast ultrasound",
                    "choiceNumber": 1,
                    "correctTaken": 1080,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain serum prolactin level",
                    "choiceNumber": 2,
                    "correctTaken": 3268,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain testicular ultrasound",
                    "choiceNumber": 3,
                    "correctTaken": 1006,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend tamoxifen therapy",
                    "choiceNumber": 4,
                    "correctTaken": 101,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend weight loss",
                    "choiceNumber": 5,
                    "correctTaken": 15173,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "300,345,true,-1,1*509,592,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22534349",
                    "mediaDataId": 0,
                    "title": "Gynecomastia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22534349",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 242,
            "othersAvgTimeSpent": 34,
            "notes": null,
            "peopleTaken": 20628,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 74,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 665,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 17767,
            "questionIndex": 19227,
            "questionText": "<p>A 55-year-old man is admitted to the hospital due to fever and altered mental status.&nbsp; He was seen in an urgent care clinic 2 days ago for cellulitis of the left leg, for which he received a prescription for oral doxycycline.&nbsp; The patient has no other medical conditions and takes no medications.&nbsp; Temperature is 39 C (102.2 F), blood pressure is 80/60 mm Hg, and pulse is 112/min.&nbsp; Oxygen saturation is 94% on 2 L/min of oxygen via nasal cannula.&nbsp; The patient is drowsy but moves all the extremities on verbal command.&nbsp; Examination of the left leg reveals significant tenderness with erythema, swelling, and warmth.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Leukocytes</td><td>30,000/mm<font size=\"2\"><sup>3</sup></font> (12% band form)</td></tr><tr><td>Sodium</td><td>140 mEq/L</td></tr><tr><td>Potassium</td><td>5.1 mEq/L</td></tr><tr><td>Creatinine</td><td>1.7 mg/dL</td></tr><tr><td>Lactate</td><td>4 mmol/L (normal: &lt;2 mmol/L)</td></tr><tr><td>Glucose</td><td>50 mg/dL</td></tr></tbody></table><p>Finger-stick blood glucose is 46 mg/dL.&nbsp; Blood pressure improves to 100/70 mm Hg with a fluid bolus.&nbsp; Which of the following is the most likely cause of the low glucose levels in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T60053\"><table class=\"table-default-style\"><tbody><tr><td><p align=\"center\"><strong>Hypoglycemia in patients without diabetes mellitus</strong></p></td></tr><tr><td><ul><li>Drugs: quinolones, quinine, beta blockers</li><li>Alcohol (usually with prolonged starvation)</li><li>Sepsis/critical illness</li><li>Adrenal insufficiency</li><li>Insulinoma</li><li>Surreptitious insulin, sulfonylurea, or meglitinide use</li><li>Depleted glycogen stores (anorexia nervosa)</li><li>Severe hepatic failure</li></ul></td></tr></tbody></table></div><p>This patient has worsening cellulitis associated with hypotension, fever, and severe leukocytosis, findings consistent with <strong>sepsis</strong>.&nbsp; He also has significant <strong>hypoglycemia</strong> despite no history of diabetes and no treatment with antidiabetic medications (eg, insulin, sulfonylureas).</p><p>Hypoglycemia is uncommon in patients who are not treated with insulin or sulfonylureas for diabetes mellitus.&nbsp; However, it can occur in those with sepsis or other critical illnesses due to <strong>increased use of glucose</strong> in the tissues, which is promoted by inflammatory cytokines.&nbsp; Sepsis may also lead to <strong>suppression of gluconeogenesis</strong> in the liver.&nbsp; The risk is also higher in patients with renal insufficiency, likely due to decreased renal gluconeogenesis and reduced clearance of endogenous insulin.</p><p>Severe physiologic stress (eg, sepsis) can lead to a catecholamine (eg, epinephrine) surge, which stimulates hepatic glycogenolysis and gluconeogenesis; however, this effect would manifest as hyperglycemia rather than hypoglycemia <strong>(Choice D)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Infection in patients with chronic adrenal insufficiency can precipitate adrenal crisis, presenting with hypoglycemia, shock, and abnormal mental status.&nbsp; However, this patient has no prior symptoms of adrenal insufficiency (eg, anorexia, weight loss) or hyponatremia.&nbsp; Also, the hypotension in adrenal crisis does not usually respond to fluids alone and typically requires cortisol replacement.&nbsp; The mild increase in this patient&#39;s serum potassium is likely due to lactic acidosis from sepsis.</p><p><strong>(Choice B)</strong>&nbsp; Depletion of glycogen stores is not a primary contributor to hypoglycemia in the early stages.&nbsp; It is typically seen after a prolonged fast (ie, &gt;24-48 hr), such as in binge alcohol drinkers.</p><p><strong>(Choice C)</strong>&nbsp; As circulating glucose levels fall in patients with sepsis, insulin secretion is suppressed, not increased.</p><p><strong>(Choice F)</strong>&nbsp; Severe pancreatic injury can cause loss of insulin-producing beta cells, leading to pancreatogenic diabetes.&nbsp; Although concurrent loss of glucagon-secreting alpha cells can increase the risk for insulin-induced hypoglycemia, hyperglycemia is the primary effect.</p><p><strong>(Choice G)</strong>&nbsp; Besides antidiabetic agents, drugs that can cause hypoglycemia include quinolones, ACE inhibitors, and likely beta blockers.&nbsp; Doxycycline does not significantly affect blood glucose.</p><p><strong>Educational objective:</strong><br>Hypoglycemia can occur in patients with critical illness due to increased use of glucose in the tissues and suppression of gluconeogenesis in the liver.&nbsp; The risk is higher in patients with renal insufficiency, likely due to decreased renal gluconeogenesis and reduced clearance of endogenous insulin.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2740,
            "topic": "Hypoglycemia",
            "titleId": 2740,
            "title": "Hypoglycemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 3442,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depleted glycogen stores",
                    "choiceNumber": 2,
                    "correctTaken": 962,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased insulin production",
                    "choiceNumber": 3,
                    "correctTaken": 783,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased sympathetic output",
                    "choiceNumber": 4,
                    "correctTaken": 1668,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased tissue glucose use",
                    "choiceNumber": 5,
                    "correctTaken": 7984,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ischemic pancreatic necrosis",
                    "choiceNumber": 6,
                    "correctTaken": 334,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effect",
                    "choiceNumber": 7,
                    "correctTaken": 893,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "88,122,true,-1,1*167,189,true,-1,1*280,323,true,-1,1*625,637,true,-1,1*747,1123,true,-1,1*1653,1873,true,-1,1*2484,2666,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "435",
                    "mediaDataId": 0,
                    "title": "Sepsis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28640135",
                    "mediaDataId": 0,
                    "title": "Hospitalization With Hypoglycemia in Patients Without Diabetes Mellitus: A Retrospective Study Using a National Inpatient Database in Japan, 2008-2012.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28640135",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 409,
            "othersAvgTimeSpent": 91,
            "notes": null,
            "peopleTaken": 16066,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1713,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 3494,
            "questionIndex": 3494,
            "questionText": "<p>A 9-year-old boy is brought to the office due to oral lesions.&nbsp; He had been living in a children&#39;s home until he was adopted 3 months ago.&nbsp; He believes the tongue nodules have always been present.&nbsp; They do not hurt or itch.&nbsp; He has no taste disturbance and eats a variety of solids and liquids.&nbsp; He is not bothered by drinking hot or cold liquids.&nbsp; Vital signs are stable.&nbsp; He is tall for his age with long arms and fingers.&nbsp; Tongue examination is shown below.&nbsp; On palpation, the tongue nodules feel discrete, firm, and rubbery.&nbsp; They are not tender.&nbsp; This patient is at greatest risk from which of the following conditions?</p><p><img  draggable=\"false\" id=\"23462\" src=\"https://www.uworld.com/media/highresdefault/U6911.png\"  ></p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T40973\" style=\"overflow-x:auto;\"><table class=\"table-default-style\" style=\"width:516px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Classification of multiple endocrine neoplasia</strong></p></td></tr><tr><td style=\"width: 15%;\"><p align=\"center\"><strong>Type 1</strong></p></td><td style=\"width: 85%;\"><ul><li><strong>Primary hyperparathyroidism</strong> (parathyroid adenomas or hyperplasia)</li><li>Pituitary tumors (prolactin, visual defects)</li><li>Pancreatic tumors (especially gastrinomas)</li></ul></td></tr><tr><td style=\"width: 15%;\"><p align=\"center\"><strong>Type 2A</strong></p></td><td style=\"width: 85%;\"><ul><li><strong>Medullary thyroid cancer</strong> (calcitonin)</li><li>Pheochromocytoma</li><li>Primary hyperparathyroidism (parathyroid hyperplasia)</li></ul></td></tr><tr><td style=\"width: 15%;\"><p align=\"center\"><strong>Type 2B</strong></p></td><td style=\"width: 85%;\"><ul><li><strong>Medullary thyroid cancer</strong> (calcitonin)</li><li>Pheochromocytoma</li><li>Mucosal neuromas/marfanoid habitus</li></ul></td></tr></tbody></table></div><p>This patient with an unknown family history, <strong>marfanoid habitus</strong> (eg, long arms and fingers), and <a href=\"2544\">mucosal neuromas</a> (eg, painless, rubbery tongue nodules) likely has <strong>multiple endocrine neoplasia type 2B (MEN2B)</strong>.&nbsp; MEN2B is caused by a <strong>germline <em>RET</em> mutation</strong> and is often identified via family history or genetic screening.&nbsp; Family members of a patient with a known germline <em>RET</em> mutation should undergo genetic testing.</p><p>The greatest threat to this patient&#39;s life is from <strong>medullary thyroid cancer (MTC)</strong>.&nbsp; MTC associated with MEN2B tends to occur at a very young age.&nbsp; Because of this risk, prophylactic thyroidectomy is often performed in infancy (eg, age &lt;1 year) in patients with known MEN2B.&nbsp; Half of patients with MEN2B also have pheochromocytoma, which needs to be evaluated (ie, with plasma-fractionated metanephrines).</p><p><strong>(Choice A)</strong>&nbsp; Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) leads to diffuse arteriovenous malformations, sometimes with life-threatening complications (eg, massive hemoptysis, gastrointestinal bleeding), and often presents with mucosal telangiectasias.&nbsp; However, these typically appear as <a href=\"67730\">ruby-colored papules that blanch with pressure</a> rather than firm, rubbery neuromas.</p><p><strong>(Choice B)</strong>&nbsp; Peutz-Jeghers syndrome is characterized by gastrointestinal tract hamartomatous polyposis.&nbsp; Although oral lesions develop, they are typically <a href=\"62558\">perioral mucocutaneous pigmented macules</a> rather than mucosal neuromas.</p><p><strong>(Choice C)</strong>&nbsp; MEN type 1 is characterized by primary hyperparathyroidism, pituitary tumors, and gastrointestinal/pancreatic endocrine tumors (eg, gastrinomas).&nbsp; It is not associated with marfanoid habitus or mucosal neuromas.</p><p><strong>(Choice D)</strong>&nbsp; Tuberous sclerosis is an inherited neurocutaneous syndrome that often includes seizures that gradually worsen over time.&nbsp; Although it can present with benign tumors, these are typically skin tumors (eg, <a href=\"56956\">ash-leaf spots</a>, <a href=\"56957\">facial angiofibromas</a>, shagreen patches) rather than mucosal neuromas.</p><p><strong>Educational objective:</strong><br>Multiple endocrine neoplasia type 2B (MEN2B) is characterized by medullary thyroid cancer (MTC), pheochromocytoma, marfanoid habitus, and mucosal neuromas.&nbsp; MTC associated with MEN2B is often very aggressive, and thyroidectomy is often recommended in infancy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23524,
            "topic": "Multiple endocrine neoplasia",
            "titleId": 23524,
            "title": "Multiple endocrine neoplasia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arteriovenous malformation",
                    "choiceNumber": 1,
                    "correctTaken": 3771,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Colon polyps",
                    "choiceNumber": 2,
                    "correctTaken": 3654,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary tumor",
                    "choiceNumber": 3,
                    "correctTaken": 1243,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refractory seizures",
                    "choiceNumber": 4,
                    "correctTaken": 1097,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid cancer",
                    "choiceNumber": 5,
                    "correctTaken": 6624,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "549,604,true,-1,1*1014,1139,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "496",
                    "mediaDataId": 0,
                    "title": "Multiple endocrine neoplasia (MEN)",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23209466",
                    "mediaDataId": 0,
                    "title": "Genetic and clinical features of multiple endocrine neoplasia types 1 and 2.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23209466",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30660595",
                    "mediaDataId": 0,
                    "title": "Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30660595",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "7491537",
                    "mediaDataId": 0,
                    "title": "Multiple endocrine neoplasia type 2B: more than an endocrine disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/7491537",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 193,
            "othersAvgTimeSpent": 41,
            "notes": null,
            "peopleTaken": 16389,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 933,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 20463,
            "questionIndex": 21964,
            "questionText": "<p>A 17-year-old boy is brought to the clinic due to a breast mass.&nbsp; He first noticed pain beneath his right nipple a month ago, and over the last few weeks, the right breast has become enlarged.&nbsp; The patient has no chronic medical conditions and takes no medications.&nbsp; He is doing well in school, and family history is unremarkable.&nbsp; Height and weight are at the 75th percentile.&nbsp; Temperature is 37 C (98.6 F), blood pressure is 110/66 mm Hg, pulse is 100/min, and respirations are 20/min.&nbsp; Examination shows a prominent right breast with a palpable and tender, 5-cm, well-circumscribed mound deep to the right nipple.&nbsp; There is no axillary or cervical lymphadenopathy.&nbsp; Cardiopulmonary examination is unremarkable, and the abdomen is soft without tenderness.&nbsp; Examination of the external genitalia shows testes without a palpable mass.&nbsp; Sexual maturity rating (Tanner) is stage 5.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">&#946;-hCG</td><td style=\"vertical-align:middle;text-align:right\">10,750 IU/L (normal: &lt;1.4)</td></tr><tr><td style=\"vertical-align:middle;\">Dehydroepiandrosterone sulfate</td><td style=\"vertical-align:middle;text-align:right\">3.2 mg/mL (normal: 1.3-5.5)</td></tr><tr><td style=\"vertical-align:middle;\">Estradiol</td><td style=\"vertical-align:middle;text-align:right\">120 pg/mL (normal: 10-30)</td></tr><tr><td style=\"vertical-align:middle;\">LH</td><td style=\"vertical-align:middle;text-align:right\">3 mU/mL (normal: 3-15)</td></tr><tr><td style=\"vertical-align:middle;\">Testosterone</td><td style=\"vertical-align:middle;text-align:right\">420 ng/dL (normal: 300-1200)</td></tr></tbody></table><p>Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"48832\" src=\"https://www.uworld.com/media/highresdefault/L76844.png\"  ></p><p><strong>Gynecomastia</strong> is abnormal growth of breast tissue in male patients.&nbsp; It generally results from an <strong>increased ratio of estrogens</strong> (which cause hyperplasia of breast ductal epithelium and fibrosis of stromal tissues) <strong>to androgens</strong> (which inhibit breast development).&nbsp; Although estrogen-induced gynecomastia is typically bilateral, unilateral findings are also common, and one breast may enlarge more rapidly than the other.</p><p>Besides rapidly progressive gynecomastia, this patient has a low to normal testosterone level, elevated estradiol, and a striking rise in &#946;-hCG, which most commonly represents an <strong>hCG-secreting germ cell tumor</strong> of the testis.&nbsp; Excessive secretion of hCG by testicular germ cell tumors suppresses testosterone production in Leydig cells and increases aromatase activity and conversion of androgens to estrogens; the resulting increase in the estrogen/androgen ratio can cause gynecomastia.&nbsp; Even though this patient has a normal testicular examination, <strong>ultrasound</strong> is indicated to exclude an occult mass.</p><p><strong>(Choice A)</strong>&nbsp; Androgen receptor defects typically present at birth with female phenotype or ambiguous genitalia, although some variants (eg, partial androgen insensitivity syndrome) may present in adulthood with gynecomastia.&nbsp; However, patients typically have undervirilization (eg, decreased facial and pubic hair) and elevated serum LH.</p><p><strong>(Choice B)</strong>&nbsp; Breast imaging (eg, mammography, ultrasound) and biopsy are indicated for patients with suspected breast malignancy.&nbsp; Typical findings include a hard or nodular mass with an eccentric location.&nbsp; This patient&#39;s well-circumscribed, subareolar swelling and hormonal abnormalities make breast cancer unlikely; in addition, there is no family history of breast cancer to warrant considering genetic diseases that may result in early-onset breast cancer.&nbsp; Both physiologic (ie, pubertal) and pathologic gynecomastia can be unilateral or bilateral.</p><p><strong>(Choice C)</strong>&nbsp; Karyotype analysis is used to diagnose Klinefelter syndrome (47,XXY), a common cause of gynecomastia.&nbsp; However, patients typically have primary hypogonadism with small, firm testes; low serum testosterone; and elevated LH levels.</p><p><strong>(Choice D)</strong>&nbsp; Reassurance is appropriate for pubertal gynecomastia, a benign, physiologic condition caused by transiently increased testicular production of estrogen and peripheral conversion of prohormones to estrogen.&nbsp; It most commonly occurs at age 12-14 during midpuberty (Tanner stage 3-4), develops gradually, and resolves within a year.&nbsp; The onset of gynecomastia outside the pubertal range after sexual maturity warrants additional workup.</p><p><strong>Educational objective:</strong><br>Gynecomastia with abnormal features (eg, rapid progression, large size, occurrence outside pubertal age range) should include laboratory evaluation to assess for a pathologic cause.&nbsp; An increased &#946;-hCG level in this setting is concerning for an hCG-secreting tumor, and a testicular ultrasound should be obtained.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 6943,
            "topic": "Gynecomastia",
            "titleId": 6943,
            "title": "Gynecomastia",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Androgen receptor mutation analysis",
                    "choiceNumber": 1,
                    "correctTaken": 644,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Breast ultrasound and biopsy",
                    "choiceNumber": 2,
                    "correctTaken": 4880,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Karyotype testing",
                    "choiceNumber": 3,
                    "correctTaken": 1529,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance",
                    "choiceNumber": 4,
                    "correctTaken": 703,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Testicular ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 8814,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "129,292,true,-1,1*674,934,true,-1,1*2403,2629,true,-1,1*1062,1387,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 152,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16570,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1990,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 3875,
            "questionIndex": 3875,
            "questionText": "<p>A 6-year-old girl is brought to the office for evaluation of breast and pubic hair development.&nbsp; Her parents noticed that she started developing breasts several months ago, and she recently started growing coarse axillary and pubic hair.&nbsp; The patient has had no changes in her behavior or school performance.&nbsp; She has no headaches, visual changes, vomiting, or vaginal bleeding.&nbsp; The patient has no chronic medical conditions and no previous surgery.&nbsp; She takes no daily medications and has no known allergies.&nbsp; BMI is at the 50th percentile for age.&nbsp; Physical examination reveals axillary hair; pubic hair is Tanner stage 3, and breasts are Tanner stage 3.&nbsp; The remainder of the examination is unremarkable.&nbsp; Bone age is consistent with age 8.&nbsp; Basal LH level is high.&nbsp; Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7168\" src=\"https://www.uworld.com/media/L17403.png\" ></p><p><strong>Central</strong> (gonadotropin-dependent) <strong>precocious puberty</strong> (PP) results from the premature activation of the hypothalamic-pituitary-gonadal (HPG) axis in girls age &lt;8 and boys age &lt;9.&nbsp; Early exposure to increased gonadal hormones results in <strong>breast development</strong> or testicular enlargement and axillary/pubic <strong>hair growth</strong> at a young age.&nbsp; High levels of androgens and estrogens also promote increased bone formation and cartilage growth, which leads to early pubertal growth spurts (increased height velocity) and <strong>advanced bone age</strong>.&nbsp; However, estrogen stimulates growth plate closure, so patients will often have shorter than expected adult height.</p><p>Central PP is distinguished from peripheral PP by an <strong>elevated LH</strong> level at baseline (due to hypothalamic secretion of GnRH) or following stimulation with a GnRH agonist.&nbsp; In contrast, elevated sex hormones in patients with peripheral PP suppress LH levels via negative feedback.</p><p>Although central PP is typically idiopathic, it can be the first manifestation of an intracranial process even in asymptomatic patients, as in this child.&nbsp; Central nervous system (CNS) lesions can cause PP through endogenous hormone production (eg, GnRH-secreting hypothalamic hamartoma, FSH- and LH-secreting pituitary adenomas) or by indirectly affecting the HPG axis due to mass effect or increased intracranial pressure (eg, craniopharyngioma).&nbsp; Patients with central PP require an <strong>MRI of the brain</strong> to evaluate for <strong>hypothalamic or pituitary tumor</strong>.</p><p>Medical and psychosocial consequences exist for PP as affected children appear different than their peers, and physical changes precede emotional maturity.&nbsp; Once a CNS tumor is excluded, the primary treatment for idiopathic central PP is <strong>GnRH agonist therapy</strong>, which prevents premature epiphyseal plate fusion and maximizes adult height potential.</p><p><strong>(Choices A and E)</strong>&nbsp; Adrenal CT scan or pelvic ultrasound evaluates for adrenal or gonadal tumors, respectively, which may cause peripheral PP.&nbsp; Patients with peripheral PP have low LH and FSH levels.</p><p><strong>(Choice B)</strong>&nbsp; Dexamethasone suppression test is used to diagnose Cushing syndrome.&nbsp; Patients may have signs of isolated adrenal androgen overproduction (eg, acne, hirsutism); there is no associated premature breast development.</p><p><strong>(Choice C)</strong>&nbsp; Karyotype analysis is not indicated in PP but is used for delayed puberty to detect chromosomal abnormalities such as Klinefelter syndrome (XXY) and Turner syndrome (XO).</p><p><strong>(Choice F)</strong>&nbsp; Reassurance can be provided in cases of isolated premature thelarche or adrenarche when bone age is normal.</p><p><strong>Educational objective:</strong><br>Central (gonadotropin-dependent) precocious puberty (PP) is characterized by premature breast and pubic/axillary hair development, advanced bone age, and an elevated LH level.&nbsp; Patients with central PP require an MRI of the brain to evaluate for a tumor prior to starting GnRH agonist therapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23716,
            "topic": "Precocious puberty",
            "titleId": 23716,
            "title": "Precocious puberty",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal CT scan",
                    "choiceNumber": 1,
                    "correctTaken": 1449,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dexamethasone suppression test",
                    "choiceNumber": 2,
                    "correctTaken": 1419,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Karyotype analysis",
                    "choiceNumber": 3,
                    "correctTaken": 545,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the brain",
                    "choiceNumber": 4,
                    "correctTaken": 9642,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic ultrasound",
                    "choiceNumber": 5,
                    "correctTaken": 2496,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance and follow-up in 6 months",
                    "choiceNumber": 6,
                    "correctTaken": 1097,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "358,668,true,-1,1*850,946,true,-1,1*1102,1395,true,-1,1*1655,1845,true,-1,1*2107,2270,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "100",
                    "mediaDataId": 0,
                    "title": "Precocious puberty",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21603196",
                    "mediaDataId": 0,
                    "title": "Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine disturbances.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21603196",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22253792",
                    "mediaDataId": 0,
                    "title": "Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22253792",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24014184",
                    "mediaDataId": 0,
                    "title": "Precocious puberty--perspectives on diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24014184",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 93,
            "othersAvgTimeSpent": 55,
            "notes": null,
            "peopleTaken": 16648,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1164,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 2176,
            "questionIndex": 2176,
            "questionText": "<p>A 40-year-old man comes to the office for follow-up of hypertension.&nbsp; He was diagnosed with mild hypertension 6 months ago and has had good control with regular exercise and weight loss.&nbsp; The patient feels well and takes no medications.&nbsp; He does not smoke and drinks a few glasses of wine per week.&nbsp; The patient&#39;s medical history is otherwise unremarkable.&nbsp; His mother has osteoporosis that is treated with oral alendronate.&nbsp; On examination, inspection and palpation of the neck show no masses.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"450\"><tbody><tr><td>Sodium</td><td>140 mEq/L</td></tr><tr><td>Potassium</td><td>4.0 mEq/L</td></tr><tr><td>Bicarbonate</td><td>25 mEq/L</td></tr><tr><td>Chloride</td><td>101 mEq/L</td></tr><tr><td>Calcium</td><td>11.8 mg/dL</td></tr><tr><td>Albumin</td><td>4.0 g/dL</td></tr><tr><td>Phosphorus</td><td>2.2 mg/dL</td></tr><tr><td>Creatinine</td><td>1.2 mg/dL</td></tr><tr><td>25-hydroxyvitamin D</td><td>38 ng/mL (normal: 25-80 ng/mL)</td></tr></tbody></table></blockquote><p>Serum parathyroid hormone level is 814 pg/mL.&nbsp; Further testing shows a high 24-hour urine calcium excretion of 325 mg.&nbsp; DXA scan reveals normal bone mineral density.&nbsp; Renal ultrasound shows multiple small (&lt;5 mm) stones in both kidneys.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t36200\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Primary hyperparathyroidism</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li><strong>Parathyroid adenoma</strong> (most common), hyperplasia,<br>carcinoma</li><li>Increased risk in MEN types 1 &amp; 2A</li></ul></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li><strong>Asymptomatic</strong> (most common)</li><li>Mild, nonspecific symptoms (eg, fatigue, constipation)</li><li>Abdominal pain, renal stones, bone pain, neuropsychiatric<br>symptoms</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnostic<br>findings</strong></p></td><td><ul><li><strong>Hypercalcemia</strong></li><li><strong>Elevated or inappropriately normal PTH</strong></li><li>Elevated 24-hour urinary calcium excretion</li></ul></td></tr><tr><td><p align=\"center\"><strong>Indications for<br>parathyroidectomy</strong></p></td><td><ul><li>Age &lt;50</li><li>Symptomatic hypercalcemia</li><li><strong>Complications: </strong>Osteoporosis (T-score &lt;&#8722;2.5, fragility<br>fracture), nephrolithiasis/calcinosis, CKD (GFR &lt;60 mL/min)</li><li><strong>Elevated risk of complications:</strong> Calcium <u>&gt;</u>1&nbsp;mg/dL above<br>normal, urinary calcium excretion &gt;400&nbsp;mg/day</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>CKD</strong> = chronic kidney disease; <strong>GFR </strong>= glomerular filtration rate;<strong> MEN</strong> = multiple<br>endocrine neoplasia; <strong>PTH</strong> = parathyroid hormone.</p></td></tr></tbody></table></div><p>This patient has <strong>hypercalcemia</strong>, hypophosphatemia, and an <strong>elevated parathyroid hormone</strong> (PTH) level consistent with <strong>primary hyperparathyroidism</strong> (PHPT).&nbsp; PTH causes increased reabsorption of calcium from the distal tubule, but net urinary calcium excretion is increased due to excess resorption of calcium from bones.&nbsp; By contrast, familial hypocalciuric hypercalcemia is characterized by hypercalcemia with an elevated PTH but low urinary calcium excretion (often &lt;100 mg/24 hr).</p><p><strong>Parathyroidectomy</strong> is recommended for patients with <strong>symptomatic hypercalcemia</strong>.&nbsp; It is also recommended for patients, such as this one, with <strong>complications</strong> (eg, osteoporosis, nephrocalcinosis, <strong>nephrolithiasis</strong>, impaired renal function) or at significant <strong>risk for complications</strong> (eg, serum calcium &#8805;1 mg/dL above normal, urinary calcium excretion &gt;400 mg/24 hr).&nbsp; In addition, younger patients (age &lt;50) such as this one are likely to have complications during their lifetime and should be offered surgery.</p><p>This patient is relatively young and has nephrolithiasis (likely as a complication of PHPT); he&nbsp;should therefore be referred for parathyroidectomy.&nbsp; Parathyroid imaging (eg, sestamibi scan, ultrasonography) helps optimize the surgical approach by potentially&nbsp;determining the affected side and evaluating for the possibility of a minimally invasive intervention.</p><p><strong>(Choice A)</strong>&nbsp; Parathyroidectomy is the treatment of choice for PHPT.&nbsp; However, bisphosphonate therapy can be used in patients who decline surgery and have osteopenia or osteoporosis.</p><p><strong>(Choice B)</strong>&nbsp; Extended CT imaging would be indicated for suspected hypercalcemia of malignancy, which typically presents with severe, symptomatic hypercalcemia, low PTH, and elevated PTH-related protein.&nbsp; Imaging to evaluate for multiple endocrine neoplasia syndromes is recommended only if there is evidence of multiglandular hyperparathyroidism or additional endocrine tumors.</p><p><strong>(Choice D)</strong>&nbsp; Continued observation is appropriate in older asymptomatic patients with near-normal calcium levels and normal bone density.</p><p><strong>(Choice E)</strong>&nbsp; Vitamin D supplementation is not recommended in patients with PHPT who do not have overt vitamin D deficiency as it may exacerbate hypercalcemia and hypercalciuria.&nbsp; This patient has a normal vitamin D level.</p><p><strong>Educational objective:</strong><br>The most common presentation of primary hyperparathyroidism is asymptomatic hypercalcemia with an elevated parathyroid hormone level.&nbsp; Parathyroidectomy is recommended for patients with symptomatic hypercalcemia and those with complications (eg, nephrolithiasis) or at increased risk for complications.&nbsp; Younger patients (age &lt;50) are likely to have complications during their lifetime and should be offered surgery.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 14203,
            "topic": "Hyperparathyroidism",
            "titleId": 14203,
            "title": "Hyperparathyroidism",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Initiate bisphosphonate therapy",
                    "choiceNumber": 1,
                    "correctTaken": 1188,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain CT scan of the chest, abdomen, and pelvis",
                    "choiceNumber": 2,
                    "correctTaken": 3492,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer for parathyroid imaging and parathyroidectomy",
                    "choiceNumber": 3,
                    "correctTaken": 12757,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Repeat serum calcium measurement in 3-6 months",
                    "choiceNumber": 4,
                    "correctTaken": 835,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start vitamin D supplementation",
                    "choiceNumber": 5,
                    "correctTaken": 296,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1971,2183,true,-1,1*1412,1822,true,-1,1*2262,2365,true,-1,1*2568,2742,true,-1,1*468,716,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "490",
                    "mediaDataId": 0,
                    "title": "Parathyroid disorders: hyperparathyroidism and hypoparathyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19193908",
                    "mediaDataId": 0,
                    "title": "Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19193908",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20844661",
                    "mediaDataId": 0,
                    "title": "Sestamibi (99mTc) scan as a single localization modality in primary hyperparathyroidism and factors impacting its accuracy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20844661",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20890202",
                    "mediaDataId": 0,
                    "title": "Primary hyperparathyroidism: an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20890202",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 193,
            "othersAvgTimeSpent": 85,
            "notes": null,
            "peopleTaken": 18568,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1289,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 4220,
            "questionIndex": 4220,
            "questionText": "<p>A 29-year-old nulligravid woman comes to the office because she has not menstruated since stopping her birth control.&nbsp; Menarche was at age 14, and she had irregular, heavy menstrual periods from age 14-16.&nbsp; The patient then took combination oral contraceptives until 6 months ago.&nbsp; Since stopping her medication, she has had more frequent headaches and increasing acne but has had no weight changes, pelvic pain, or abnormal hair loss or growth.&nbsp; The patient is a high school teacher and coaches the cross-country and track teams.&nbsp; She runs recreationally and eats a well-balanced diet.&nbsp; She does not use tobacco, alcohol, or illicit drugs.&nbsp; Vital signs are normal and BMI is 22 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; A few open comedones are seen on the forehead.&nbsp; The remainder of the physical examination, including pelvic examination, is normal.&nbsp; Urine pregnancy test is negative and pelvic ultrasound is normal.&nbsp; Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"15463\" src=\"https://www.uworld.com/media/U2542.png\"  ></p><p>This patient has <strong>secondary amenorrhea</strong>, defined as amenorrhea for &#8805;3 months in women with previously regular menses (or &#8805;6 months in women with previously irregular menses).&nbsp; Most women have return of spontaneous menses within 1-3 months after cessation of oral contraceptives; those who do not have a return of menses (as with this patient) require further evaluation <strong>(Choice C)</strong>.</p><p>The most common cause of secondary amenorrhea is pregnancy, followed by <strong>hypothalamic-pituitary-ovarian (HPO) axis dysfunction</strong> (eg, functional hypothalamic amenorrhea, primary ovarian insufficiency) and <strong>endocrine abnormalities</strong> that affect the HPO axis (eg, pituitary or thyroid dysfunction).&nbsp; Therefore, initial evaluation is with a pregnancy test followed by serum <strong>FSH, TSH, and prolactin levels</strong>, which help differentiate between the causes of secondary amenorrhea.&nbsp; The results of this initial testing determine the next steps in evaluation (eg, karyotype analysis, imaging).</p><p><strong>(Choice A)</strong>&nbsp; Karyotype analysis is performed in patients with primary ovarian insufficiency (POI), as POI is associated with chromosomal abnormalities (eg, Turner syndrome, fragile X syndrome).&nbsp; However, the diagnosis of POI is made with an elevated FSH level (to postmenopausal levels) in women age &lt;40 who have oligo- or amenorrhea.</p><p><strong>(Choice B)</strong>&nbsp; Prolactinomas can cause secondary amenorrhea and frequent headaches (as in this patient).&nbsp; However, an MRI of the pituitary is performed after patients are found to have elevated prolactin levels.&nbsp; In addition, this patient&#39;s headache is nonspecific and could be related to estrogen fluctuations after discontinuation of her oral contraceptives.</p><p><strong>(Choice D)</strong>&nbsp; Serum 17-hydroxyprogesterone is elevated in nonclassic (adult-onset)&nbsp;congenital adrenal hyperplasia (21-hydroxylase deficiency), which can cause abnormal uterine bleeding and hyperandrogenism (eg, severe acne, hirsutism).&nbsp; Although this patient has acne, it is likely due to the cessation of hormonal contraception, which typically worsens acne (due to the anti-androgenic properties of contraceptives).&nbsp; In addition, this patient&#39;s acne is mild and likely represents a normal variant.</p><p><strong>Educational objective:</strong><br>Secondary amenorrhea is amenorrhea for &#8805;3 months in women with previously regular menses (or &#8805;6 months in women with previously irregular menses).&nbsp; Initial evaluation includes a pregnancy test, followed by serum prolactin, TSH, and FSH level testing.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 103,
            "subject": "Obstetrics & Gynecology",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23429,
            "topic": "Amenorrhea",
            "titleId": 23429,
            "title": "Amenorrhea",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "5",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Karyotype analysis",
                    "choiceNumber": 1,
                    "correctTaken": 17,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the pituitary",
                    "choiceNumber": 2,
                    "correctTaken": 267,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No further evaluation indicated",
                    "choiceNumber": 3,
                    "correctTaken": 1403,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum 17-hydroxyprogesterone level",
                    "choiceNumber": 4,
                    "correctTaken": 689,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum prolactin and TSH levels",
                    "choiceNumber": 5,
                    "correctTaken": 2555,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "32,203,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "700",
                    "mediaDataId": 0,
                    "title": "Evaluation of secondary amenorrhea",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23588065",
                    "mediaDataId": 0,
                    "title": "Using an algorithmic approach to secondary amenorrhea:  avoiding diagnostic error.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23588065",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23939500",
                    "mediaDataId": 0,
                    "title": "Amenorrhea:  an approach to diagnosis and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23939500",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25581597",
                    "mediaDataId": 0,
                    "title": "Neuroendocrine causes of amenorrheaan update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25581597",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 213,
            "othersAvgTimeSpent": 92,
            "notes": null,
            "peopleTaken": 5011,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1069,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 12390,
            "questionIndex": 13626,
            "questionText": "<p>A 5-year-old girl is brought to the office for evaluation of pubic hair.&nbsp; Her mother first noticed dark hair in the genital area while helping her daughter bathe several weeks ago.&nbsp; The patient has also developed axillary hair and adult-type body odor over the last 2 weeks.&nbsp; She has no known medical conditions and takes no daily medications.&nbsp; She started kindergarten 3 months ago.&nbsp; The girl&#39;s mother underwent menarche at age 12.&nbsp; Weight is at the 75th percentile, height is at the 90th percentile, and BMI is at the 25th percentile.&nbsp; Fundoscopic examination and pupillary reaction are normal bilaterally.&nbsp; Cardiopulmonary examination is normal.&nbsp; The abdomen is soft and nontender; no masses are palpable.&nbsp; Breasts are prepubertal.&nbsp; Sparse, dark, coarse hair is noted in both axillae and over the mons pubis and labia majora.&nbsp; There is no clitoromegaly.&nbsp; Mild comedonal acne is present on the forehead, nose, and chin.&nbsp; Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7168\" src=\"https://www.uworld.com/media/L17403.png\" ></p><p>This child has <strong>precocious puberty</strong>, the premature development of secondary sexual characteristics in <strong>girls age &lt;8</strong> or in <strong>boys age &lt;9</strong>.&nbsp; Secondary sexual characteristics include breast tissue (stimulated by estrogens), as well as acne, adult-type body odor, and pubic and axillary hair (stimulated by androgens).&nbsp; By history and examination, the patient in this vignette has signs of excess androgens (ie, acne, body odor, axillary and pubic hair) but normal estrogen levels (no evidence of breast development).</p><p><strong>Initial management</strong> typically includes a <strong>bone age</strong> evaluation, which is a radiographic assessment of the hand and wrist to assess <strong>skeletal maturation</strong>.&nbsp; Normal ossification of bone occurs in a predictable, age-specific sequence.&nbsp; This ossification can be affected by genetics and nutrition in addition to pathologic hormonal causes (eg, excessive estrogen).&nbsp; For example, premature elevated estrogen in cases of precocious puberty can lead to premature epiphyseal fusion and, in turn, an advanced bone age compared to chronologic age.&nbsp; Conversely, if a patient&#39;s bone age correlates with chronologic age, the clinical findings are often attributed to a benign pubertal variant.</p><p><strong>(Choice B)</strong>&nbsp; Karyotype analysis, which identifies chromosomal abnormalities, is not routinely performed in the evaluation of precocious puberty.&nbsp; Karyotyping is most useful postnatally when a specific chromosomal disorder is suspected (eg, Klinefelter syndrome, Turner syndrome).</p><p><strong>(Choice C)</strong>&nbsp; An abdominal or pelvic ultrasound may be indicated in the evaluation of precocious puberty if there is concern for a peripheral production of endogenous hormones (eg, ovarian or adrenal tumor).&nbsp; Supportive findings would include an advanced bone age with suppressed LH and FSH levels.&nbsp; This patient&#39;s presentation first warrants a bone age evaluation.</p><p><strong>(Choice D)</strong>&nbsp; Prolactinomas are typically benign pituitary tumors that produce elevated prolactin levels causing secondary amenorrhea and/or galactorrhea.&nbsp; An elevated prolactin level does not cause precocious puberty.</p><p><strong>(Choice E)</strong>&nbsp; Rarely, chronic hypothyroidism can present with precocious puberty in addition to classic signs of hypothyroidism (eg, constipation, short stature).&nbsp; TSH is thought to inappropriately activate the FSH receptor.&nbsp; However, the increased estrogens produce breast development or vaginal bleeding, which this patient does not have.</p><p><strong>Educational objective:</strong><br>Precocious puberty is the onset of secondary sexual characteristics before age 8 in girls and age 9 in boys.&nbsp; Initial evaluation includes obtaining a bone age evaluation to assess skeletal maturation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23716,
            "topic": "Precocious puberty",
            "titleId": 23716,
            "title": "Precocious puberty",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "1",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone age evaluation",
                    "choiceNumber": 1,
                    "correctTaken": 11628,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Karyotype analysis",
                    "choiceNumber": 2,
                    "correctTaken": 668,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pelvic ultrasound",
                    "choiceNumber": 3,
                    "correctTaken": 3105,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum prolactin level",
                    "choiceNumber": 4,
                    "correctTaken": 648,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum TSH level",
                    "choiceNumber": 5,
                    "correctTaken": 657,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "908,1214,true,-1,1*2236,2413,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "100",
                    "mediaDataId": 0,
                    "title": "Precocious puberty",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29323690",
                    "mediaDataId": 0,
                    "title": "Premature adrenarche.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29323690",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 113,
            "othersAvgTimeSpent": 47,
            "notes": null,
            "peopleTaken": 16706,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 964,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 17118,
            "questionIndex": 18569,
            "questionText": "<p>A 43-year-old woman comes to the emergency department due to nausea, dizziness, and headache for a day.&nbsp; Her menses began 2 days ago.&nbsp; She has occasionally had fatigue and dizziness during her menstrual periods, but today&#39;s symptoms feel different.&nbsp; The patient has a history of von Willebrand disease, causing recurrent, heavy menstrual blood loss, and is scheduled for an endometrial ablation procedure.&nbsp; Her only medication is intranasal desmopressin taken on the first 3 days of her menstrual period.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 120/80 mm Hg, pulse is 92/min and regular, and respirations are 18/min.&nbsp; The patient appears restless.&nbsp; Mucous membranes are moist.&nbsp; Deep tendon reflexes are 2+ throughout and Babinski sign is absent.&nbsp; Sensory examination shows no focal deficits.&nbsp; The chest is clear to auscultation.&nbsp; The abdomen is soft and nontender.&nbsp; There is no peripheral edema.&nbsp; The remainder of the examination is unremarkable.&nbsp; Which of the following is the most appropriate next step in diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t34700\"><table class=\"table-default-style table-header-footer-style\" style=\"width:594px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Syndrome of inappropriate antidiuretic hormone</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiologies</strong></p></td><td><ul><li>CNS disturbance (eg,&nbsp;stroke, hemorrhage, trauma)</li><li>Medications (eg,&nbsp;carbamazepine, SSRIs, NSAIDs)</li><li>Lung disease (eg,&nbsp;pneumonia)</li><li>Ectopic ADH secretion (eg,&nbsp;small cell lung cancer)</li><li>Pain &amp;/or nausea</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>Mild/moderate hyponatremia: nausea, forgetfulness</li><li>Severe hyponatremia: seizures, coma</li><li>Euvolemia (eg,&nbsp;moist mucous membranes, no edema, no JVD)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br>findings</strong></p></td><td><ul><li>Hyponatremia</li><li>Serum osmolality &lt;275&nbsp;mOsm/kg&nbsp;H<sub>2</sub>O (hypotonic)</li><li>Urine osmolality &gt;100&nbsp;mOsm/kg&nbsp;H<sub>2</sub>O</li><li>Urine sodium &gt;40&nbsp;mEq/L</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Fluid restriction&nbsp;&plusmn; salt tablets</li><li>Hypertonic&nbsp;(3%) saline for severe hyponatremia</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>ADH</strong>&nbsp;=&nbsp;antidiuretic hormone; <strong>JVD</strong>&nbsp;=&nbsp;jugular venous distension; <strong>NSAIDs</strong>&nbsp;=&nbsp;nonsteroidal anti-inflammatory drugs; <strong>SSRIs</strong>&nbsp;=&nbsp;selective serotonin reuptake inhibitors.</p></td></tr></tbody></table></div><p>This patient&#39;s acute nausea is&nbsp;likely due to <strong>hyponatremia</strong> induced by recent use of intranasal <strong>desmopressin</strong>.&nbsp; Desmopressin is an analogue of <strong>antidiuretic hormone</strong> (ADH) commonly used to treat central diabetes insipidus; it also promotes the release of von Willebrand factor, and can treat mild to moderately heavy menstrual bleeding associated with von Willebrand disease.&nbsp; However, since desmopressin induces physiologic effects of ADH (eg, renal water reabsorption, concentration of urine), it can cause hyponatremia and excess ADH stimulation, manifesting as <strong>syndrome of inappropriate ADH secretion (SIADH)</strong>.&nbsp; Therefore<strong>, serum electrolytes</strong> should be obtained first in this patient to check for hyponatremia and rule in the diagnosis of SIADH.</p><p>Expected laboratory findings in patients with SIADH include <strong>hypotonic hyponatremia</strong> (due to ADH-mediated water retention and reabsorption), <strong>high urine osmolality</strong> (ie, concentrated urine), and <strong>high urine sodium</strong> (due to increased secretion of natriuretic peptides).&nbsp; As seen in this patient, SIADH is also associated with <strong>euvolemia</strong> (eg, absence of edema or jugular venous distension) on physical examination.&nbsp; At first, ADH-mediated water reabsorption slightly increases extracellular volume; however, increased natriuretic peptide secretion leads to sodium and water excretion, ultimately normalizing extracellular volume.</p><p><strong>(Choice A)</strong>&nbsp; Although hypoxemia (eg, from pulmonary embolism) may manifest with nausea, elevated heart rate, and dizziness, this patient has no risk factors for pulmonary disease or symptoms of respiratory distress (eg, shortness of breath, chest pain).&nbsp; Therefore, serum electrolytes are a better initial test.</p><p><strong>(Choice B)</strong>&nbsp; Although acute liver failure may cause excessive bleeding and present with nausea and dizziness, this patient lacks associated findings of jaundice and abdominal pain and has no risk factors (eg, infection, excess alcohol intake).</p><p><strong>(Choice C)</strong>&nbsp; MRI of the brain can be used to assess for CNS pathology (eg, bleeding, acute stroke) that could manifest with headache or dizziness.&nbsp; However, this patient lacks focal neurologic signs; therefore, a metabolic workup with serum electrolytes is a more appropriate initial test.</p><p><strong>(Choice D)</strong>&nbsp; Plasma desmopressin is not routinely measured.&nbsp; It may be high in this patient, given her recent medication use with the onset of menses, but serum electrolytes are a more rapid initial step for confirming hyponatremia and SIADH.</p><p><strong>Educational objective:</strong><br>The administration of desmopressin, an analogue of antidiuretic hormone (ADH), can induce the syndrome of inappropriate ADH secretion.&nbsp; Urinary water excretion is impaired, leading to hypotonic hyponatremia.&nbsp; Laboratory studies, including serum electrolytes, urine osmolality, and urine sodium, are the first step in establishing the diagnosis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 4691,
            "topic": "Hyponatremia",
            "titleId": 4691,
            "title": "Hyponatremia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arterial blood gas",
                    "choiceNumber": 1,
                    "correctTaken": 851,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Liver function studies",
                    "choiceNumber": 2,
                    "correctTaken": 425,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI of the brain",
                    "choiceNumber": 3,
                    "correctTaken": 1354,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma desmopressin level",
                    "choiceNumber": 4,
                    "correctTaken": 4175,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum electrolytes",
                    "choiceNumber": 5,
                    "correctTaken": 10490,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "491,520,true,-1,1*555,577,true,-1,1*933,948,true,-1,1*1047,1196,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "557",
                    "mediaDataId": 0,
                    "title": "Hyponatremia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "8700794",
                    "mediaDataId": 0,
                    "title": "Intranasal desmopressin-induced hyponatremia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/8700794",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31634354",
                    "mediaDataId": 0,
                    "title": "Desmopressin and the risk of hyponatremia: a population-based cohort study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31634354",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 133,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 17295,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1180,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 4309,
            "questionIndex": 4309,
            "questionText": "<p>A 17-year-old boy is brought to the emergency department following a motor vehicle accident.&nbsp; He is found to have an extensive cerebral hemorrhage leading to deep coma, as well as fractures of the C4 vertebra, pelvis, and right femur.&nbsp; Following admission to the hospital, he is intubated and central lines are placed.&nbsp; The patient develops acute renal failure due to rhabdomyolysis, which improves rapidly with treatment.&nbsp; He is extubated after regaining consciousness.&nbsp; He also undergoes percutaneous endoscopic gastrostomy tube placement due to persistent problems with swallowing.&nbsp; The patient is unable to ambulate due to quadriparesis resulting from cervical cord injury.&nbsp; Four weeks after his initial injury, he develops nausea and polyuria.&nbsp; His laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr><td>Calcium</td><td>12.1 mg/dL</td></tr><tr><td>Albumin</td><td>3.0 g/dL</td></tr><tr><td>Creatinine</td><td>1.4 mg/dL</td></tr><tr><td>Phosphorus</td><td>3.1 mg/dL</td></tr><tr><td>Glucose</td><td>108 mg/dL</td></tr><tr><td>Parathyroid hormone</td><td>9 pg/mL</td></tr><tr><td>Parathyroid hormone-related protein</td><td>undetectable</td></tr><tr><td>1,25-dihydroxyvitamin D</td><td>19 pg/mL (normal: 20-60 pg/mL)</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s hypercalcemia?</p>",
            "questionHeader": "",
            "explanationText": "<p><img id=\"286\"  src=\"https://www.uworld.com/media/L7026.png\" draggable=\"false\" ></p><p>This patient with quadriparesis has a corrected calcium level of 12.9 mg/dL:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td align=\"center\"><p>corrected calcium = measured calcium + 0.8 &times; (4 &ndash; albumin)</p></td></tr><tr><td align=\"center\"><p>12.1 + 0.8 &times; (4 &ndash; 3) = 12.1 + 0.8 = 12.9 mg/dL</p></td></tr></tbody></table></blockquote><p>with symptomatic <strong>hypercalcemia</strong> (nausea, polyuria) and <strong>suppressed parathyroid hormone (PTH)</strong> level likely due to <strong>immobilization</strong>.&nbsp; Hypercalcemia of immobilization is likely due to increased <strong>osteoclastic bone resorption</strong>.&nbsp; The risk is increased in patients with a pre-existing high rate of bone turnover (eg, younger individuals, Paget disease).&nbsp; The onset of hypercalcemia is usually around 4 weeks after immobilization, although patients with chronic renal insufficiency may develop hypercalcemia in as little as 3 days.</p><p>The onset of hypercalcemia due to immobilization is often insidious, and the presenting symptoms can be nonspecific.&nbsp; <strong>Bisphosphonates</strong> inhibit osteoclastic bone resorption and are effective in treating hypercalcemia of immobilization and reducing the associated bone loss.</p><p><strong>(Choice A)</strong>&nbsp; Approximately 40% of circulating calcium is bound to proteins (predominantly albumin).&nbsp; Hypoalbuminemia will lower the total serum calcium level; therefore, measured calcium levels are corrected upward based on the extent of hypoalbuminemia.&nbsp; Conversely, hyperalbuminemia is associated with an increase in total calcium.&nbsp; In either case, the ionized fraction is unaffected, and patients will not have calcium-related symptoms directly related to the change in albumin levels.</p><p><strong>(Choices C and F)</strong>&nbsp; Hypercalcemia in malignancy can be due to osteolytic metastasis, secretion of PTH-related protein (PTHrP), or increased formation of 1,25-dihydroxyvitamin D.&nbsp; This patient&#39;s PTHrP and 1,25-dihydroxyvitamin D levels are low.</p><p><strong>(Choice D)</strong>&nbsp; This patient&#39;s PTH level is suppressed, which makes primary hyperparathyroidism unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Acute rhabdomyolysis causes hypocalcemia due to precipitation of calcium and phosphorus in damaged muscles.&nbsp; Hypercalcemia can occur due to remobilization of calcium during the diuretic/recovery phase of the illness, often with concurrent hyperphosphatemia.&nbsp; However, this patient recovered from rhabdomyolysis several weeks before the onset of hypercalcemia.</p><p><strong>Educational objective:</strong><br>Hypercalcemia can occur in prolonged immobilization due to increased osteoclastic activity, especially in individuals with a high baseline rate of bone turnover.&nbsp; Bisphosphonates can reduce this hypercalcemia and prevent bone loss.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2698,
            "topic": "Hypercalcemia",
            "titleId": 2698,
            "title": "Hypercalcemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Hypoalbuminemia",
                    "choiceNumber": 1,
                    "correctTaken": 3627,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Immobilization",
                    "choiceNumber": 2,
                    "correctTaken": 8792,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Malignancy",
                    "choiceNumber": 3,
                    "correctTaken": 161,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperparathyroidism",
                    "choiceNumber": 4,
                    "correctTaken": 512,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rhabdomyolysis",
                    "choiceNumber": 5,
                    "correctTaken": 3201,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin D-induced hypercalcemia",
                    "choiceNumber": 6,
                    "correctTaken": 432,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "432,732,true,-1,1*849,1004,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27252745",
                    "mediaDataId": 0,
                    "title": "Immobilization induced hypercalcemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27252745",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 162,
            "othersAvgTimeSpent": 91,
            "notes": null,
            "peopleTaken": 16725,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 53,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1578,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 20933,
            "questionIndex": 22436,
            "questionText": "<p>A 52-year-old woman comes to the office for a routine follow-up.&nbsp; The patient takes hormone replacement therapy for menopausal vasomotor symptoms.&nbsp; Her hormone dosage was increased a year ago after she began taking carbamazepine for trigeminal neuralgia.&nbsp; She adheres to both treatments and reports no symptoms at present.&nbsp; The patient drinks a glass of wine 2 or 3 times a week and does not use tobacco or recreational drugs.&nbsp; She works as a tour boat operator and spends most of her time outdoors.&nbsp; The patient consumes a balanced diet but does not exercise regularly.&nbsp; Family history is significant for osteoporosis in her mother.&nbsp; Vital signs are within normal limits.&nbsp; BMI is 26 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows no abnormalities.&nbsp; Laboratory results show a decreased serum 25-hydroxyvitamin D level.&nbsp; Which of the following is the greatest risk factor contributing to this patient&#39;s vitamin deficiency?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T76656\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Causes of vitamin D deficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Inadequate intake</strong></p></td><td><ul><li>Lactose intolerance or milk avoidance</li><li>Vegan diet (without fortification)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Malabsorption</strong></p></td><td><ul><li>Crohn disease</li><li>Celiac disease</li><li>Bariatric surgery (eg, gastric bypass), gastrectomy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Inadequate sunlight exposure</strong></p></td><td><ul><li>Extreme northern/southern latitudes</li><li>Heavy skin pigmentation</li><li>Sedentary/indoor lifestyle</li></ul></td></tr><tr><td><p align=\"center\"><strong>Metabolic disorders</strong></p></td><td><ul><li>Chronic kidney disease</li><li>Chronic liver disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Increased catabolism</strong></p></td><td><ul><li>Drugs: anticonvulsants (eg, phenytoin, carbamazepine),<br>isoniazid, rifampin</li></ul></td></tr></tbody></table></div><p>This patient has <strong>vitamin D deficiency</strong>, confirmed with a low serum 25-hydroxyvitamin D level.&nbsp; However, she has no classic risk factors for dietary deficiency (eg, restricted diet, malabsorption) or inadequate dermal vitamin D production (eg, nursing home residence).</p><p>Patients with adequate sources of vitamin D can develop deficiency due to excessive catabolism.&nbsp; <strong>Catabolism of vitamin D</strong> is initiated by <strong>CYP24A1</strong> (also called 24-hydroxylase), which acts on both the 25- and 1,25- hydroxylated vitamin D forms, converting them to inactive forms.&nbsp; <strong>Carbamazepine</strong> and other anticonvulsants (eg, phenytoin) <strong>induce expression</strong> of this enzyme, which can lead to increased breakdown of vitamin D and vitamin D deficiency.</p><p><strong>(Choice A)</strong>&nbsp; Heavy alcohol use with secondary liver or pancreatic disease can lead to deficiency of fat-soluble vitamins (eg, A, D, E, K).&nbsp; However, light alcohol intake, as in this patient, does not cause hepatic or pancreatic dysfunction and is not associated with any significant nutritional deficiencies.</p><p><strong>(Choice C)</strong>&nbsp; The etiology of osteoporosis in most patients is multifactorial; major contributing factors include age, female sex (and menopausal status), body habitus, and lifestyle factors (eg, diet, smoking).&nbsp; Genetic factors are important but usually lesser contributors, and inherited vitamin D disorders are rare.</p><p><strong>(Choice D)</strong>&nbsp; Most (~85%) of vitamin D in circulation is bound to vitamin D&ndash;binding protein (DBP), providing a large pool of vitamin D that is largely resistant to degradation.&nbsp; Supplemental estrogen (eg, oral contraceptives, menopausal replacement) can increase synthesis of DBP, leading to a higher (not lower) measured vitamin D level.</p><p><strong>(Choice E)</strong>&nbsp; Regular exercise promotes bone density maximization during childhood and slows bone density loss during adulthood.&nbsp; Lack of regular exercise can increase the risk for osteoporosis but has little effect on vitamin D levels.&nbsp; Although patients who do not exercise regularly also may spend little time outdoors, contributing to vitamin D deficiency (due to inadequate sunlight exposure), this patient has an outdoor occupation.</p><p><strong>Educational objective:</strong><br>Patients with adequate dietary and dermal sources of vitamin D can develop deficiency due to increased catabolism of vitamin D.&nbsp; Commonly used anticonvulsants (eg, carbamazepine, phenytoin) can induce CYP24A1, which catabolizes vitamin D to inactive forms, leading to vitamin D deficiency.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11552,
            "topic": "Vitamin D deficiency",
            "titleId": 11552,
            "title": "Vitamin D deficiency",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Alcohol consumption",
                    "choiceNumber": 1,
                    "correctTaken": 1329,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carbamazepine therapy",
                    "choiceNumber": 2,
                    "correctTaken": 6959,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Family history of osteoporosis",
                    "choiceNumber": 3,
                    "correctTaken": 3063,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hormone replacement therapy",
                    "choiceNumber": 4,
                    "correctTaken": 3569,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lack of regular exercise",
                    "choiceNumber": 5,
                    "correctTaken": 2633,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2037,2198,true,-1,1*455,523,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "575",
                    "mediaDataId": 0,
                    "title": "Vitamin deficiencies and toxicities",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30514991",
                    "mediaDataId": 0,
                    "title": "Effect of long-term carbamazepine therapy on bone health.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30514991",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 176,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 17553,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 40,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 806,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 3595,
            "questionIndex": 3595,
            "questionText": "<p>A 65-year-old man comes to the office with a 1-year history of erectile dysfunction and decreased libido.&nbsp; He has hypertension that was diagnosed 5 years ago and is controlled with amlodipine.&nbsp; The patient has no history of cardiac problems, unexpected weight loss, visual changes, or symptoms of neuropathy.&nbsp; Family history is unremarkable.&nbsp; On examination, there is minimal bilateral gynecomastia without galactorrhea.&nbsp; Genitourinary examination shows decreased testicular size.&nbsp; The remainder of the physical examination, including visual fields on confrontation, is unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"padding-left: 2em;\">Creatinine</td><td style=\"vertical-align:middle;\">1.1 mg/dL</td></tr><tr><td style=\"padding-left: 2em;\">Alanine aminotransferase (SGPT)</td><td style=\"vertical-align:middle;\">21 U/L</td></tr><tr><td colspan=\"2\">Endocrine</td></tr><tr><td style=\"padding-left: 2em;\">Hemoglobin A1c</td><td style=\"vertical-align:middle;\">5.8%</td></tr><tr><td style=\"padding-left: 2em;\">FSH, serum</td><td style=\"vertical-align:middle;\">4 mIU/mL (normal: 4-25)</td></tr><tr><td style=\"padding-left: 2em;\">LH, serum</td><td style=\"vertical-align:middle;\">5 mIU/mL (normal: 6-23)</td></tr><tr><td style=\"padding-left: 2em;\">Testosterone, serum</td><td style=\"vertical-align:middle;\">174 ng/dL (normal: 300-800)</td></tr><tr><td style=\"padding-left: 2em;\">TSH</td><td style=\"vertical-align:middle;\">1.3 &micro;U/mL</td></tr></tbody></table><p>Repeat early-morning testosterone level is 162 ng/dL.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T81598\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Male hypogonadism</strong></p></td></tr><tr><td style=\"width: 20%;\"></td><td style=\"width: 40%;\"><p align=\"center\"><strong>Primary</strong></p><p align=\"center\"><strong>(testicular disease)</strong></p></td><td style=\"width: 40%;\"><p align=\"center\"><strong>Secondary</strong></p><p align=\"center\"><strong>(pituitary/hypothalamic disease)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Findings</strong></p></td><td><ul><li>&#8595; Energy/libido, &#8595; body hair</li><li>Gynecomastia more likely</li><li>&#8593; LH/FSH</li><li>&#8595;&#8595; Testosterone/sperm count</li></ul></td><td><ul><li>&#8595; Energy/libido, &#8595; body hair</li><li>Gynecomastia less likely</li><li>&#8595; Normal LH/FSH</li><li>&#8595; Testosterone/sperm count</li></ul></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Congenital<ul style=\"list-style-type:circle;\"><li>Klinefelter syndrome</li><li>Varicocele</li></ul></li><li>Acquired<ul style=\"list-style-type:circle;\"><li>Radiation</li><li>Infection (eg, mumps)</li><li>Trauma</li><li>Medications (eg, alkylating agents, glucocorticoids)</li><li>Chronic disease</li></ul></li></ul></td><td><ul><li>Congenital<ul style=\"list-style-type:circle;\"><li>Kallman syndrome</li></ul></li><li>Gonadotropin suppression<ul style=\"list-style-type:circle;\"><li>Hyperprolactinemia</li><li>Glucocorticoids/opiates</li></ul></li><li>Gonadotroph cell damage<ul style=\"list-style-type:circle;\"><li>Benign/malignant tumors</li><li>Pituitary apoplexy</li><li>Infiltration (eg, hemochromatosis)</li><li>Systemic disease</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Karyotype</li><li>Others based on clinical suspicion</li></ul></td><td><ul><li>Prolactin</li><li>Transferrin</li><li>&plusmn; MRI</li></ul></td></tr></tbody></table></div><p>This patient has gynecomastia and testicular atrophy.&nbsp; His laboratory results show low testosterone levels and inappropriately low/normal gonadotropin (ie, LH, FSH) levels, indicating <strong>secondary (central) hypogonadism</strong>.&nbsp; Low levels of testosterone normally increase LH and FSH levels due to loss of feedback inhibition; therefore, low or even normal LH and FSH levels suggest an inappropriate hypothalamic-pituitary response (in contrast, primary hypogonadism is usually associated with overtly elevated gonadotropin levels).</p><p>Causes of secondary hypogonadism include:</p><ul><li>Mass lesions in the hypothalamus or pituitary (eg, prolactinomas), severe systemic illness: due to gonadotroph cell damage</li><li>Hyperprolactinemia, long-term use of glucocorticoids or opiates: due to <a href=\"6154\">suppression of gonadotropin-releasing hormone</a></li></ul><p>Secondary hypogonadism is also more common in individuals with obesity or type 2 diabetes mellitus.</p><p>Patients with secondary hypogonadism should have measurement of <strong>serum prolactin </strong>(as well as screening for other pituitary hormone deficiencies, such as TSH).&nbsp; In men with prolactinoma, gynecomastia (only present in ~1/3 of patients)&nbsp;is generally mild, and galactorrhea is uncommon because enough estrogen (primarily derived from androgens) is needed for this process to occur (galactorrhea is more common in women with prolactinoma); visual field defects are present only when the prolactinoma impinges on the optic chiasm.&nbsp; Therefore,&nbsp;<strong>p</strong><strong>ituitary imaging</strong> with MRI is indicated for patients with elevated prolactin, mass-effect symptoms (eg, visual field defects), very low (&lt;150 ng/dL) testosterone levels, or disruptions in other pituitary hormones.</p><p><strong>(Choice A)</strong>&nbsp; Although some antihypertensive medications (eg, beta blockers) can cause fatigue and erectile dysfunction, they usually do not cause low testosterone levels.&nbsp; Sexual dysfunction is uncommon with calcium channel blockers (eg, amlodipine).</p><p><strong>(Choice C)</strong>&nbsp; Hemochromatosis (ie, elevated transferrin&nbsp;saturation) in men is typically apparent at age &lt;50 and should be suspected when hypogonadism is associated with abnormal skin pigmentation, diabetes mellitus, elevated liver enzymes, and arthropathy.&nbsp; It is unlikely that this patient has hemochromatosis considering the absence of a positive family history, his age at presentation, and the lack of other clinical features.</p><p><strong>(Choice D)</strong>&nbsp; Phosphodiesterase type 5 inhibitors (eg, sildenafil) are useful in patients with erectile dysfunction due to a variety of causes.&nbsp; However, symptomatic treatment may not be needed if a correctable cause is found.</p><p><strong>(Choice E)</strong>&nbsp; Testosterone therapy may be required if serum prolactin and MRI of the pituitary are normal.&nbsp; Dopaminergic agonists are the preferred therapy for prolactinoma.</p><p><strong>Educational objective:</strong><br>Secondary hypogonadism can be due to mass lesions in the hypothalamus or pituitary, hyperprolactinemia, long-term use of glucocorticoids or opiates, or severe systemic illness.&nbsp; Patients should have measurement of serum prolactin and screening for other pituitary hormone deficiencies.&nbsp; Pituitary imaging is indicated for patients with elevated prolactin, mass-effect symptoms, very low testosterone levels, or disruptions in other pituitary hormones.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 4600,
            "topic": "Male sexual dysfunction",
            "titleId": 4600,
            "title": "Male sexual dysfunction",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinue amlodipine",
                    "choiceNumber": 1,
                    "correctTaken": 506,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measure serum prolactin level",
                    "choiceNumber": 2,
                    "correctTaken": 10110,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Measure transferrin saturation",
                    "choiceNumber": 3,
                    "correctTaken": 466,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe sildenafil treatment",
                    "choiceNumber": 4,
                    "correctTaken": 774,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe testosterone therapy",
                    "choiceNumber": 5,
                    "correctTaken": 4176,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "159,183,true,-1,1*250,274,true,-1,1*416,484,true,-1,1*496,512,true,-1,1*557,580,true,-1,1*666,699,true,-1,1*1473,1590,true,-1,1*1591,1690,true,-1,1*1848,2123,true,-1,1*2354,2395,true,-1,1*3643,3715,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "481",
                    "mediaDataId": 0,
                    "title": "Sexual dysfunction",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21896895",
                    "mediaDataId": 0,
                    "title": "Update: hypogonadotropic hypogonadism in type 2 diabetes and obesity.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21896895",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 133,
            "othersAvgTimeSpent": 74,
            "notes": null,
            "peopleTaken": 16032,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 3334,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 15792,
            "questionIndex": 17229,
            "questionText": "<p>A 30-year-old man comes to the office due to a 3-month history of progressive left breast enlargement.&nbsp; He has had no breast pain or nipple discharge.&nbsp; The patient has Klinefelter syndrome and takes testosterone replacement therapy.&nbsp; Vital signs are normal.&nbsp; BMI is 30 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows a 2.5-cm, nontender, firm subareolar mass on the left breast.&nbsp; The right breast is normal.&nbsp; The testes are atrophic, and body hair is sparse.&nbsp; Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T60538\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Male breast cancer</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Family history; <em>BRCA1</em> or <em>BRCA2</em> mutation</li><li>Abnormal estrogen/androgen ratio: Klinefelter syndrome, obesity, cirrhosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Subareolar mass</li><li>Skin &amp; nipple dimpling, induration, ulceration</li><li>Often detected at advanced stage</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Mammography</li><li>Biopsy: invasive ductal carcinoma (hormone receptor positive) most common</li></ul></td></tr></tbody></table></div><p>This patient has a firm, unilateral breast mass concerning for breast cancer.&nbsp; <strong>Klinefelter syndrome</strong> (47,XXY) is associated with testicular fibrosis and is a common cause of <strong>primary hypogonadism</strong>.&nbsp; Testosterone production is reduced, and the compensatory increase in gonadotropins causes increased expression of aromatase, leading to increased conversion of testosterone to estradiol and an <strong>elevated estrogen/androgen ratio</strong>.&nbsp; In the breast, this causes <strong>gynecomastia</strong> and an elevated risk of <strong>breast cancer</strong>.</p><p>Initial evaluation of suspected breast cancer in men is similar to that for women and includes <strong>breast imaging</strong> (eg, mammography).&nbsp; Characteristic features can distinguish benign gynecomastia from malignancy:</p><ul><li><p>Gynecomastia can have variable density but is typically symmetric and centrally located with respect to the nipple; it may have an indistinct margin with surrounding fat.</p></li><li><p>In breast cancer, the mass is more likely eccentric (ie, off center) to the nipple; it also is more likely to have well-defined or spiculated margins and may contain calcifications.</p></li></ul><p>The diagnosis can be confirmed with biopsy (eg, fine-needle aspiration, core-needle biopsy).&nbsp; Invasive ductal carcinoma is the most common histologic type, as it is in women, and most tumors are hormone receptor positive.</p><p><strong>(Choice A)</strong>&nbsp; Gonadotropin (ie, FSH, LH) levels are used to differentiate primary from secondary/central hypogonadism, and the levels are elevated in most patients with Klinefelter syndrome.&nbsp; Serum FSH and LH levels are not needed for this patient with an established diagnosis of Klinefelter syndrome.</p><p><strong>(Choice B)</strong>&nbsp; Androgen therapy can alleviate the symptoms of hypogonadism (eg, decreased libido) but has minimal benefit for established gynecomastia.&nbsp; Malignancy should be ruled out first in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Selective estrogen receptor modulators (eg, tamoxifen) are commonly used as adjuvant therapy for estrogen receptor&ndash;positive breast cancer and are occasionally used to treat symptoms of gynecomastia in adolescents with Klinefelter syndrome.&nbsp; However, initiating any therapy before the suspicious (eg, firm, unilateral) breast mass is evaluated with imaging is inappropriate.</p><p><strong>(Choice E)</strong>&nbsp; Weight loss can be helpful for patients with pseudogynecomastia due to excessive breast fat.&nbsp; However, this patient has a firm breast mass suspicious for cancer and requires additional evaluation.</p><p><strong>Educational objective:</strong><br>Klinefelter syndrome is a common cause of primary hypogonadism and is associated with an elevated estrogen/androgen ratio.&nbsp; This causes gynecomastia and increases the risk for breast cancer, which can present as a firm, unilateral breast mass.&nbsp; The initial evaluation of suspected breast cancer includes breast imaging (eg, mammography).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 18386,
            "topic": "Klinefelter syndrome",
            "titleId": 18386,
            "title": "Klinefelter syndrome",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Check serum FSH and LH levels",
                    "choiceNumber": 1,
                    "correctTaken": 2102,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase testosterone dose",
                    "choiceNumber": 2,
                    "correctTaken": 458,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain breast imaging",
                    "choiceNumber": 3,
                    "correctTaken": 11584,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe a selective estrogen receptor modulator",
                    "choiceNumber": 4,
                    "correctTaken": 895,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance and recommend weight loss",
                    "choiceNumber": 5,
                    "correctTaken": 2247,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "316,381,true,-1,1*102,176,true,-1,1*190,205,true,-1,1*509,529,true,-1,1*578,805,true,-1,1*806,884,true,-1,1*1447,1668,true,-1,1*1093,1446,true,-1,1*2186,2425,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "483",
                    "mediaDataId": 0,
                    "title": "Breast cancer",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29752333",
                    "mediaDataId": 0,
                    "title": "The endocrinology of male breast cancer.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29752333",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 113,
            "othersAvgTimeSpent": 38,
            "notes": null,
            "peopleTaken": 17286,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 67,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1926,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 2414,
            "questionIndex": 2414,
            "questionText": "<p>A 25-year-old woman comes to the office due to hair loss.&nbsp; For the past 6 months, she has noticed thinning hair on her head and an increased amount of hair in the shower drain.&nbsp; The patient is not currently sexually active but has had 5 lifetime partners.&nbsp; Menarche was at age 11.&nbsp; She has light periods every 35-50 days.&nbsp; She takes an over-the-counter sleep aid, but does not use tobacco, alcohol, or illicit drugs.&nbsp; The patient&#39;s mother is age 56 and has endometrial carcinoma; her paternal grandmother died from metastatic breast cancer diagnosed at age 72.&nbsp; Review of systems is negative except for extensive facial and back acne.&nbsp; BMI is 33 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows thinning hair at the forehead with a receding hairline.&nbsp; The thyroid is nonenlarged with no nodules.&nbsp; Cardiac examination shows a regular rate and rhythm; there are no murmurs.&nbsp; The abdomen is obese with no palpable masses.&nbsp; A urine pregnancy test is negative.&nbsp; Serum prolactin and thyroid function tests are normal.&nbsp; Which of the following additional tests is indicated in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33552\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polycystic ovary syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Androgen excess</strong> (eg,&nbsp;acne, male pattern baldness, hirsutism)</li><li>Oligoovulation or anovulation (eg,&nbsp;<strong>menstrual irregularities</strong>)</li><li>Obesity</li><li><strong>Polycystic ovaries</strong> on ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>&uarr;&nbsp;Testosterone levels</li><li>&uarr;&nbsp;Estrogen levels</li><li>LH/FSH imbalance</li></ul></td></tr><tr><td><p align=\"center\"><strong>Comorbidities</strong></p></td><td><ul><li>Metabolic syndrome (eg,&nbsp;diabetes mellitus, hypertension)</li><li>Obstructive sleep apnea</li><li>Metabolic dysfunction&ndash;associated steatohepatitis</li><li>Endometrial hyperplasia/cancer</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment<br />options</strong></p></td><td><ul><li>Weight loss (first line)</li><li>Oral contraceptive pills for menstrual regulation</li><li>Letrozole for ovulation induction</li></ul></td></tr></tbody></table></div><p>This patient has clinical evidence of hyperandrogenism, <strong>irregular menses</strong>, and obesity typical of <strong>polycystic ovary syndrome (PCOS)</strong>.&nbsp; Hyperandrogenism is manifested by <strong>male pattern hair loss</strong> (eg, androgenic alopecia), hirsutism, and <strong>severe acne</strong> (eg, nodulocystic, acne on the back).&nbsp; These findings alone are sufficient to make a diagnosis of PCOS.&nbsp; In addition, ultrasound may show polycystic ovaries.</p><p>Patients with PCOS are at increased risk for multiple comorbidities, including dyslipidemia, hypertension, and type 2 diabetes mellitus (eg, metabolic syndrome) and should undergo screening for these conditions.&nbsp; An <strong>oral glucose tolerance test</strong> is the gold standard for diagnosing <strong>type 2 diabetes mellitus</strong> in patients with PCOS as it is more sensitive in detecting glucose intolerance than standard screening tests (eg, fasting glucose, HbA1c).&nbsp; Due to obesity and metabolic syndrome, patients are at risk for developing obstructive sleep apnea, nonalcoholic fatty liver disease, and endometrial cancer.</p><p><strong>(Choice A)</strong>&nbsp; <em>BRCA</em> mutation testing is indicated for patients with a family history of ovarian cancer at any age or personal/family history of breast cancer at age &#8804;50 in a first-degree relative.&nbsp; It is not indicated for a family history of endometrial cancer or breast cancer at an advanced age.</p><p><strong>(Choice B)</strong>&nbsp; A diagnostic laparoscopy would demonstrate enlarged polycystic ovaries in a patient with PCOS, but it is not required for this diagnosis.&nbsp; Polycystic ovaries can also be incidental findings in some patients without hyperandrogenism or menstrual irregularities (eg, no PCOS).</p><p><strong>(Choice C)</strong>&nbsp; Excessive menstrual bleeding can cause iron deficiency, which in severe cases may lead to diffuse hair loss (eg, telogen effluvium).&nbsp; However, this patient has oligomenorrhea with minimal vaginal bleeding, making anemia unlikely.</p><p><strong>(Choice E)</strong>&nbsp; Rapid plasma reagin serology is used to detect syphilis, a sexually transmitted infection.&nbsp; Secondary syphilis may present with patchy or &#x22;moth-eaten&#x22; alopecia, but typical presentation also includes constitutional symptoms (eg, malaise, fever, weight loss) and a maculopapular rash.</p><p><strong>Educational objective:</strong><br>Polycystic ovary syndrome (PCOS) may present with androgenic alopecia (male-pattern hair loss), irregular menses, and obesity.&nbsp; Patients with PCOS are at increased risk of developing type 2 diabetes mellitus and should be screened with an oral glucose tolerance test.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8274,
            "topic": "Polycystic ovary disease",
            "titleId": 8274,
            "title": "Polycystic ovary disease",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<em>BRCA</em> mutation testing",
                    "choiceNumber": 1,
                    "correctTaken": 2630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diagnostic laparoscopy",
                    "choiceNumber": 2,
                    "correctTaken": 864,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Iron studies",
                    "choiceNumber": 3,
                    "correctTaken": 1695,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral glucose tolerance test",
                    "choiceNumber": 4,
                    "correctTaken": 10553,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid plasma reagin serology",
                    "choiceNumber": 5,
                    "correctTaken": 521,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "583,616,true,-1,1*101,122,true,-1,1*258,314,true,-1,1*386,489,true,-1,1*1231,1620,true,-1,1*1632,1915,true,-1,1*2214,2347,true,-1,1*2549,2740,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "60",
                    "mediaDataId": 0,
                    "title": "Polycystic ovary syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27570464",
                    "mediaDataId": 0,
                    "title": "Pathophysiology, risk factors, and screening methods for prediabetes in women with polycystic ovary syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27570464",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 147,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 16263,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1084,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 3083,
            "questionIndex": 3083,
            "questionText": "<p>A 65-year-old woman comes to the emergency department due to a 2-week history of constipation and abdominal pain.&nbsp; The patient also has urinary frequency and constant thirst.&nbsp; Her medical history is significant for persistent atrial fibrillation treated with diltiazem and rivaroxaban, hypertension treated with hydrochlorothiazide, and hypothyroidism treated with levothyroxine.&nbsp; There has been no recent change in any of these medications.&nbsp; In addition, the patient was diagnosed with osteoporosis 3 months ago; she declined treatment with bisphosphonates and instead opted to treat only with over-the-counter vitamin and mineral supplements.&nbsp; She does not use tobacco or alcohol.&nbsp; On physical examination, temperature is 36.8 C (98.2 F), blood pressure is 120/70 mm Hg, pulse is 90/min and irregular, and respirations are 12/min.&nbsp; Mucous membranes are dry, and the abdomen is soft and nontender without rebound tenderness or rigidity.&nbsp; Bowel sounds are decreased but present.&nbsp; Bedside dipstick urinalysis is within normal limits.&nbsp; Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t52312\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Milk-alkali syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>Excessive intake of <strong>calcium &amp; absorbable alkali</strong></li><li>Renal vasoconstriction &amp; decreased GFR</li><li>Renal loss of sodium &amp; water, reabsorption of bicarbonate</li></ul></td></tr><tr><td><p align=\"center\"><strong>Symptoms</strong></p></td><td><ul><li>Nausea, vomiting, constipation</li><li>Polyuria, polydipsia</li><li>Neuropsychiatric symptoms</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Hypercalcemia</li><li>Metabolic alkalosis</li><li>Acute kidney injury</li><li>Suppressed PTH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Discontinuation of causative agent</li><li>Isotonic saline followed by furosemide</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>GFR</strong> = glomerular filtration rate; <strong>PTH</strong> = parathyroid hormone.</p></td></tr></tbody></table></div><p>This patient has typical symptoms of <strong>hypercalcemia</strong>, including abdominal pain, constipation, and polydipsia.&nbsp; In light of initiation of over-the-counter supplements for osteoporosis 3 months ago, her symptoms are likely due to <strong>milk-alkali syndrome</strong> (MAS).&nbsp; MAS is caused by excessive intake of <strong>calcium and absorbable alkali</strong> (eg, calcium carbonate preparations used in patients with osteoporosis).&nbsp; The resulting hypercalcemia causes <strong>renal vasoconstriction</strong> and decreased glomerular blood flow.&nbsp; In addition, inhibition of the Na-K-2Cl cotransporter (due to activation of calcium-sensing receptors in the thick ascending loop) and impaired antidiuretic hormone activity lead to loss of sodium and free water.&nbsp; This results in hypovolemia and increased reabsorption of bicarbonate (augmented by the increased intake of alkali).</p><p>Medications that raise the risk of MAS include thiazide diuretics, ACE inhibitors/angiotensin II receptor blockers, and nonsteroidal anti-inflammatory drugs.&nbsp; In addition to hypercalcemia, metabolic findings in MAS include hypophosphatemia, hypomagnesemia, <strong>metabolic alkalosis</strong>, and <strong>acute kidney injury</strong>.&nbsp; Parathyroid hormone levels are suppressed.</p><p><strong>(Choice A)</strong>&nbsp; Diltiazem is a calcium channel blocker that can cause constipation, but it does not cause other symptoms of hypercalcemia (ie, polyuria and polydipsia).</p><p><strong>(Choice B)</strong>&nbsp; Diabetic ketoacidosis can be the initial presentation of type 1 diabetes mellitus and presents with polyuria, polydipsia, and weight loss.&nbsp; However, new onset of type 1 diabetes is uncommon in older individuals, and urinalysis would show glucose and ketones.</p><p><strong>(Choice C)</strong>&nbsp; Hypothyroidism can cause constipation but is unlikely to lead to hypercalcemia and would be accompanied by other findings (eg, weight gain, cold intolerance, fatigue).&nbsp; Hyperthyroidism (and excessive replacement of levothyroxine in hypothyroidism) can cause mild hypercalcemia due to increased bone turnover but is unlikely to cause constipation.</p><p><strong>(Choices E)</strong>&nbsp; Thiazides can be associated with mild hypercalcemia due to increased calcium reabsorption in the distal tubule, but severe, symptomatic calcemia as seen in this patient would be extremely unlikely due to thiazide therapy alone.&nbsp; In addition, there is no indication that her thiazide dose has changed.</p><p><strong>(Choice F)&nbsp; </strong>Excessive doses of vitamin A can increase bone turnover and lead to abdominal pain and hypercalcemia; however, hypercalcemia is usually mild, and vitamin A toxicity would also manifest as dry skin, headache, and blurry vision.</p><p><strong>Educational objective:</strong><br>Milk-alkali syndrome is caused by excessive intake of calcium and absorbable alkali.&nbsp; It can be seen in patients taking calcium bicarbonate for osteoporosis.&nbsp; Clinical findings include symptomatic hypercalcemia, metabolic alkalosis, and acute kidney injury.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2698,
            "topic": "Hypercalcemia",
            "titleId": 2698,
            "title": "Hypercalcemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adverse effect of diltiazem",
                    "choiceNumber": 1,
                    "correctTaken": 1315,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Diabetic ketoacidosis",
                    "choiceNumber": 2,
                    "correctTaken": 318,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 3,
                    "correctTaken": 896,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Milk-alkali syndrome",
                    "choiceNumber": 4,
                    "correctTaken": 8100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thiazide-induced hypercalcemia",
                    "choiceNumber": 5,
                    "correctTaken": 4609,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin A toxicity",
                    "choiceNumber": 6,
                    "correctTaken": 847,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2510,2810,true,-1,1*433,471,true,-1,1*2823,2926,true,-1,1*2319,2497,true,-1,1*1514,1702,true,-1,1*1356,1513,true,-1,1*927,1355,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23431478",
                    "mediaDataId": 0,
                    "title": "Antacids, altered mental status, and milk-alkali syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23431478",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21738535",
                    "mediaDataId": 0,
                    "title": "Milk alkali and hydrochlorothiazide: a case report.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21738535",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 185,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 16085,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 50,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1913,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 14800,
            "questionIndex": 16223,
            "questionText": "<p>A 6-month-old boy is brought to the office for a well-child visit.&nbsp; The patient sits with support, mouths toys, and responds to his name.&nbsp; He has not yet started babbling or using a pincer grasp.&nbsp; The patient drinks 24-28 oz daily of donated, pasteurized breast milk obtained through a local milk bank.&nbsp; He was adopted from Uganda at age 2 months.&nbsp; The only available birth history is that the patient was born full-term and that labor and delivery were uncomplicated.&nbsp; Family history is unknown.&nbsp; Immunizations are up to date.&nbsp; He has no chronic medical conditions and takes no medications.&nbsp; Height and weight are at the 20th and 40th percentiles, respectively.&nbsp; Head circumference is at the 30th percentile.&nbsp; The patient has no dysmorphic facial features.&nbsp; The anterior fontanel is open and flat, and the skull bones are soft and flexible to pressure.&nbsp; Bilateral swelling of the wrist is present.&nbsp; There is no bowing of the lower extremities.&nbsp; Cardiopulmonary and abdominal examinations are normal.&nbsp; An <a href=\"22755\">x-ray of the wrist</a> is performed.&nbsp; Which of the following is the most likely cause of this patient&#39;s x-ray abnormality?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t49228\"><table class=\"table-default-style\" style=\"width:504px\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vitamin D deficiency in children</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Exclusive breastfeeding</li><li>Inadequate sun exposure, heavy skin pigmentation</li><li>Absence of fortified dairy (dairy alternative) foods</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical<br />manifestations</strong></p></td><td><ul><li>Decreased muscle tone &amp; delayed development</li><li>Delayed fontanelle closure, frontal bossing</li><li>Widening of epiphyses</li><li>Hypertrophy of costochondral joints</li><li>Short stature, femoral &amp; tibial bowing</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory<br />findings</strong></p></td><td><ul><li>Low 25-hydroxyvitamin D</li><li>Elevated alkaline phosphatase</li><li>Low/normal calcium, low phosphorus</li><li>Elevated parathyroid hormone</li><li>Low urine calcium</li></ul></td></tr><tr><td><p align=\"center\"><strong>Histopathology</strong></p></td><td><ul><li>Excess unmineralized osteoid</li></ul></td></tr></tbody></table></div><p><strong>Nutritional rickets</strong> is most commonly caused by deficiency of <strong>vitamin D</strong>, which is necessary for calcium metabolism and skeletal growth.&nbsp; Risk factors include limited sun exposure and increased skin pigmentation.&nbsp; An exclusive diet of <strong>breast milk without vitamin D supplementation</strong>, as in this infant, is a major risk factor because breast milk alone contains inadequate vitamin D.</p><p>Deficiency of vitamin D and calcium leads to poor bone mineralization and accumulation of growth plate cartilage.&nbsp; <strong>Infants</strong> may have <strong>craniotabes</strong> (skull bones that depress with pressure), as seen here.&nbsp; <strong>Widened wrists</strong> may be apparent due to growth plate enlargement.&nbsp; Additional findings include radial/ulnar bowing and delayed fontanel closure.&nbsp; Lower extremity bowing (genu varum) is apparent once children become weight-bearing.</p><p>X-ray of rapidly growing skeletal areas (eg, wrists, knees) is a helpful diagnostic tool.&nbsp; <a href=\"22757\">X-ray findings</a> include metaphyseal widening with cupping and fraying (white arrow), as seen here.&nbsp; Costochondral joint widening is also classic.</p><p>Treatment includes vitamin D and calcium supplementation.</p><p><strong>(Choice A)</strong>&nbsp; Systemic juvenile idiopathic arthritis is an autoimmune inflammatory disorder that presents with fever, arthritis, and rash, none of which are present here.&nbsp; In addition, x-ray findings include soft tissue swelling and loss of joint space.</p><p><strong>(Choice B)</strong>&nbsp; Hurler syndrome is an autosomal recessive lysosomal storage disease that presents with dysostosis multiplex, a range of skeletal findings including shortened and thickened long bones.&nbsp; Patients also typically have coarse facial features (eg, wide nasal bridge, flat midface), developmental delay, and frequent infections, none of which are seen here.</p><p><strong>(Choice C)</strong>&nbsp; HIV can be transmitted via breast milk.&nbsp; However, clinical features in infants include hepatosplenomegaly, lymphadenopathy, and failure to thrive, not the bony abnormalities seen here.&nbsp; In addition, milk banks screen donors for infectious disease and pasteurize milk to destroy pathogens, including HIV.</p><p><strong>(Choice D)</strong>&nbsp; Congenital syphilis is often asymptomatic but may cause skeletal abnormalities, including craniotabes and osseous destruction of the long bones, not metaphyseal cupping and fraying.&nbsp; Other findings in symptomatic patients include hepatosplenomegaly, rash, and lymphadenopathy, which are also not seen here.</p><p><strong>(Choice E)</strong>&nbsp; Nonaccidental trauma can present with localized swelling and no reported history of trauma.&nbsp; However, new and/or old fractures would be expected on x-ray.&nbsp; In addition, craniotabes would not be seen.</p><p><strong>Educational objective:</strong><br>Nutritional rickets classically occurs in exclusively breastfed infants without vitamin D supplementation.&nbsp; Presentation includes craniotabes (soft skull bones) and forearm deformities (widened wrists, radial/ulnar bowing).&nbsp; Lower extremity bowing occurs once patients are weight-bearing.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 24208,
            "topic": "Rickets",
            "titleId": 24208,
            "title": "Rickets",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Autoimmune inflammatory disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Autosomal recessive lysosomal storage disorder",
                    "choiceNumber": 2,
                    "correctTaken": 1756,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Breast milk&ndash;transmitted infection",
                    "choiceNumber": 3,
                    "correctTaken": 168,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital infection",
                    "choiceNumber": 4,
                    "correctTaken": 1867,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nonaccidental trauma",
                    "choiceNumber": 5,
                    "correctTaken": 1009,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin deficiency",
                    "choiceNumber": 6,
                    "correctTaken": 10716,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "226,313,true,-1,1*455,484,true,-1,1*549,566,true,-1,1*582,610,true,-1,1*1656,1712,true,-1,1*1420,1508,true,-1,1*1977,2328,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "905",
                    "mediaDataId": 0,
                    "title": "Vitamin D deficiency rickets",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29265106",
                    "mediaDataId": 0,
                    "title": "Rickets.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29265106",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21274312",
                    "mediaDataId": 0,
                    "title": "Nutritional rickets.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21274312",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 73,
            "othersAvgTimeSpent": 76,
            "notes": null,
            "peopleTaken": 16616,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1315,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 8862,
            "questionIndex": 8876,
            "questionText": "<p>A 36-year-old woman comes to the office for evaluation of fatigue and generalized weakness for the past several weeks.&nbsp; She has had no appetite or weight changes, heat or cold intolerance, nausea or vomiting, or constipation.&nbsp; The patient&#39;s medical and family histories are unremarkable.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 120/70 mm Hg, pulse is 76/min, and respirations are 14/min.&nbsp; Physical examination shows normal heart and lung sounds, an unremarkable abdominal examination, and no focal neurologic deficits.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hematocrit</td><td>43%</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>7.8 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Magnesium</td><td>1.7 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.9 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td>4.0 g/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td>Serum parathyroid hormone</td><td>110 pg/mL</td></tr></tbody></table><p>Which of the following is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7195\" src=\"https://www.uworld.com/media/L18773.jpg\" ></p><p>This patient with fatigue and weakness has <strong>symptomatic hypocalcemia</strong>.&nbsp; The first step in evaluating hypocalcemia is to measure the serum albumin level because hypoalbuminemia lowers total circulating calcium (measured on the basic metabolic profile) without affecting the metabolically active ionized calcium concentration (pseudohypocalcemia).&nbsp; If albumin is low, a corrected calcium level can be calculated (corrected calcium = [measured calcium] + 0.8 &times; [4.0 g/dL &#8722; serum albumin in g/dL]).&nbsp; Once true hypocalcemia is confirmed, the next step is to exclude causes such as massive blood transfusion, whereby citrate in transfused products binds to ionized calcium; and hypomagnesemia, which causes resistance to parathyroid hormone (PTH), the hormone that regulates minute-to-minute calcium concentrations.&nbsp;&nbsp;This patient has a normal albumin level, has not had any transfusions, and has a normal serum magnesium level.</p><p><b>PTH</b> is secreted in response to hypocalcemia, and hypocalcemia may develop when PTH secretion is insufficient.&nbsp; Therefore, patients with hypocalcemia should have a serum PTH level measured to exclude hypoparathyroidism (eg, autoimmune).&nbsp; This patient&#39;s PTH level is <strong>appropriately elevated</strong> given her hypocalcemia.&nbsp; In contrast to PTH, vitamin D regulates calcium levels over the longer term.&nbsp; Therefore, once hypoparathyroidism has been excluded, the next step is to measure a <strong>serum 25-hydroxyvitamin D</strong> level to rule out <strong>vitamin D deficiency</strong>.&nbsp; Common causes of vitamin D deficiency include inadequate dietary intake, inadequate sunlight exposure (which converts 7-dehydrocholesterol to vitamin D3 in the skin), and malabsorptive disorders.&nbsp; Levels of 1,25-dihydroxyvitamin D correlate with PTH activity rather than total body vitamin D stores and are not usually measured.</p><p><strong>(Choice A)</strong>&nbsp; Parathyroid scintigraphy is used to localize parathyroid adenomas in patients with hyperparathyroidism, which presents with hypercalcemia (not hypocalcemia).</p><p><strong>(Choice B)</strong>&nbsp; Fibroblast growth factor 23 (FGF23) lowers phosphate levels by decreasing intestinal absorption and increasing urinary excretion of phosphate.&nbsp; Elevated plasma FGF23 levels are seen in patients with phosphate retention and secondary hyperparathyroidism due to chronic kidney disease.</p><p><strong>(Choice C)</strong>&nbsp; Ectopic production of PTH-related peptide causes humoral hypercalcemia of malignancy; patients have hypercalcemia with suppressed PTH levels.</p><p><strong>(Choice D)</strong>&nbsp; A skeletal survey is used in evaluation of multiple myeloma, which typically causes hypercalcemia and primarily occurs in older adults.&nbsp; It has less utility in the evaluation of hypocalcemia.</p><p><strong>(Choice F)</strong>&nbsp; Alkaline phosphatase can be elevated in chronic or severe vitamin D deficiency but has low sensitivity; directly measuring vitamin D is preferred.</p><p><strong>Educational objective:</strong><br>Vitamin D deficiency can lead to hypocalcemia with an elevated parathyroid hormone level.&nbsp; Causes include inadequate dietary intake of vitamin D, inadequate sunlight exposure, or malabsorptive disorders.&nbsp; Evaluation includes measuring the serum 25-hydroxyvitamin D level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2731,
            "topic": "Hypocalcemia",
            "titleId": 2731,
            "title": "Hypocalcemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Parathyroid scintigraphy",
                    "choiceNumber": 1,
                    "correctTaken": 2235,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma fibroblast growth factor 23 level",
                    "choiceNumber": 2,
                    "correctTaken": 579,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma parathyroid hormone&ndash;related protein level",
                    "choiceNumber": 3,
                    "correctTaken": 638,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Radiographic skeletal survey",
                    "choiceNumber": 4,
                    "correctTaken": 359,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum 25-hydroxyvitamin D level",
                    "choiceNumber": 5,
                    "correctTaken": 11245,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum alkaline phosphatase level",
                    "choiceNumber": 6,
                    "correctTaken": 835,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "526,840,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22439169",
                    "mediaDataId": 0,
                    "title": "Hypocalcemia: updates in diagnosis and management for primary care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22439169",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 134,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 15891,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 71,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1946,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 8884,
            "questionIndex": 8901,
            "questionText": "<p>A 34-year-old woman comes to the office due to diarrhea, weight loss, and fatigue over the past year.&nbsp; The diarrhea occurs 2 or 3 times daily and is accompanied by crampy abdominal pain.&nbsp; She has diarrhea occasionally at night but no tenesmus or blood in the stool.&nbsp; The patient describes her stools as very foul smelling and floating.&nbsp; Associated symptoms include diffuse bone pain.&nbsp; Physical examination is unremarkable.&nbsp; Laboratory results show hemoglobin of 9.8 g/dL with a mean corpuscular volume of 72 &micro;m<font size=\"2\"><sup>3</sup></font>.&nbsp; Which of the following serum laboratory findings would be expected in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38256\"><table class=\"table-default-style\" style=\"width:100.06%\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Clinical manifestations of celiac disease</strong></p></td></tr><tr><td><p align=\"center\"><strong>Gastrointestinal</strong></p></td><td><ul><li>Diarrhea, &plusmn; steatorrhea, weight loss</li><li>Abdominal pain</li><li>Flatulence/bloating</li><li>Late manifestations: ulcerative jejunitis, enteropathy-associated T-cell lymphoma</li></ul></td></tr><tr><td><p align=\"center\"><strong>Mucocutaneous</strong></p></td><td><ul><li>Dermatitis herpetiformis</li><li>Atrophic glossitis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Endocrine</strong></p></td><td><ul><li>Vitamin D deficiency</li><li>Secondary hyperparathyroidism</li></ul></td></tr><tr><td><p align=\"center\"><strong>Bone disorders</strong></p></td><td><ul><li>Osteomalacia/osteoporosis (adults)</li><li>Rickets (children)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Hematologic</strong></p></td><td><ul><li>Iron deficiency anemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Neuropsychiatric</strong></p></td><td><ul><li>Peripheral neuropathy</li><li>Depression/anxiety</li></ul></td></tr></tbody></table></div><p>This patient has chronic diarrhea and abdominal pain; the associated weight loss and steatorrhea (ie, foul-smelling, greasy, or floating stools) suggest a <strong>malabsorptive disorder</strong>, most likely <strong>celiac disease</strong> (CD) (ie, immune-mediated hypersensitivity to gluten).&nbsp; CD causes villous atrophy in the small bowel, reducing its absorptive capacity.</p><p>CD is often complicated by nutritional deficiencies due to inadequate absorption.&nbsp; In particular, malabsorption of iron is common and leads to <strong>iron deficiency</strong> (microcytic) <strong>anemia</strong>, as in this patient.&nbsp; Deficiencies of fat-soluble vitamins (eg, A, D, E, K) are also common.</p><p><a href=\"2966\">1,25-dihydroxyvitamin D</a> (calcitriol, the active form of vitamin D) is required for optimal intestinal absorption of calcium and phosphorus.&nbsp; In <strong>vitamin D deficiency</strong>, absorption of calcium is impaired, which stimulates secretion of <strong>parathyroid hormone</strong> (PTH) (ie, secondary hyperparathyroidism).&nbsp; PTH causes release of calcium from bone, increases renal calcium reabsorption, and suppresses renal phosphate reabsorption.&nbsp; Circulating <strong>calcium</strong> is restored to <strong>normal or mildly low</strong> levels, but <strong>phosphate</strong> levels are significantly <strong>reduced</strong>.&nbsp; In the bone, vitamin D deficiency can lead to osteomalacia (ie, abnormal mineralization with bone pain) and osteoporosis (ie, decreased bone density).</p><p><strong>(Choice B)</strong>&nbsp; In some patients with malabsorption due to CD, calcium may be restored to normal, but this requires elevated levels of PTH (ie, PTH would not be low).</p><p><strong>(Choice C)</strong>&nbsp; Hypoparathyroidism is characterized by hypocalcemia, hyperphosphatemia, and low PTH; it is most often a complication of thyroid surgery with inadvertent damage to the parathyroid glands.&nbsp; Symptoms are primarily related to hypocalcemia (eg, paresthesia, muscle cramps).&nbsp; Malabsorptive syndromes are typically associated with secondary hyperparathyroidism, not hypoparathyroidism.</p><p><strong>(Choice D)</strong>&nbsp; 25-hydroxyvitamin D is converted to 1,25-dihydroxyvitamin D by 1-alpha-hydroxylase in the kidneys.&nbsp; In patients with chronic kidney disease (CKD), production of 1,25-dihydroxyvitamin D is reduced, leading to hypocalcemia and secondary hyperparathyroidism.&nbsp; However, unlike in CD and other malabsorptive disorders, serum phosphate is elevated due to decreased renal phosphate clearance.</p><p><strong>(Choice E)</strong>&nbsp; Primary hyperparathyroidism (eg, PTH-secreting parathyroid adenoma) would lead to high PTH, hypercalcemia, and hypophosphatemia.&nbsp; Calcium is not elevated in patients with secondary hyperparathyroidism due to malabsorption.</p><p><strong>Educational objective:</strong><br>Celiac disease (ie, immune-mediated hypersensitivity to gluten) commonly presents with diarrhea, abdominal pain, and weight loss.&nbsp; The associated villous atrophy leads to malabsorption, causing fat-soluble vitamin (eg, A, D, E, K) deficiencies and iron deficiency anemia.&nbsp; Vitamin D deficiency can lead to hypocalcemia, hypophosphatemia, and secondary hyperparathyroidism.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11552,
            "topic": "Vitamin D deficiency",
            "titleId": 11552,
            "title": "Vitamin D deficiency",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:360px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Low</td><td style=\"width:33%; vertical-align:middle;\">Low</td><td style=\"width:33%; vertical-align:middle;\">High</td></tr></tbody></table>",
                    "choiceNumber": 1,
                    "correctTaken": 7542,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:360px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Normal</td><td style=\"width:33%; vertical-align:middle;\">Low</td><td style=\"width:33%; vertical-align:middle;\">Low</td></tr></tbody></table>",
                    "choiceNumber": 2,
                    "correctTaken": 219,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:360px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Low</td><td style=\"width:33%; vertical-align:middle;\">High</td><td style=\"width:33%; vertical-align:middle;\">Low</td></tr></tbody></table>",
                    "choiceNumber": 3,
                    "correctTaken": 630,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:360px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">Low</td><td style=\"width:33%; vertical-align:middle;\">High</td><td style=\"width:33%; vertical-align:middle;\">High</td></tr></tbody></table>",
                    "choiceNumber": 4,
                    "correctTaken": 2334,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:360px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\">High</td><td style=\"width:33%; vertical-align:middle;\">Low</td><td style=\"width:33%; vertical-align:middle;\">High</td></tr></tbody></table>",
                    "choiceNumber": 5,
                    "correctTaken": 2934,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "377,430,true,-1,1*182,242,true,-1,1*282,300,true,-1,1*786,865,true,-1,1*2487,2773,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "358",
                    "mediaDataId": 0,
                    "title": "Celiac disease",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22439169",
                    "mediaDataId": 0,
                    "title": "Hypocalcemia: updates in diagnosis and management for primary care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22439169",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 83,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 13659,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 55,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"width:360px;\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; vertical-align:middle;\"><strong>Calcium</strong></td><td style=\"width:33%; vertical-align:middle;\"><strong>Phosphate</strong></td><td style=\"width:33%; vertical-align:middle;\"><strong>Parathyroid hormone</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 689,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 13700,
            "questionIndex": 15090,
            "questionText": "<p>A 21-year-old college student comes to the office due to swelling in her feet and ankles.&nbsp; The patient noticed the swelling a few days ago when her shoes would not fit.&nbsp; She says, &#x22;I have become so fat and have such low energy since coming to college even though I run every day and eat only healthy foods.&nbsp; I am also worried about my grades because my concentration is so poor.&#x22;&nbsp; The patient has a medical history of chondromalacia patellae, which she uses a knee brace for during runs.&nbsp; Physical examination shows a thin habitus, dry skin, excoriations on her forearms, 2+ pitting edema of her ankles, and a distended abdomen with hypoactive bowel sounds.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 85/60 mm Hg, pulse is 50/min, and respirations are 14/min.&nbsp; BMI is 17 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Which of the following abnormalities is most likely present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t41019\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Anorexia nervosa</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnostic criteria</strong></p></td><td><ul><li>Significantly low weight</li><li>Fear of weight gain</li><li>Distorted views of body weight &amp; shape</li></ul></td></tr><tr><td><p align=\"center\"><strong>Complications</strong></p></td><td><ul><li>Cardiovascular: myocardial atrophy, bradycardia, hypotension, arrhythmias</li><li>Renal: poor urinary concentration, dehydration</li><li>Neurological: seizures, cognitive impairment</li><li>Dermatological: dry skin, lanugo</li><li>Gynecological: amenorrhea, infertility</li><li>Gastrointestinal: gastroparesis, constipation</li><li>Hematological: cytopenia</li><li>Other: electrolyte depletion, osteopenia, hypercholesterolemia, hypercarotenemia</li></ul></td></tr></tbody></table></div><p>This patient&#39;s low BMI and distorted body image are suggestive of <strong>anorexia nervosa (AN)</strong>.&nbsp; Weight loss and chronic malnutrition lead to dysfunction in multiple organ systems.&nbsp; This patient&#39;s clinical presentation of <strong>dry skin</strong> causing scratching and excoriations, edema, <strong>abdominal distension</strong>, hypoactive bowel sounds, and vital sign abnormalities (eg, <strong>hypotension</strong>, <strong>bradycardia</strong>) is consistent with medical complications due to AN.&nbsp; Gastroparesis and abdominal bloating are common.&nbsp; Edema is caused by electrolyte and fluid disturbances and is commonly seen in the ankles and around the eyes.</p><p><strong>Decreased bone mineral density</strong> is due to a combination of factors&mdash;including various endocrine abnormalities, hypercortisolism, and growth hormone resistance&mdash;that result in an increased risk of bone fractures.&nbsp; Other complications include hypercarotenemia, accelerated metabolism of cholesterol leading to hypercholesterolemia, cardiac atrophy, arrhythmias, amenorrhea, lanugo, and seizures.</p><p><strong>(Choices B and C)</strong>&nbsp; Electrolytes, including magnesium, potassium, sodium, and phosphate, may be normal or depleted rather than increased.&nbsp; Hypokalemia due to self-induced vomiting is a common feature in patients with the binge-eating/purging subtype of AN.</p><p><strong>(Choice D)</strong>&nbsp; Hypocarotenemia is not classically associated with AN. &nbsp;Hypercarotenemia, which presents with yellowing skin, particularly in the palms, can be seen in patients with AN.&nbsp; It is due to excessive consumption of low-calorie, carotene-rich foods (eg, carrots, squash) and impairment in hepatic clearance.</p><p><strong>(Choice E)</strong>&nbsp; The suppression of the hypothalamic-pituitary-ovarian axis in AN results in decreased GnRH and LH levels, with resultant amenorrhea and infertility.</p><p><strong>(Choice F)</strong>&nbsp; Primary hypothyroidism would not explain this patient&#39;s low BMI and distorted body image.&nbsp; Thyroid abnormalities can occur in AN as an adaptation to chronic nutritional depletion; however, these abnormalities commonly present as euthyroid sick syndrome.&nbsp; The T3 and/or T4 may be low while the TSH is normal to low rather than elevated, as in primary hypothyroidism.</p><p><strong>Educational objective:</strong><br>Anorexia nervosa is characterized by a distorted body image and fear of weight gain despite an abnormally low BMI.&nbsp; Medical complications due to malnutrition include bradycardia, hypotension, edema, gastroparesis, cardiac atrophy, and decreased bone mineral density.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 15771,
            "topic": "Anorexia nervosa",
            "titleId": 15771,
            "title": "Anorexia nervosa",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased bone mineral density",
                    "choiceNumber": 1,
                    "correctTaken": 10024,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperkalemia",
                    "choiceNumber": 2,
                    "correctTaken": 1364,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypernatremia",
                    "choiceNumber": 3,
                    "correctTaken": 946,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypocarotenemia",
                    "choiceNumber": 4,
                    "correctTaken": 775,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased LH",
                    "choiceNumber": 5,
                    "correctTaken": 327,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased TSH",
                    "choiceNumber": 6,
                    "correctTaken": 2493,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "180,200,true,-1,1*244,272,true,-1,1*419,448,true,-1,1*515,554,true,-1,1*981,1141,true,-1,1*1250,1353,true,-1,1*1857,2102,true,-1,1*2366,2641,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "112",
                    "mediaDataId": 0,
                    "title": "Anorexia nervosa",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27166107",
                    "mediaDataId": 0,
                    "title": "Medical complications of anorexia nervosa.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27166107",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26138740",
                    "mediaDataId": 0,
                    "title": "Medical complications of anorexia nervosa and their treatments: an update on some critical aspects.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26138740",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 535,
            "othersAvgTimeSpent": 60,
            "notes": null,
            "peopleTaken": 15929,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 934,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 4635,
            "questionIndex": 4635,
            "questionText": "<p>A 52-year-old man comes to the office due to decreased libido and inability to achieve and maintain erections for the past several months.&nbsp; He has also had fatigue, anorexia, and a 5-kg (11-lb) weight loss over the same duration.&nbsp; The patient is married and has one child.&nbsp; He drinks alcohol but does not use tobacco or recreational drugs.&nbsp; Blood pressure is 110/70 mm Hg and pulse is 82/min.&nbsp; Physical examination shows bilateral gynecomastia and firm and small testes.&nbsp; Laboratory testing shows normal TSH with decreased levels of total triiodothyronine (T3) and thyroxine (T4).&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"3269\" src=\"https://www.uworld.com/media/highresdefault/L25246.jpg\"  ></p><p>This patient&#39;s erectile dysfunction and testicular atrophy are most likely due to <strong>hypogonadism</strong>, which is a common complication of chronic liver disease with cirrhosis.&nbsp; <strong>Cirrhosis</strong> (especially due to alcoholic liver disease or hemochromatosis) can cause hypogonadism due to primary gonadal injury or hypothalamic-pituitary dysfunction.&nbsp; In this patient with a history of <strong>alcohol use</strong>, several clues suggest the diagnosis of cirrhosis.</p><p>Cirrhosis is associated with elevated circulating levels of <strong>estradiol</strong> (eg, increased conversion from androgens, decreased hepatic metabolism).&nbsp; Findings due to excess estrogen include telangiectasias, palmar erythema, <strong>testicular atrophy</strong>, and <strong>gynecomastia</strong> (usually bilateral but can be unilateral).</p><p>In addition, the liver produces serum binding proteins for thyroid hormones (eg, thyroxine-binding globulin, transthyretin, albumin, lipoproteins).&nbsp; Cirrhosis leads to decreased synthesis of these proteins, which lowers the <strong>total</strong> triiodothyronine (T3) and thyroxine (T4) in circulation (as seen here); however, free T3 and T4 levels are unchanged, and TSH will be normal, reflecting a euthyroid status.</p><p>Patients with cirrhosis frequently have malnutrition due to a combination of factors including poor oral intake (eg, decreased appetite, early satiety from ascites), malabsorption, and a catabolic state.&nbsp; Therefore, patients often experience net <strong>weight loss</strong> despite volume overload (eg, ascites, peripheral edema), particularly in advanced disease.</p><p><strong>(Choice A)</strong>&nbsp; Adrenal insufficiency (AI) can cause fatigue, weakness, anorexia, and weight loss.&nbsp; In women with AI, features of hypogonadism (eg, loss of libido, decreased pubic hair) can be seen due to decreased adrenal androgen production; however, men with AI do not develop these findings as androgens are primarily produced in the testes.&nbsp; In addition, AI would not explain this patient&#39;s gynecomastia, testicular atrophy, or thyroid hormone laboratory abnormalities.</p><p><strong>(Choice C)</strong>&nbsp; Exogenous thyroid hormone intake can cause weight loss, fatigue, and anxiety.&nbsp; However, TSH would be suppressed.</p><p><strong>(Choice D)</strong>&nbsp; Hashimoto thyroiditis (chronic autoimmune thyroiditis) is due to lymphocytic infiltration of the thyroid causing hypothyroidism.&nbsp; Laboratory studies show elevated TSH, decreased T4, and thyroid peroxidase antibodies.</p><p><strong>(Choice E)</strong>&nbsp; Arterial insufficiency is a common cause of erectile dysfunction.&nbsp; However, this would not cause gynecomastia or testicular atrophy, and most patients would have other signs of arterial disease.</p><p><strong>(Choice F)</strong>&nbsp; Androgen insensitivity is caused by mutations in the androgen receptor and would cause primary infertility (eg, primary amenorrhea in a genetically male but phenotypically female individual [complete androgen insensitivity syndrome]).&nbsp; It is unlikely in this patient with recent-onset sexual dysfunction.</p><p><strong>Educational objective:</strong><br>Cirrhosis can cause hypogonadism due to primary gonadal injury or hypothalamic-pituitary dysfunction.&nbsp; Cirrhosis is also associated with elevated circulating levels of estradiol due to increased conversion from androgens.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 4600,
            "topic": "Male sexual dysfunction",
            "titleId": 4600,
            "title": "Male sexual dysfunction",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adrenal insufficiency",
                    "choiceNumber": 1,
                    "correctTaken": 814,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic liver disease",
                    "choiceNumber": 2,
                    "correctTaken": 2427,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exogenous thyroxine intake",
                    "choiceNumber": 3,
                    "correctTaken": 468,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hashimoto thyroiditis",
                    "choiceNumber": 4,
                    "correctTaken": 649,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Penile vascular occlusion",
                    "choiceNumber": 5,
                    "correctTaken": 19,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Testosterone insensitivity",
                    "choiceNumber": 6,
                    "correctTaken": 695,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "608,760,true,-1,1*200,368,true,-1,1*774,909,true,-1,1*1610,1859,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "410",
                    "mediaDataId": 0,
                    "title": "Cirrhosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31360138",
                    "mediaDataId": 0,
                    "title": "Nutrition in patients with cirrhosis",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31360138",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18560267",
                    "mediaDataId": 0,
                    "title": "Male hypogonadism in cirrhosis and after liver transplantation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18560267",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 204,
            "othersAvgTimeSpent": 99,
            "notes": null,
            "peopleTaken": 5072,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 848,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 16155,
            "questionIndex": 17597,
            "questionText": "<p>A 65-year-old woman comes to the office due to concerns about her risk for osteoporotic fractures.&nbsp; She reports that her sister takes medication for osteoporosis.&nbsp; Medical history is notable for hypothyroidism treated with levothyroxine and hypertension treated with hydrochlorothiazide.&nbsp; The patient underwent hysterectomy with salpingo-oophorectomy at age 51.&nbsp; She has a 10-pack-year history of cigarette smoking but quit at age 40, and she drinks 2 or 3 glasses of wine a week.&nbsp; Vital signs are normal.&nbsp; BMI is 23 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Examination of the heart, lungs, and abdomen is normal.&nbsp; Pelvic examination shows vaginal atrophy.&nbsp; Laboratory evaluation is normal.&nbsp; DXA scan reveals a T-score of &#8722;2.5 at the lumbar spine and &#8722;1.9 at the femoral neck, which is consistent with osteoporosis.&nbsp; In addition to calcium and vitamin D supplementation, which of the following is the most appropriate treatment for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T56564\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Medications for osteoporosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Bisphosphonates</strong><br>(eg, alendronate,<br>risedronate)</p></td><td style=\"width: 70%;\"><ul><li>First-line treatment for most patients</li><li>Taken with water on an empty stomach an hour before food &amp; other medications</li><li>Not recommended for patients with renal impairment</li><li>Atypical fractures possible with prolonged use</li><li>Oral &amp; parenteral options available</li></ul></td></tr><tr><td><p align=\"center\"><strong>Denosumab</strong></p></td><td><ul><li>Risk of infection &amp; skin reactions</li><li>Close monitoring for hypocalcemia needed</li></ul></td></tr><tr><td><p align=\"center\"><strong>Anabolic agents</strong><br>(eg, teriparatide)</p></td><td><ul><li>Useful in severe osteoporosis</li><li>Monitor serum calcium, uric acid &amp; renal function</li></ul></td></tr><tr><td><p align=\"center\"><strong>Nasal calcitonin</strong></p></td><td><ul><li>Modest reduction in fracture risk</li><li>Reduces pain from fracture</li></ul></td></tr><tr><td style=\"width: 30%;\"><p align=\"center\"><strong>Selective estrogen<br>receptor modulators</strong><br>(eg, raloxifene)</p></td><td><ul><li>Less effective than bisphosphonates</li><li>May lower risk of breast cancer</li><li>Increased risk of DVT</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>DVT</strong> = deep vein thrombosis.</p></td></tr></tbody></table></div><p>This woman has multiple risk factors for osteoporosis, including age &#8805;65, postmenopausal status, smoking history, and family history of osteoporosis.&nbsp; Her screening DXA scan shows a T-score of &#8722;2.5, which is consistent with <strong>osteoporosis</strong>.&nbsp; Initial management should address lifestyle factors, including regular <strong>weight-bearing exercise</strong>, avoidance of tobacco and excessive alcohol use, and adequate intake of <strong>calcium and vitamin D</strong> (using supplements as needed).</p><p>In addition, women with osteoporosis confirmed by DXA (ie, T-score &#8804;&#8722;2.5) or with an osteoporotic fragility fracture warrant pharmacologic <strong>antiresorptive therapy</strong>.&nbsp; Antiresorptive therapy is also appropriate for patients with osteopenia (T-score between &#8722;1 and &#8722;2.5) who are at high risk for fragility fracture.</p><p>First-line treatment for most patients with postmenopausal osteoporosis is a <strong>bisphosphonate</strong> (eg, alendronate, risedronate).&nbsp; Bisphosphonates preserve bone density and decrease the risk of vertebral and hip fracture.&nbsp; After initiation of bisphosphonate therapy, bone density is typically remeasured after 2 years to assess the response.&nbsp; Most experts recommend discontinuation after 5 years due to a risk of atypical fracture with prolonged use.</p><p><strong>(Choice A)</strong>&nbsp; Nasal calcitonin has relatively modest antiresorptive properties and is not recommended as first-line treatment for osteoporosis.&nbsp; However, it often has benefits for pain relief in patients with osteoporotic fracture.</p><p><strong>(Choice B)</strong>&nbsp; This patient has confirmed osteoporosis, warranting bisphosphonate therapy.&nbsp; Follow-up testing is typically performed within 2-5 years; shorter testing intervals (eg, 1 year) are used primarily for patients with accelerated bone loss (eg, glucocorticoid therapy).</p><p><strong>(Choice D)</strong>&nbsp; Raloxifene is a selective estrogen receptor modulator.&nbsp; It is less effective than bisphosphonates for treating osteoporosis and is associated with an increased risk for venous thromboembolism.&nbsp; However, raloxifene is associated with a reduced risk for invasive breast cancer and may be useful for women with high breast cancer risk.</p><p><strong>(Choice E)</strong>&nbsp; Estrogen replacement therapy has moderate benefits in maintaining bone density but is associated with an increased risk for breast cancer.&nbsp; It is recommended primarily for women with severe vasomotor symptoms (eg, hot flashes) and low risk for breast cancer.&nbsp; This patient&#39;s vaginal mucosal atrophy is a common finding in postmenopausal women and does not warrant estrogen therapy in the absence of significant symptoms.</p><p><strong>Educational objective:</strong><br>Bisphosphonates (eg, alendronate, risedronate) are the first-line treatment for most women with postmenopausal osteoporosis.&nbsp; After initiation of bisphosphonate therapy, bone density is typically remeasured after 2 years to assess response.&nbsp; Treatment is usually discontinued after 5 years due to a risk of atypical fracture with prolonged use.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 3749,
            "topic": "Osteoporosis",
            "titleId": 3749,
            "title": "Osteoporosis",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Nasal calcitonin",
                    "choiceNumber": 1,
                    "correctTaken": 225,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "No additional treatment, repeat DXA in a year",
                    "choiceNumber": 2,
                    "correctTaken": 1244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral alendronate",
                    "choiceNumber": 3,
                    "correctTaken": 11964,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Oral raloxifene",
                    "choiceNumber": 4,
                    "correctTaken": 2966,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Transdermal estrogen",
                    "choiceNumber": 5,
                    "correctTaken": 1805,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2402,2529,true,-1,1*2744,2874,true,-1,1*2973,3145,true,-1,1*1431,1578,true,-1,1*906,957,true,-1,1*222,272,true,-1,1*608,634,true,-1,1*366,441,true,-1,1*477,556,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "623",
                    "mediaDataId": 0,
                    "title": "Osteoporosis and osteoporosis medications",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 50,
            "notes": null,
            "peopleTaken": 18204,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 66,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 662,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 23746,
            "questionIndex": 107984,
            "questionText": "<p>A 6-year-old girl is brought to the office for a routine health supervision visit.&nbsp; The mother is concerned about her growth and picky eating habits.&nbsp; The patient has no gastrointestinal symptoms.&nbsp; She was born at 37 weeks gestation with a birth weight of 2.7 kg (5 lb 15 oz) after an uncomplicated pregnancy.&nbsp; The patient performs well in school.&nbsp; She has had surgery for strabismus.&nbsp; Her mother is 170 cm (5 ft 7 in) and her father is 183 cm (6 ft).&nbsp; The patient&#39;s height is 2.5 standard deviations below the mean.&nbsp; Weight is tracking at the 30th percentile.&nbsp; Temperature is 36.9 C (98.4 F), blood pressure is 92/50 mm Hg, and pulse is 86/min.&nbsp; The patient has a high-arched palate, malocclusion of the teeth, and short metacarpal bones.&nbsp; Which of the following is the most appropriate supplementation for this child for improving growth?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t91407\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Turner syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Etiology</strong></p></td><td><ul><li>Complete or partial loss of X chromosome</li></ul></td></tr><tr><td><p align=\"center\"><strong>Presentation</strong></p></td><td><ul><li>Infancy:<ul style=\"list-style-type:circle;\"><li>Lymphedema, cystic hygroma</li><li>Renal &amp; heart defects (eg, horseshoe kidney, aortic coarctation, bicuspid aortic valve)</li></ul></li><li>Childhood:<ul style=\"list-style-type:circle;\"><li>Short stature</li><li>Dysmorphic features (eg, webbed neck, broad chest, high-arched palate, cubitus valgus, short 4th metacarpals)</li></ul></li><li>Adolescence:<ul style=\"list-style-type:circle;\"><li>Delayed thelarche</li><li>Amenorrhea (primary or secondary)</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis &amp; management</strong></p></td><td><ul><li>Karyotype (45,X)</li><li>Comorbidity screening (eg, cardiac &amp; renal imaging)</li></ul><ul><li>Growth hormone &amp; estrogen (&plusmn; progestin) therapy</li></ul></td></tr></tbody></table></div><p>This patient has short stature, defined as height &#8805;2 standard deviations below the mean or &#8804;2nd percentile for age.&nbsp; Given her high-arched palate with dental malocclusion, short metacarpal bones, and history of strabismus, her findings are suggestive of <strong>Turner syndrome</strong> (TS).</p><p>TS is caused by the loss of one X chromosome (45,X) and classically presents with the following:</p><ul><li><p><strong>Short stature</strong> occurs in virtually all patients because the <em>SHOX</em> (short stature homeobox) gene is contained on the X chromosome.&nbsp; It is often the presenting finding in children without associated manifestations (eg, lymphedema) in infancy.</p></li><li><p><a href=\"1006\">Dysmorphic features</a> include <strong>high-arched palate</strong>, <a href=\"61173\">short fourth metacarpals</a>, broad chest, and webbed neck.</p></li><li><p>Gonadal insufficiency is due to replacement of ovarian follicles by connective tissue (&#x22;streak ovaries&#x22;) and becomes apparent in adolescence (eg, absent breast development, primary amenorrhea).</p></li><li><p>Associated comorbidities include congenital heart defects and <strong>strabismus</strong>.</p></li></ul><p>Diagnosis of TS is with a <a href=\"1032\">karyotype</a>, and treatment is <strong>recombinant growth hormone</strong> when height falls &lt;5th percentile to maximize linear growth potential.&nbsp; Estradiol therapy is initiated around age 11 to induce puberty and breast development and reduce the risk for osteoporosis and associated cardiovascular complications <strong>(Choice B)</strong>.&nbsp; After menarche, progestin is typically added to mitigate endometrial hyperplasia risk.</p><p><strong>(Choice A)</strong>&nbsp; Patients with Albright hereditary osteodystrophy (pseudohypoparathyroidism), characterized by hypocalcemia and hyperphosphatemia due to parathyroid hormone resistance, typically have short stature, round facies, and short metacarpals, but symptoms of hypocalcemia (eg, paresthesia, cramping) would be expected.&nbsp; Moreover, calcium supplementation promotes bone strength by increasing bone mineral density but does not add to linear growth.</p><p><strong>(Choice C)</strong>&nbsp; High-calorie diet is indicated for malnutrition due to insufficient caloric intake, excessive nutritional losses (eg, malabsorption), or increased metabolic requirements (eg, congenital heart disease).&nbsp; Although malnutrition can result in short stature, it first causes a decline in weight percentiles.&nbsp; This patient&#39;s weight tracks normally along the 30th percentile.</p><p><strong>(Choice D)</strong>&nbsp; High-phosphorus diet may be helpful for hypophosphatemic rickets, which can cause short stature, but leg bowing would be expected.&nbsp; In addition, a high-arched palate and short metacarpals are not associated findings.</p><p><strong>(Choice F)</strong>&nbsp; Testosterone therapy is indicated in boys with hypogonadism (eg, Prader-Willi syndrome), which can be associated with short stature and pubertal delay, but this treatment is not appropriate for a prepubertal girl.</p><p><strong>Educational objective:</strong><br>Turner syndrome should be suspected in a girl with short stature and dysmorphic features (eg, short metacarpals).&nbsp; Treatment includes recombinant growth hormone to maximize linear growth potential.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 19817,
            "topic": "Turner syndrome",
            "titleId": 19817,
            "title": "Turner syndrome",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Calcium supplementation",
                    "choiceNumber": 1,
                    "correctTaken": 1883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Estradiol therapy",
                    "choiceNumber": 2,
                    "correctTaken": 540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High-calorie diet",
                    "choiceNumber": 3,
                    "correctTaken": 257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "High-phosphorus diet",
                    "choiceNumber": 4,
                    "correctTaken": 254,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recombinant growth hormone",
                    "choiceNumber": 5,
                    "correctTaken": 2045,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Testosterone therapy",
                    "choiceNumber": 6,
                    "correctTaken": 21,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1713,1980,true,-1,1*1992,2431,true,-1,1*573,690,true,-1,1*1005,1073,true,-1,1*1487,1560,true,-1,1*473,572,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "78",
                    "mediaDataId": 0,
                    "title": "Turner syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31213699",
                    "mediaDataId": 0,
                    "title": "Turner syndrome: mechanisms and management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31213699",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 5000,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 41,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 864,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 2170,
            "questionIndex": 2170,
            "questionText": "<p>A 45-year-old woman comes to the office due to 3 months of excessive hair growth over her face and body.&nbsp; Her last menstrual period was 4 months ago.&nbsp; The patient&#39;s menstrual cycle had previously been regular, and she has had 2 successful pregnancies.&nbsp; Medical history includes hypothyroidism, for which she takes a stable dose of levothyroxine; a recent TSH level was normal.&nbsp; The patient has smoked half a pack of cigarettes daily for 25 years.&nbsp; Blood pressure is 124/82 mm Hg and pulse is 72/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The patient is muscular and has an enlarged clitoris.&nbsp; There is temporal balding, and a large amount of coarse terminal hair is present on the face, back, chest, and lower abdomen.&nbsp; The remainder of the physical examination is normal.&nbsp; Urine pregnancy test is negative.&nbsp; Which of the following is the best next step in evaluation of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t37431\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Causes of hyperandrogenism in women</strong></p></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\"><strong>PCOS</strong></p></td><td><p>Oligoovulation, clinical or biochemical hyperandrogenemia, polycystic ovaries on imaging, no evidence of another diagnosis</p></td></tr><tr><td><p align=\"center\"><strong>Nonclassic CAH</strong></p></td><td><p>Oligoovulation, hyperandrogenemia, &uarr;&nbsp;17-hydroxyprogesterone levels</p></td></tr><tr><td><p align=\"center\"><strong>Ovarian/adrenal<br />tumors</strong></p></td><td><p>Older age, rapidly progressive symptoms, &uarr;&nbsp;androgen levels (&gt;3&nbsp;times upper limit of normal)</p></td></tr><tr><td><p align=\"center\"><strong>Hyperprolactinemia</strong></p></td><td><p>Amenorrhea, galactorrhea, &uarr;&nbsp;prolactin levels</p></td></tr><tr><td><p align=\"center\"><strong>Cushing syndrome</strong></p></td><td><p>Cushingoid features, nonsuppressible dexamethasone suppression test, &uarr;&nbsp;24-hour urinary free cortisol</p></td></tr><tr><td><p align=\"center\"><strong>Acromegaly</strong></p></td><td><p>Excessive growth, &uarr;&nbsp;GH &amp; IGF-1 levels</p></td></tr><tr><td colspan=\"2\"><p><strong>CAH</strong>&nbsp;=&nbsp;congenital adrenal hyperplasia; <strong>GH</strong>&nbsp;=&nbsp;growth hormone; <strong>IGF-1</strong>&nbsp;=&nbsp;insulin-like growth factor&nbsp;1; <strong>PCOS</strong>&nbsp;=&nbsp;polycystic ovary syndrome.</p></td></tr></tbody></table></div><p>Although most women with hirsutism (excessive terminal hair growth) have polycystic ovary syndrome (PCOS), <strong>rapid-onset hirsutism</strong> (eg, &lt;1 year), particularly with <strong>virilization</strong> (eg, temporal balding, excessive muscular development, enlarged clitoris), suggests very high androgen levels due to an <strong>androgen-secreting neoplasm</strong> of the ovaries or adrenal glands.</p><p>The primary ovarian androgens are testosterone, androstenedione, and dehydroepiandrosterone (DHEA).&nbsp; The adrenals also produce these androgens as well as DHEA sulfate (DHEAS).&nbsp; Therefore, women with a suspected androgen-producing tumor should be evaluated with serum <strong>testosterone and DHEAS levels</strong>:</p><ul><li>Elevated testosterone levels with normal DHEAS levels suggest an ovarian source (more common).</li><li>Elevated DHEAS levels suggest an adrenal tumor (far less common).</li></ul><p>DHEAS and DHEA have negligible intrinsic androgenic action but are converted to androstenedione and subsequently to testosterone in peripheral tissues.</p><p><strong>(Choice A)</strong>&nbsp; Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency causes elevated androgen precursors (eg, 17-hydroxyprogesterone).&nbsp; Female infants with classic CAH present at birth with ambiguous genitalia.&nbsp; In contrast, women with nonclassic CAH due to partial 21-hydroxylase deficiency develop hyperandrogenism from late childhood to early adulthood.&nbsp; However, symptoms are typically slowly progressive over years.&nbsp; Initial testing is with a basal 17-hydroxyprogesterone level; an ACTH stimulation test may be performed in patients with a moderately elevated basal screening for diagnosis.</p><p><strong>(Choice B)</strong>&nbsp; Imaging studies prior to biochemical confirmation of hyperandrogenism can be misleading because many patients have nonfunctioning adrenal and ovarian masses that have no disease manifestations.&nbsp; If DHEAS levels are elevated, an abdominal CT scan is performed to evaluate the adrenal glands.</p><p><strong>(Choice C)</strong>&nbsp; Excessive body hair is common in women with acromegaly (elevated growth hormone increases insulin-like growth factor 1 levels).&nbsp; However, hair growth is usually not rapidly progressive, and other clinical features of acromegaly (eg, enlarging facial features, macroglossia) are typically seen.</p><p><strong>(Choice D)</strong>&nbsp; An increased LH to FSH ratio is sometimes seen in PCOS; however, it is not diagnostic as results are inconsistent.&nbsp; Hirsutism is common in patients with PCOS but is typically chronic and slowly progressive, beginning around puberty.</p><p><strong>Educational objective:</strong><br>Rapid-onset hyperandrogenism, particularly with virilization, suggests an androgen-secreting ovarian or adrenal neoplasm.&nbsp; Serum testosterone and DHEAS levels are used to delineate the site of androgen production.&nbsp; Elevated testosterone with normal DHEAS suggests an ovarian source, whereas elevated DHEAS suggests an adrenal source.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 7232,
            "topic": "Hirsutism",
            "titleId": 7232,
            "title": "Hirsutism",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "ACTH stimulation test",
                    "choiceNumber": 1,
                    "correctTaken": 670,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "CT scan of the abdomen",
                    "choiceNumber": 2,
                    "correctTaken": 1293,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin-like growth factor 1 level",
                    "choiceNumber": 3,
                    "correctTaken": 232,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "LH to FSH ratio",
                    "choiceNumber": 4,
                    "correctTaken": 2108,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Testosterone and dehydroepiandrosterone sulfate levels",
                    "choiceNumber": 5,
                    "correctTaken": 11702,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24188447",
                    "mediaDataId": 0,
                    "title": "Hyperandrogenism in post-menopausal women:  a diagnosis challenge.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24188447",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29342266",
                    "mediaDataId": 0,
                    "title": "Causes, patterns, and severity of androgen excess in 1205 consecutively recruited women.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29342266",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27936531",
                    "mediaDataId": 0,
                    "title": "Endocrinology update:  hirsutism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27936531",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 221,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 16015,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 191,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 4134,
            "questionIndex": 4134,
            "questionText": "<p>A 60-year-old man is brought to the emergency department by his daughter due to a 2-day history of confusion and lethargy.&nbsp; According to the daughter, he has had a constant dry cough, fatigue, anorexia, polyuria, and constipation for several weeks.&nbsp; In addition, the patient has lost 9.1 kg (20 lb) over the past 3 months.&nbsp; He has no associated pain.&nbsp; The patient&#39;s medical history is significant for hypertension treated with chlorthalidone and for gastroesophageal reflux disease treated with over-the-counter antacids.&nbsp; He smokes 2 packs of cigarettes daily and consumes alcohol occasionally.&nbsp; Blood pressure is 130/90 mm Hg and pulse is 90/min.&nbsp; Temporal wasting is noted.&nbsp; Chest and abdominal examinations are normal.&nbsp; Mental status examination shows somnolence and disorientation to time.&nbsp; Neurologic examination shows decreased deep tendon reflexes.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"350\"><tbody><tr><td>Serum chemistry</td></tr><tr><td>&nbsp; &nbsp; Sodium</td><td>140 mEq/L</td></tr><tr><td>&nbsp; &nbsp; Potassium</td><td>4 mEq/L</td></tr><tr><td>&nbsp; &nbsp; Chloride</td><td>104 mEq/L</td></tr><tr><td>&nbsp; &nbsp; Bicarbonate</td><td>24 mEq/L</td></tr><tr><td>&nbsp; &nbsp; Creatinine</td><td>1.6 mg/dL</td></tr><tr><td>&nbsp; &nbsp; Calcium</td><td>14.4 mg/dL</td></tr><tr><td>&nbsp; &nbsp; Glucose</td><td>100 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td>Alkaline phosphatase, serum</td><td>130 U/L</td></tr><tr><td>Phosphorus (inorganic), serum</td><td>2.2 mg/dL</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t32505\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"4\"><p align=\"center\"><strong>Hypercalcemia of malignancy</strong></p></td></tr><tr><td><p align=\"center\"><strong>Cause</strong></p></td><td><p align=\"center\"><strong>Tumor type</strong></p></td><td><p align=\"center\"><strong>Mechanism</strong></p></td><td><p align=\"center\"><strong>Diagnostic</strong></p></td></tr><tr><td><p align=\"center\"><strong>PTHrP*</strong></p></td><td><ul><li>Squamous cell</li><li>Kidney &amp; bladder</li><li>Breast &amp; ovarian</li></ul></td><td><ul><li>PTH mimic</li></ul></td><td><ul><li>&darr; PTH</li><li><strong>&uarr;</strong> PTHrP</li></ul></td></tr><tr><td><p align=\"center\"><strong>Bone metastases</strong></p></td><td><ul><li>Breast</li><li>Multiple myeloma</li></ul></td><td><ul><li>&uarr; Osteolysis</li></ul></td><td><ul><li>&darr; PTH &amp; PTHrP</li><li>&darr; Vitamin D</li></ul></td></tr><tr><td><p align=\"center\"><strong>1,25-dihydroxyvitamin D</strong></p></td><td><ul><li>Lymphoma</li></ul></td><td><ul><li>&uarr; Calcium absorption</li></ul></td><td><ul><li>&darr; PTH</li><li><strong>&uarr;</strong> Vitamin D</li></ul></td></tr><tr><td colspan=\"4\"><p>*PTHrP causes ~80% of malignancy-associated hypercalcemia.</p><p><strong>PTH</strong> = parathyroid hormone; <strong>PTHrP</strong> = PTH-related protein.</p></td></tr></tbody></table></div></p><p>This patient has polyuria and neuropsychiatric symptoms consistent with hypercalcemia.&nbsp; Severe hypercalcemia can also cause impaired neuromuscular excitability, leading to weakness, diminished reflexes, and decreased gastrointestinal motility.&nbsp; In light of this patient&#39;s weight loss, temporal wasting, dry cough, and smoking history, he most likely has <strong>humoral hypercalcemia of malignancy (HHM)</strong> due to squamous cell carcinoma of the lung.&nbsp; HHM is a paraneoplastic syndrome due to the release of <strong>parathyroid hormone-related protein</strong> (PTHrP) by malignant cells, which is structurally similar to parathyroid hormone (PTH) and acts on the PTH-1 receptor.&nbsp; PTHrP causes increased bone resorption and reabsorption of calcium in the distal renal tubule.&nbsp; Increased phosphate excretion leads to hypophosphatemia.</p><p>HHM is characterized by <strong>severe</strong> (eg, &gt;14 mg/dL) <strong>and rapid-onset hypercalcemia</strong>.&nbsp; The diagnosis is often suspected on clinical grounds and can be confirmed by an elevated PTHrP level and suppressed PTH level.&nbsp; HHM is usually seen in advanced malignancy and confers a poor prognosis.</p><p><strong>(Choice A)</strong>&nbsp; Primary hyperparathyroidism causes gradual-onset, mild-to-moderate hypercalcemia (usually &lt;14 mg/dL).&nbsp; Symptoms (eg, renal stones, osteoporosis, constipation), if present, are typically chronic and nonspecific.</p><p><strong>(Choice C)</strong>&nbsp; Granulomatous diseases (eg, sarcoidosis) and lymphoma can cause hypercalcemia due to extrarenal production of 1,25-dihydroxyvitamin D.&nbsp; However, hypercalcemia due to excess 1,25-dihydroxyvitamin D would be associated with hyperphosphatemia rather than hypophosphatemia.&nbsp; Also, sarcoidosis is more common at age &lt;40.</p><p><strong>(Choices D and E)</strong>&nbsp; Osteolytic malignancies (eg, breast cancer, multiple myeloma) cause hypercalcemia due to stimulation of osteoclasts by local production of cytokines.&nbsp; This is significantly less common than HHM, and serum phosphorus levels are usually normal.&nbsp; In addition, most patients have significant associated bone pain.</p><p><strong>(Choice F)</strong>&nbsp; Milk-alkali syndrome is caused by excessive intake of calcium and absorbable alkali.&nbsp; It is characterized by hypercalcemia, metabolic alkalosis, and acute kidney injury.&nbsp; Bicarbonate levels are elevated due to increased intake and decreased renal excretion of bicarbonate.</p><p><strong>(Choice G)</strong>&nbsp; Thiazide diuretics cause increased reabsorption of calcium in the distal tubule.&nbsp; The resulting hypercalcemia is mild (usually &lt;12 mg/dL) and rarely symptomatic.</p><p><strong>Educational objective:</strong><br>Humoral hypercalcemia of malignancy is characterized by severe, symptomatic hypercalcemia.&nbsp; It is due to the release of parathyroid hormone-related protein by tumor cells, leading to increased bone resorption and reabsorption of calcium in the distal renal tubule.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2698,
            "topic": "Hypercalcemia",
            "titleId": 2698,
            "title": "Hypercalcemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Elevated parathyroid hormone",
                    "choiceNumber": 1,
                    "correctTaken": 1439,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Elevated parathyroid hormone-related protein",
                    "choiceNumber": 2,
                    "correctTaken": 12959,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased 1,25-dihydroxyvitamin D production",
                    "choiceNumber": 3,
                    "correctTaken": 207,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Local cytokine production",
                    "choiceNumber": 4,
                    "correctTaken": 89,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Metastatic osteolysis",
                    "choiceNumber": 5,
                    "correctTaken": 1411,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Milk-alkali syndrome",
                    "choiceNumber": 6,
                    "correctTaken": 774,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thiazide-induced hypercalcemia",
                    "choiceNumber": 7,
                    "correctTaken": 467,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "118,151,true,-1,1*1761,1897,true,-1,1*2097,2247,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27170690",
                    "mediaDataId": 0,
                    "title": "Cancer-related hypercalcemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27170690",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 133,
            "othersAvgTimeSpent": 88,
            "notes": null,
            "peopleTaken": 17346,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 75,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 522,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 8859,
            "questionIndex": 8871,
            "questionText": "<p>A 17-year-old girl is admitted to the hospital due to purging behavior, weight loss, and syncope.&nbsp; Nasogastric feeds are initiated, and her activities are restricted.&nbsp; On the second day of admission, the patient reports severe shortness of breath and has recurrent episodes of nonsustained ventricular tachycardia.&nbsp; Blood pressure is 82/55 mm Hg, pulse is 112/min, and respirations are 22/min.&nbsp; BMI is 14 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows an emaciated girl with bibasilar crackles and jugular venous distension.&nbsp; Serum chemistry results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Sodium</td><td style=\"vertical-align:middle;\">138 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Potassium</td><td style=\"vertical-align:middle;\">2.1 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Chloride</td><td style=\"vertical-align:middle;\">92 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Bicarbonate</td><td style=\"vertical-align:middle;\">28 mEq/L</td></tr><tr><td style=\"vertical-align:middle;\">Blood urea nitrogen</td><td style=\"vertical-align:middle;\">14 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Creatinine</td><td style=\"vertical-align:middle;\">0.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Glucose</td><td style=\"vertical-align:middle;\">90 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Magnesium</td><td style=\"vertical-align:middle;\">1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Phosphorus</td><td style=\"vertical-align:middle;\">0.9 mg/dL</td></tr></tbody></table><p>A marked increase in which of the following hormones best explains this patient&#39;s deterioration?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7368\" src=\"https://www.uworld.com/media/L17365.png\" ></p><p>This patient with anorexia nervosa developed severe electrolyte abnormalities, cardiac arrhythmias, and evidence of congestive heart failure (ie, increased pulse and respiratory rate, jugular venous distension, bibasilar lung crackles) after beginning tube feeding.&nbsp; This presentation is consistent with acute <strong>refeeding syndrome</strong>, a potentially life-threatening complication of the reintroduction of nutrition in patients with anorexia nervosa.</p><p>Refeeding syndrome is the constellation of pathologic derangements resulting from <strong>increased insulin activity</strong> as the body shifts from a state of prolonged catabolism to anabolism.&nbsp; Carbohydrate ingestion, whether enteral or intravenous, causes pancreatic insulin secretion and cellular uptake of phosphorus, potassium, and magnesium, leading to serum electrolyte deficiencies.&nbsp; <strong>Phosphorus</strong> is the primary deficient electrolyte because it is required for energy (in the form of ATP).&nbsp; Deficiencies in potassium and magnesium potentiate <strong>cardiac arrhythmias</strong> in a heart that is already atrophic from prolonged malnutrition.</p><p>Therefore, aggressive initiation of nutrition without adequate electrolyte repletion can rapidly precipitate <strong>congestive heart failure</strong> (eg, jugular venous distension, pulmonary crackles, tachypnea, as seen in this patient).&nbsp; Other common complications involve the muscular (eg, weakness, rhabdomyolysis), gastrointestinal (eg, diarrhea, elevated transaminases), and neurologic (eg, tremor, seizure) systems.</p><p><strong>(Choices A and B)</strong>&nbsp; Aldosterone and cortisol stimulate water resorption, sodium conservation, and potassium secretion to maintain blood pressure.&nbsp; These steroid hormones are high during starvation but less so during refeeding.&nbsp; In addition, they do not directly impact phosphorus or magnesium uptake.</p><p><strong>(Choice C)</strong>&nbsp; Glucagon activity is elevated during starvation but decreased during refeeding.</p><p><strong>(Choice E)</strong>&nbsp; Patients with anorexia nervosa have euthyroid hypothyroxinemia, which is characterized by normal TSH and normal to decreased serum thyroxine and triiodothyronine.</p><p><strong>Educational objective:</strong><br>Refeeding syndrome is a potentially fatal complication of nutritional rehabilitation in anorexia nervosa.&nbsp; Carbohydrate intake stimulates insulin activity, which in turn promotes cellular uptake of phosphorus, potassium, and magnesium, leading to electrolyte deficiency.&nbsp; Cardiac manifestations include arrhythmias and congestive heart failure.&nbsp; Other common complications involve the muscular (eg, weakness, rhabdomyolysis), gastrointestinal (eg, diarrhea, elevated transaminases), and neurologic (eg, tremor, seizure) systems.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 1659,
            "topic": "Refeeding Syndrome",
            "titleId": 1659,
            "title": "Refeeding Syndrome",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aldosterone",
                    "choiceNumber": 1,
                    "correctTaken": 3001,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cortisol",
                    "choiceNumber": 2,
                    "correctTaken": 1789,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Glucagon",
                    "choiceNumber": 3,
                    "correctTaken": 620,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insulin",
                    "choiceNumber": 4,
                    "correctTaken": 9810,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Triiodothyronine",
                    "choiceNumber": 5,
                    "correctTaken": 812,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "901",
                    "mediaDataId": 0,
                    "title": "Refeeding syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20798756",
                    "mediaDataId": 0,
                    "title": "Nutritional rehabilitation: practical guidelines for refeeding the anorectic patient.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20798756",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "12507806",
                    "mediaDataId": 0,
                    "title": "Hypophosphatemia during nutritional rehabilitation in anorexia nervosa: implications for refeeding and monitoring.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/12507806",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 64,
            "notes": null,
            "peopleTaken": 16032,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 61,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1767,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 3489,
            "questionIndex": 3489,
            "questionText": "<p>A 48-year-old man comes to the office due to generalized bone pain.&nbsp; The patient has a history of Crohn disease and underwent extensive small bowel resection several months ago.&nbsp; His current medications are mesalamine and infliximab, and he has not used glucocorticoids recently.&nbsp; The patient has a sedentary lifestyle and spends most of his time watching television.&nbsp; Physical examination shows bony tenderness of the lower spine, pelvis, and lower extremities.&nbsp; There is mild weakness of proximal limb muscles.&nbsp; Radiographs reveal diffuse osteopenia of the spine and pseudofractures in both femoral necks.&nbsp; Which of the following sets of laboratory findings is most consistent with this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t52397\"><table class=\"table-default-style table-header-footer-style\" style=\"width:531px\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features of osteomalacia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Malabsorption</li><li>Intestinal bypass surgery</li><li>Celiac disease</li><li>Chronic liver disease</li><li>Chronic kidney disease</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Symptoms/signs</strong></p></td><td><ul><li>May be asymptomatic</li><li>Bone pain &amp; muscle weakness</li><li>Muscle cramps</li><li>Difficulty walking, waddling gait</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Diagnosis</strong></p></td><td><ul><li>&uarr; Alkaline phosphatase, &uarr; PTH</li><li>&darr; Serum calcium &amp; phosphorus, &darr; urinary calcium</li><li>&darr; 25(OH)D levels</li><li>Imaging<ul style=\"list-style-type:circle;\"><li>Cortical thinning &amp; reduced bone density</li><li>Bilateral symmetric pseudofractures (Looser zones)</li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p><strong>25(OH)D</strong> = 25-hydroxycholecalciferol; <strong>PTH</strong> = parathyroid hormone.</p></td></tr></tbody></table></div><p>This patient with Crohn disease who underwent extensive bowel resection now has bone pain,&nbsp;proximal muscle weakness, and x-rays revealing osteopenia and pseudofractures (cortical infarction/insufficiency fractures traversing part of the bone).&nbsp; This presentation suggests&nbsp;<strong>osteomalacia</strong>, characterized by reduced mineralization of osteoid at bone-forming sites.&nbsp; Osteomalacia is common in patients with malabsorptive disorders (eg, Crohn disease with bowel resection) due to <strong>chronic deficiency of vitamin D</strong>.</p><p>Although patients can be asymptomatic, many develop <strong>generalized&nbsp;</strong><strong>bone pain</strong>&nbsp;(including at the sites of pseudofractures) and <strong>muscle weakness</strong>.&nbsp; Alkaline phosphatase levels are almost always elevated, reflecting increased bone remodeling.&nbsp; Vitamin D deficiency leads to decreased intestinal calcium (leading to hypocalcemia) and phosphorus absorption (leading to hypophosphatemia).&nbsp; Hypocalcemia and low vitamin D levels trigger increased <strong>parathyroid hormone (PTH)</strong>&nbsp;secretion (ie, secondary hyperparathyroidism), which <a href=\"20543\">increases bone resorption and renal calcium reabsorption</a>.&nbsp; PTH also increases urinary phosphate excretion, which further worsens hypophosphatemia.&nbsp; Therefore, the net effect is <strong>increased PTH</strong>, <strong>very low serum phosphorus</strong>, and <strong>mildly low or low-normal serum calcium</strong>.</p><p>Although 25-hydroxyvitamin D levels are low (decreased total body stores), levels of 1,25-dihydroxyvitamin D are variable because it is produced in the kidneys in response to PTH.&nbsp; &nbsp;X-ray findings seen with osteomalacia&nbsp;include cortical thinning, concave vertebral bodies (codfish vertebrae), and <strong>pseudofractures</strong> (<a href=\"26250\">Looser zones</a>).</p><p><strong>(Choice A)</strong>&nbsp; Increased calcium, low phosphate, and increased PTH levels are seen in patients with primary hyperparathyroidism.&nbsp; Although hyperparathyroidism can cause osteopenia, most patients are asymptomatic or have minor, nonspecific symptoms (eg, fatigue, constipation).&nbsp; Pseudofractures, diffuse bony tenderness, and history of intestinal resection more strongly suggest osteomalacia.</p><p><strong>(Choice B)</strong>&nbsp; Low calcium, increased phosphate, and low PTH levels are seen in patients with hypoparathyroidism.&nbsp; Symptoms typically relate to hypocalcemia (eg, carpal spasm, perioral paresthesia), and osteopenia would be unexpected.</p><p><strong>(Choice D)</strong>&nbsp; Normal levels of calcium, vitamin D, and PTH would be seen in osteoporosis, which would cause decreased bone density but would not cause generalized bone pain/tenderness, muscle weakness, or pseudofractures.</p><p><strong>(Choice E)</strong>&nbsp; Osteolytic bone metastases release calcium and phosphorus from bone, suppressing PTH secretion.&nbsp; A compensatory increase in fibroblast growth factor 23 may subsequently normalize serum phosphorus.&nbsp; X-rays would show irregular lytic lesions rather than symmetric pseudofractures.</p><p><strong>Educational objective:</strong><br>Intestinal malabsorption with chronic vitamin D deficiency can lead to osteomalacia, which is characterized by reduced mineralization of osteoid.&nbsp; Symptoms include bone pain and muscle weakness.&nbsp; Laboratory findings include hypocalcemia, hypophosphatemia, increased parathyroid hormone, and elevated alkaline phosphatase.&nbsp; X-ray findings include cortical thinning, concave vertebral bodies, and pseudofractures.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11552,
            "topic": "Vitamin D deficiency",
            "titleId": 11552,
            "title": "Vitamin D deficiency",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; \">Increased</td><td style=\"width:33%; \">Decreased</td><td style=\"width:33%; \">Increased</td></tr></tbody></table>",
                    "choiceNumber": 1,
                    "correctTaken": 3023,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; \">Decreased</td><td style=\"width:33%; \">Increased</td><td style=\"width:33%;\">Decreased</td></tr></tbody></table>",
                    "choiceNumber": 2,
                    "correctTaken": 840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; \">Decreased</td><td style=\"width:33%; \">Decreased</td><td style=\"width:33%;\">Increased</td></tr></tbody></table>",
                    "choiceNumber": 3,
                    "correctTaken": 10078,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; \">Normal</td><td style=\"width:33%; \">Normal</td><td style=\"width:33%; \">Normal</td></tr></tbody></table>",
                    "choiceNumber": 4,
                    "correctTaken": 875,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%;\">Increased</td><td style=\"width:33%; \">Normal</td><td style=\"width:33%; \">Decreased</td></tr></tbody></table>",
                    "choiceNumber": 5,
                    "correctTaken": 1170,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "395,486,true,-1,1*292,314,true,-1,1*206,233,true,-1,1*3014,3293,true,-1,1*2794,2871,true,-1,1*2299,2338,true,-1,1*370,386,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "575",
                    "mediaDataId": 0,
                    "title": "Vitamin deficiencies and toxicities",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22525844",
                    "mediaDataId": 0,
                    "title": "Osteomalacia as a result of vitamin D deficiency.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22525844",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 87,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 15986,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"420\"><tbody><tr style=\"text-align:center;\"><td style=\"width:33%; \"><strong>Serum calcium</strong></td><td style=\"width:33%; \"><strong>Serum phosphate</strong></td><td style=\"width:33%; \"><strong>Serum parathyroid hormone</strong></td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 1157,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 20932,
            "questionIndex": 22435,
            "questionText": "<p>A 54-year-old man is evaluated for progressive fatigue with diffuse muscle aches and generalized pain over the last 3 months.&nbsp; Two years earlier, he was transferred to a long-term care facility after developing paraplegia from a back injury sustained in a motor vehicle collision.&nbsp; The patient has neurogenic bladder, managed with intermittent urinary catheterization.&nbsp; He is a lifelong nonsmoker and has never consumed alcohol.&nbsp; Vital signs are normal.&nbsp; Bilateral lower extremity weakness with increased tone and hyperreflexia is noted.&nbsp; There is tenderness on palpation over the anterior tibia on both sides.&nbsp; The remainder of the examination is unremarkable.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Complete blood count</td><td style=\"vertical-align:middle;\">Normal</td></tr><tr><td style=\"vertical-align:middle;\">Erythrocyte sedimentation rate</td><td style=\"vertical-align:middle;\">14 mm/hr</td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\"></td></tr><tr><td colspan=\"2\" style=\"vertical-align:middle;\">Serum chemistry</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td style=\"vertical-align:middle;\">1.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td style=\"vertical-align:middle;\">8.6 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;Albumin</td><td style=\"vertical-align:middle;\">3.9 g/L</td></tr><tr><td style=\"vertical-align:middle;\">&nbsp;&nbsp;&nbsp;&nbsp;TSH</td><td style=\"vertical-align:middle;\">1.3 &micro;U/mL</td></tr></tbody></table><p>Which of the following is the most appropriate next step?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T76369\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Vitamin D deficiency</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Decreased sun exposure (eg, nocturnal occupation,<br>nursing home residence, northern latitudes)</li><li>Heavy skin pigmentation</li><li>Obesity</li><li>Malabsorption</li><li>Advanced age</li><li>Chronic kidney disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Asymptomatic or nonspecific musculoskeletal symptoms</li><li>Low bone density, bone fracture</li><li>Osteomalacia: bone pain, muscle weakness</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Serum 25-hydroxyvitamin D<ul style=\"list-style-type:circle;\"><li>Insufficiency: 20-30 ng/mL</li><li>Deficiency: &lt;20 ng/mL</li></ul></li></ul></td></tr></tbody></table></div><p>This patient with chronic residual paraplegia (increased tone and hyperreflexia) now has nonspecific myalgia with bone pain and tenderness.&nbsp; Common causes of myalgia include inflammatory conditions (eg, polymyalgia rheumatica) and thyroid disease, but the patient&#39;s normal erythrocyte sedimentation rate (ESR) and TSH make these less likely.&nbsp; In light of his residence in a long-term care facility, this should raise suspicion for <strong>osteomalacia</strong> (decreased osteoid mineralization) due to <strong>vitamin D deficiency</strong>.</p><p><a href=\"2966\">Vitamin D</a> is derived from <strong>dietary sources</strong> (eg, fortified dairy products, oily fish) and is also generated in the skin due to <strong>sunlight exposure</strong>.&nbsp; Dietary vitamin D deficiency can occur in patients with malabsorption or a significant change in dietary habits, whereas inadequate dermal production is frequently seen in patients with reduced sunlight exposure due to nocturnal occupation or <strong>residence in a long-term health care facility</strong>.</p><p>Deficiency of vitamin D causes impaired intestinal absorption of calcium.&nbsp; The compensatory rise in parathyroid hormone (PTH) restores calcium levels to normal or near normal (by inducing calcium absorption from the intestine and reabsorption from the kidney) but leads to renal phosphate wasting and impaired bone mineralization.&nbsp; Vitamin D deficiency should be confirmed with a <strong>serum 25-hydroxyvitamin D level</strong>, which reflects total body stores (1,25-dihydroxyvitamin D primarily reflects PTH levels and renal function and is not an accurate marker for deficiency).</p><p><strong>(Choice B)</strong>&nbsp; Antinuclear antibodies are sensitive for systemic lupus erythematosus and related disorders.&nbsp; Lupus may cause fatigue and nonspecific symptoms, but is uncommon in men, especially after age 50; most patients have elevated inflammatory markers (eg, ESR).</p><p><strong>(Choice C)</strong>&nbsp; Paget disease of bone, which often can be identified on bone scintigraphy, is most common at age &gt;50 and can cause chronic bone pain and tenderness.&nbsp; However, symptoms are typically focal and asymmetric; muscle pain and generalized body pain are uncommon.</p><p><strong>(Choice D)</strong>&nbsp; Serum protein electrophoresis can identify a monoclonal gammopathy (eg, multiple myeloma) or a polyclonal gammopathy due to a variety of inflammatory diseases.&nbsp; However, ESR is usually elevated in these disorders, and this patient&#39;s normal blood counts, calcium, and creatinine make myeloma unlikely.</p><p><strong>Educational objective:</strong><br>Vitamin D is derived from dietary sources and generated in the skin due to sunlight exposure.&nbsp; Deficiency can occur in patients with inadequate sunlight exposure, such as residents of long-term health care facilities.&nbsp; Vitamin D deficiency is confirmed with a serum 25-hydroxyvitamin D level.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11552,
            "topic": "Vitamin D deficiency",
            "titleId": 11552,
            "title": "Vitamin D deficiency",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "25-hydroxyvitamin D level",
                    "choiceNumber": 1,
                    "correctTaken": 2410,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Antinuclear antibody assay",
                    "choiceNumber": 2,
                    "correctTaken": 494,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bone scan",
                    "choiceNumber": 3,
                    "correctTaken": 1503,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum protein electrophoresis",
                    "choiceNumber": 4,
                    "correctTaken": 618,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1487,1741,true,-1,1*92,157,true,-1,1*158,189,true,-1,1*204,216,true,-1,1*311,327,true,-1,1*329,342,true,-1,1*2256,2511,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "575",
                    "mediaDataId": 0,
                    "title": "Vitamin deficiencies and toxicities",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 202,
            "othersAvgTimeSpent": 132,
            "notes": null,
            "peopleTaken": 5025,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 781,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 4308,
            "questionIndex": 4308,
            "questionText": "<p>A 56-year-old man is admitted to the hospital with severe nausea and vomiting.&nbsp; He has also had fatigue, poor appetite, polyuria, polydipsia, and constipation for several weeks.&nbsp; The patient has a history of hypertension and type 2 diabetes mellitus.&nbsp; His home medications include metformin, lisinopril, and hydrochlorothiazide.&nbsp; He has a 40-pack-year smoking history and drinks alcohol occasionally.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 110/70 mm Hg, pulse is 102/min, and respirations are 16/min.&nbsp; His mucous membranes are dry.&nbsp; The rest of the physical examination is unremarkable.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td>Calcium</td><td>14.8 mg/dL</td></tr><tr><td>Albumin</td><td>4.0 g/dL</td></tr><tr><td>Parathyroid hormone, intact</td><td>5 pg/mL</td></tr><tr><td>Creatinine</td><td>1.9 mg/dL</td></tr><tr><td>Urea nitrogen</td><td>54 mg/dL</td></tr><tr><td>Glucose</td><td>180 mg/dL</td></tr><tr><td>25-hydroxyvitamin D</td><td>50 ng/mL (normal, 20-60 ng/mL)</td></tr><tr><td>1,25-dihydroxyvitamin D</td><td>17 pg/mL (normal, 15-65 pg/mL)</td></tr></tbody></table></blockquote><p>Which of the following is the most likely cause of this patient&#39;s hypercalcemia?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"286\" src=\"https://www.uworld.com/media/L7026.png\" ></p><p><strong>Hypercalcemia</strong> can be categorized as either <strong>parathyroid hormone (PTH) dependent</strong> (high-normal or increased PTH [eg, hyperparathyroidism]) or <strong>independent</strong> (low/suppressed PTH).&nbsp; <strong>Humoral hypercalcemia of malignancy</strong> (HHM) is the most common cause of PTH-independent hypercalcemia and frequently presents with very high (eg, &gt;14 mg/dL), symptomatic (eg, polyuria, constipation, nausea) calcium levels.&nbsp; HHM should be strongly suspected in this patient in light of his smoking history, systemic symptoms (eg, fatigue, poor appetite), and <strong>markedly elevated calcium</strong> with <strong>low PTH</strong>.</p><p>HHM is due to secretion of <strong>PTH-related protein</strong> (PTHrP) by malignant cells and is associated with squamous cell (eg, lung, head and neck), renal, bladder, breast, or ovarian carcinomas.&nbsp; PTHrP causes increased bone resorption and increased reabsorption of calcium in the distal renal tubule.&nbsp; However, PTHrP does not induce the conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D to the same extent as PTH does, and so 1,25-dihydroxyvitamin D levels will be low or low-normal.</p><p>Other causes of PTH-independent hypercalcemia in malignancy include bony destruction by osteolytic metastasis (eg, breast, non-small cell lung cancer, non-Hodgkin lymphoma, multiple myeloma), increased production of 1,25-dihydroxyvitamin D (eg, lymphoma), and increased interleukin-6 levels (eg, multiple myeloma).</p><p><strong>(Choice A)</strong>&nbsp; Chronic kidney disease causes decreased renal production of vitamin D, leading to hypocalcemia, hyperphosphatemia, and a compensatory rise in PTH (secondary hyperparathyroidism).</p><p><strong>(Choice B)</strong>&nbsp; Hydrochlorothiazide increases urinary calcium reabsorption, which can mildly increase serum calcium levels (usually &lt;12 mg/dL).&nbsp; Severe hypercalcemia does not occur.</p><p><strong>(Choice D)</strong>&nbsp; Rapid bony destruction due to skeletal metastasis may cause hypercalcemia, but the gradual bone loss seen in osteoporosis does not affect serum calcium levels.</p><p><strong>(Choice E)</strong>&nbsp; Primary hyperparathyroidism rarely causes severe hypercalcemia (calcium is usually &lt;12 mg/dL), and this patient&#39;s suppressed PTH level rules out this diagnosis.</p><p><strong>(Choice F)</strong>&nbsp; Sarcoidosis and certain hematologic malignancies (eg, lymphoma) can cause hypercalcemia due to increased conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D.&nbsp; However, this patient&#39;s low-normal 1,25-dihydroxyvitamin D level makes this less likely.</p><p><strong>Educational objective:</strong><br>Humoral hypercalcemia of malignancy is the most common cause of parathyroid hormone (PTH)-independent hypercalcemia and frequently presents with very high, symptomatic calcium levels.&nbsp; It is due to secretion of PTH-related protein by malignant cells.&nbsp; Other mechanisms of tumor-related hypercalcemia include osteolytic bone metastasis, increased production of 1,25-dihydroxyvitamin D, and increased interleukin-6 levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2698,
            "topic": "Hypercalcemia",
            "titleId": 2698,
            "title": "Hypercalcemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic kidney disease",
                    "choiceNumber": 1,
                    "correctTaken": 4351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hydrochlorothiazide-induced hypercalcemia",
                    "choiceNumber": 2,
                    "correctTaken": 7877,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypercalcemia of malignancy",
                    "choiceNumber": 3,
                    "correctTaken": 16877,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteoporosis",
                    "choiceNumber": 4,
                    "correctTaken": 43,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperparathyroidism",
                    "choiceNumber": 5,
                    "correctTaken": 451,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoidosis",
                    "choiceNumber": 6,
                    "correctTaken": 280,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "787,891,true,-1,1*1346,1401,true,-1,1*1783,1941,true,-1,1*2215,2295,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24021907",
                    "mediaDataId": 0,
                    "title": "Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24021907",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21897221",
                    "mediaDataId": 0,
                    "title": "Mechanisms and treatment of hypercalcemia of malignancy.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21897221",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 131,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 29879,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 623,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 18133,
            "questionIndex": 19597,
            "questionText": "<p>A 45-year-old man comes to the office due to loss of sexual desire and failure to attain satisfactory erections during intercourse.&nbsp; He has no morning erections.&nbsp; The patient has no leg or buttock pain with exertion but has had intermittent bilateral hand pain.&nbsp; Medical history is significant for type 2 diabetes mellitus and recent-onset peripheral neuropathy.&nbsp; He does not use tobacco or alcohol.&nbsp; The patient has a 12-year-old child from a previous marriage and now lives with his second wife.&nbsp; Blood pressure is 120/70 mm Hg and pulse is 70/min.&nbsp; BMI is 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; The neck is supple with no thyromegaly or lymphadenopathy.&nbsp; Cardiopulmonary examination is normal.&nbsp; The abdomen is soft and nontender with palpable hepatomegaly.&nbsp; Genital examination shows small testes bilaterally but otherwise normal secondary sexual characteristics.&nbsp; Peripheral pulses are 2+, and capillary refill in the feet is normal.&nbsp; Neurologic examination demonstrates normal deep tendon reflexes and muscle strength; sensation is mildly decreased in both ankles.&nbsp; Visual field testing is normal.&nbsp; What is the best next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T61062\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hereditary hemochromatosis</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Hyperpigmentation</li><li>Arthropathy</li><li>Hepatomegaly, cirrhosis, hepatocellular carcinoma</li><li>Diabetes mellitus</li><li>Hypopituitarism, secondary hypogonadism</li><li>Cardiomyopathy</li></ul></td></tr><tr><td><p align=\"center\"><strong>Diagnosis</strong></p></td><td><ul><li>Elevated liver transaminases</li><li>Elevated serum ferritin, transferrin saturation</li><li><em>HFE</em>&nbsp;genetic mutations</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Therapeutic phlebotomy (urgent if ferritin &gt;1,000 ng/mL)</li></ul></td></tr></tbody></table></div><p>This patient has hypogonadism presenting with decreased libido and erectile dysfunction (ED); the loss of morning erections suggests an organic rather than psychogenic cause of ED.&nbsp; In addition, he has features suggestive of <strong>hereditary hemochromatosis</strong> (HH), including diabetes mellitus (despite a normal BMI), joint pain, and hepatomegaly.&nbsp; HH is due to <strong>excessive absorption of iron</strong> and <strong>deposition of excess iron</strong> in the tissues.&nbsp; HH can cause <strong>secondary hypogonadism</strong> due to iron deposition in the pituitary, which impairs production of gonadotropins (and often other pituitary hormones), leading to decreased testicular testosterone production and testicular atrophy.</p><p>Initial assessment of iron stores in patients with suspected HH should include <strong>serum iron, serum ferritin</strong>, and <strong>transferrin saturation</strong> (ie, serum iron/total iron binding capacity &times; 100).&nbsp; The diagnosis is confirmed with <em><strong>HFE</strong></em>&nbsp;<strong>genetic testing</strong>.&nbsp; Concurrently, hypogonadism can be assessed with serum testosterone, FSH, and LH, which are characteristically low.&nbsp; Treatment includes therapeutic phlebotomy.</p><p><strong>(Choice A)</strong>&nbsp; Klinefelter syndrome (ie, 47,XXY by karyotype analysis) can cause hypogonadism; however, patients are typically infertile (this patient has a child).&nbsp; Also, Klinefelter syndrome does not cause joint pain or hepatomegaly.</p><p><strong>(Choice B)</strong>&nbsp; Nocturnal polysomnography is used as an initial test for obstructive sleep apnea, which can be associated with erectile dysfunction.&nbsp; Obstructive sleep apnea is common in patients with diabetes but is typically seen in those with significant obesity.&nbsp; This patient has a normal BMI and no specific symptoms (eg, morning headache) of sleep apnea.</p><p><strong>(Choices C and F)</strong>&nbsp; Testosterone replacement can treat hypogonadal symptoms (eg, decreased libido), and phosphodiesterase-5 inhibitors (eg, sildenafil) can often improve erectile function.&nbsp; These interventions may be useful for this patient later but may be unnecessary if phlebotomy restores gonadal function.&nbsp; Empiric treatment without proper diagnostic evaluation can lead to serious complications of HH, such as heart failure and cirrhosis.&nbsp; This patient has a normal BMI, which indicates that his diabetes (and neuropathy) could be due to underlying undiagnosed HH rather than insulin resistance from obesity.</p><p><strong>(Choice D)</strong>&nbsp; Scrotal ultrasound is typically performed in patients with possible testicular malignancy (eg, scrotal mass) or other structural abnormalities (eg, hydrocele).&nbsp; It is unlikely to be helpful in evaluation of bilateral testicular atrophy.</p><p><strong>Educational objective:</strong><br>Hereditary hemochromatosis can cause secondary hypogonadism due to iron deposition in the pituitary with deficient production of gonadotropins.&nbsp; Initial assessment should include serum iron, serum ferritin, and transferrin saturation.&nbsp; The diagnosis is confirmed with <em>HFE</em> genetic testing.&nbsp; Treatment includes therapeutic phlebotomy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 16509,
            "topic": "Hemochromatosis",
            "titleId": 16509,
            "title": "Hemochromatosis",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Karyotype analysis",
                    "choiceNumber": 1,
                    "correctTaken": 510,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Nocturnal polysomnography",
                    "choiceNumber": 2,
                    "correctTaken": 527,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phosphodiesterase-5 inhibitor therapy",
                    "choiceNumber": 3,
                    "correctTaken": 3702,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Scrotal ultrasound",
                    "choiceNumber": 4,
                    "correctTaken": 874,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum ferritin level",
                    "choiceNumber": 5,
                    "correctTaken": 5276,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Testosterone replacement therapy",
                    "choiceNumber": 6,
                    "correctTaken": 2785,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "354,410,true,-1,1*1779,1855,true,-1,1*2086,2682,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "626",
                    "mediaDataId": 0,
                    "title": "Hemochromatosis",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 205,
            "othersAvgTimeSpent": 81,
            "notes": null,
            "peopleTaken": 13674,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 39,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 833,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 3102,
            "questionIndex": 3102,
            "questionText": "<p>A 56-year-old woman is found to have hypercalcemia during routine laboratory testing for a life insurance policy.&nbsp; She has a history of moderate asthma and has been evaluated for 2 episodes of acute bronchitis in the last 3 years.&nbsp; The patient has a 30-pack-year smoking history but does not use alcohol or illicit drugs.&nbsp; Her family history is negative for hypercalcemia.&nbsp; Current medications include inhaled budesonide and albuterol, and the patient takes a daily multivitamin tablet.&nbsp; Her temperature is 36.7 C (98 F), blood pressure is 120/70 mm Hg, pulse is 76/min, and respirations are 14/min.&nbsp; Neurologic examination shows no focal deficits and deep-tendon reflexes are normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td>Hematocrit</td><td>43%</td></tr><tr><td>Leukocytes</td><td>6,300/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Platelets</td><td>200,000/mm<font size=\"2\"><sup>3</sup></font></td></tr><tr><td>Serum calcium</td><td>11.2 mg/dL</td></tr><tr><td>Serum albumin</td><td>4.0 g/dL</td></tr><tr><td>Serum creatinine</td><td>1.0 mg/dL</td></tr></tbody></table><p>Review of the patient&#39;s medical records reveals a serum calcium level of 10.9 mg/dL a year ago.&nbsp; Which of the following is the best next step to determine the cause of this patient&#39;s hypercalcemia?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"286\" src=\"https://www.uworld.com/media/L7026.png\" ></p><p>Causes of <strong>hypercalcemia</strong> can be categorized on the basis of parathyroid hormone (PTH) levels as PTH-dependent or PTH-independent:</p><ul><li><strong>PTH-independent</strong> hypercalcemia (suppressed PTH) is usually due to malignancy, vitamin D toxicity, or extra-renal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D in granulomatous diseases (eg, sarcoidosis).</li><li><strong>PTH-dependent</strong> hypercalcemia (elevated or inappropriately normal PTH) is usually due to <strong>primary hyperparathyroidism</strong> (PHPT).</li></ul><p>This patient has chronic, asymptomatic hypercalcemia, most likely due to PHPT.&nbsp; In normal individuals, elevated plasma calcium <a href=\"629\">suppresses PTH secretion</a>.&nbsp; However, in PHPT, PTH secretion from autonomously functioning parathyroid adenomas or parathyroid hyperplasia is not suppressed.&nbsp; Most patients with PHPT present with <strong>mild, asymptomatic hypercalcemia</strong>, although potential clinical features may include nephrolithiasis, osteoporosis, nausea, constipation, and neuropsychiatric symptoms (&#x22;stones, bones, abdominal moans, psychic groans&#x22;).&nbsp; In this patient with chronic, asymptomatic hypercalcemia and no family history of hypercalcemia, an elevated PTH level would be virtually diagnostic for PHPT.</p><p><strong>(Choices A, B, E, and F)</strong>&nbsp; Most cases of PTH-independent hypercalcemia are due to malignancy.&nbsp; If the PTH is suppressed, diagnostic options may include chest imaging (primary or metastatic lung cancer), PTH-related protein (humoral hypercalcemia of malignancy), scintigraphic bone scan (bony metastasis), and serum protein electrophoresis (multiple myeloma).&nbsp; However, in hypercalcemia due to malignancy, serum calcium is typically much higher (often &gt;14 mg/dL) than in this patient and more acute.&nbsp; In addition, patients are more likely to be symptomatic (eg, polyuria, dehydration, mental status changes).</p><p><strong>(Choice C)</strong>&nbsp; Although elevated alkaline phosphatase can suggest a possible bone disorder, it is not specific enough to detail the type of bone condition causing the hypercalcemia.</p><p><strong>Educational objective:</strong><br>Causes of hypercalcemia should be categorized on the basis of parathyroid hormone (PTH) levels.&nbsp; PTH-independent hypercalcemia (suppressed PTH) is usually due to malignancy.&nbsp; PTH-dependent hypercalcemia (elevated or inappropriately normal PTH) is usually due to primary hyperparathyroidism.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 2698,
            "topic": "Hypercalcemia",
            "titleId": 2698,
            "title": "Hypercalcemia",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "4",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bone scan",
                    "choiceNumber": 1,
                    "correctTaken": 459,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chest x-ray",
                    "choiceNumber": 2,
                    "correctTaken": 5244,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum alkaline phosphatase level",
                    "choiceNumber": 3,
                    "correctTaken": 567,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum parathyroid hormone level",
                    "choiceNumber": 4,
                    "correctTaken": 19010,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum parathyroid hormone-related protein level",
                    "choiceNumber": 5,
                    "correctTaken": 4059,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Serum protein electrophoresis",
                    "choiceNumber": 6,
                    "correctTaken": 233,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1040,1200,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "468",
                    "mediaDataId": 0,
                    "title": "Calcium disorders",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "1763670",
                    "mediaDataId": 0,
                    "title": "Differential diagnosis of hypercalcemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/1763670",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "1599819",
                    "mediaDataId": 0,
                    "title": "Hypercalcemia and parathyroid disorders.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/1599819",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 188,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 29572,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 64,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 698,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 3868,
            "questionIndex": 3868,
            "questionText": "<p>A 6-year-old girl is brought to the office by her parents after they noticed the development of axillary and pubic hair.&nbsp; She has also had a significant growth spurt over the past year.&nbsp; There has been no change in her behavior or school performance.&nbsp; The patient has no headaches, vomiting, or visual disturbances.&nbsp; She has no chronic medical conditions and takes no medications.&nbsp; Family history is unremarkable.&nbsp; BMI is at the 97th percentile for age and sex.&nbsp; The abdomen is soft, nontender, and nondistended.&nbsp; Axillary hair is present and pubic hair is Tanner stage 3; external genitalia are normal.&nbsp; The breasts are Tanner stage 3.&nbsp; Neurologic examination is normal.&nbsp; Bone age is advanced.&nbsp; Serum FSH and LH levels are elevated.&nbsp; Which of the following is the most likely etiology of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7168\" src=\"https://www.uworld.com/media/L17403.png\" ></p><p>This patient has <strong>breast</strong> and <strong>pubic/axillary hair</strong> development consistent with <strong>precocious puberty</strong>, the onset of secondary sexual characteristics in girls age &lt;8 and boys age &lt;9.&nbsp; The initial evaluation of patients with precocious puberty is a bone age radiograph, which helps differentiate true precocious puberty from other causes of early pubic/axillary hair development (eg, premature adrenarche).&nbsp; Patients with true precocious puberty have increased estrogen/testosterone levels that accelerate skeletal maturation, resulting in <strong>advanced bone age</strong> and increased growth velocity (as seen in this patient).</p><p>The etiology of precocious puberty is categorized as either central (gonadotropin-dependent) or peripheral (gonadotropin-independent).</p><ul><li><p><strong>Central precocious puberty</strong> (CPP) results from <strong>early activation</strong> of the <strong>hypothalamic-pituitary-gonadal (HPG) axis</strong>.&nbsp; Pulsatile GnRH secretion stimulates <strong>elevated FSH and LH levels</strong>, as seen in this patient.</p></li><li><p>Peripheral precocious puberty (PPP) is caused by gonadal or adrenal release of excess sex hormones.&nbsp; Basal levels of FSH and LH are typically low due to negative feedback and remain low following GnRH agonist stimulation.</p></li></ul><p>Patients with CPP require MRI of the brain to evaluate for a hypothalamic or pituitary tumor activating the HPG axis.&nbsp; If MRI is negative, the cause is most likely idiopathic precocious puberty, and GnRH therapy can be initiated.&nbsp; GnRH desensitizes the pituitary and suppresses FSH and LH secretion to slow pubertal progression and maximize height potential.</p><p><strong>(Choices B and E)</strong>&nbsp; Estrogen-producing ovarian cysts and exogenous estrogen exposure result in PPP.&nbsp; Although girls may demonstrate premature development of secondary sexual characteristics and may also have advanced bone age, they have low FSH and LH levels.</p><p><strong>(Choice C)</strong>&nbsp; Excess peripheral conversion of testosterone to estrogen, as seen with aromatase excess, results in precocious puberty in girls but low FSH and LH due to feedback inhibition.</p><p><strong>(Choices D and F)</strong>&nbsp; Elevated 17-hydroxyprogesterone is found in patients with congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency.&nbsp; Significant increases in dehydroepiandrosterone sulfate occur in patients with an adrenal tumor.&nbsp; CAH and adrenal tumors can cause PPP; affected patients have low FSH and LH levels.</p><p><strong>Educational objective:</strong><br>Precocious puberty, the onset of secondary sexual characteristics in girls age &lt;8 and boys age &lt;9, has both central and peripheral causes.&nbsp; Central precocious puberty is due to early activation of the hypothalamic-pituitary-gonadal axis and presents with increased levels of FSH and LH.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23716,
            "topic": "Precocious puberty",
            "titleId": 23716,
            "title": "Precocious puberty",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Early activation of the hypothalamic-pituitary-ovarian axis",
                    "choiceNumber": 1,
                    "correctTaken": 13650,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Estrogen-producing ovarian cysts",
                    "choiceNumber": 2,
                    "correctTaken": 345,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Excess peripheral conversion of testosterone to estrogen",
                    "choiceNumber": 3,
                    "correctTaken": 977,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Excess production of 17-hydroxyprogesterone",
                    "choiceNumber": 4,
                    "correctTaken": 840,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Exogenous estrogen exposure",
                    "choiceNumber": 5,
                    "correctTaken": 176,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased adrenal production of dehydroepiandrosterone sulfate",
                    "choiceNumber": 6,
                    "correctTaken": 651,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "431,636,true,-1,1*888,976,true,-1,1*1200,1558,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "100",
                    "mediaDataId": 0,
                    "title": "Precocious puberty",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27191050",
                    "mediaDataId": 0,
                    "title": "Central precocious puberty:  revisiting the diagnosis and therapeutic management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27191050",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22016677",
                    "mediaDataId": 0,
                    "title": "Gonadotropin-releasing hormone stimulation test for precocious puberty.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22016677",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16639,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1116,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 3598,
            "questionIndex": 3598,
            "questionText": "<p>A 27-year-old woman comes to the office due to a 2-month history of dark hair growth on her cheeks, chin, and upper lip.&nbsp; Her last menstrual period was 12 weeks ago, but she did not seek medical care because a home pregnancy test was negative.&nbsp; The patient is gravida 0 para 0; her menstrual cycles began at age 11 and have previously been regular.&nbsp; She has no associated weight changes, visual disturbances, skin striae, headaches, or proximal muscle weakness.&nbsp; She takes no medications, including over-the-counter medications.&nbsp; Family history is unremarkable.&nbsp; Physical examination shows a BMI of 24 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Her skin is oily with acne on the forehead and cheeks.&nbsp; Dark terminal hairs are noted on the upper lip, cheeks, chin, chest, and lower abdomen.&nbsp; Examination of the genitals shows clitoromegaly.&nbsp; Abdominal examination is normal.&nbsp; Pelvic ultrasound reveals a normal uterus and ovaries.&nbsp; CT scan of the abdomen reveals a left adrenal mass.&nbsp; Which of the following patterns of plasma hormone levels is likely to be present in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t37200\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Causes of hirsutism in women </strong></p></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Etiology </strong></p></td><td style=\"width: 65%;\"><p align=\"center\"><strong>Clinical features </strong></p></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Polycystic ovary syndrome </strong></p></td><td style=\"width: 65%;\"><ul><li>Oligomenorrhea, hyperandrogenism, obesity</li><li>Associated with type 2 diabetes, dyslipidemia, hypertension</li></ul></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Idiopathic hirsutism </strong></p></td><td style=\"width: 65%;\"><ul><li>Normal menstruation</li><li>Normal serum androgens</li></ul></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Nonclassic<br />21-hydroxylase deficiency </strong></p></td><td style=\"width: 65%;\"><ul><li>Similar to polycystic ovary syndrome</li><li>Elevated serum 17-hydroxyprogesterone</li></ul></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Androgen-secreting ovarian tumors, ovarian hyperthecosis </strong></p></td><td style=\"width: 65%;\"><ul><li>More common in postmenopausal women</li><li>Rapidly progressive hirsutism with virilization</li><li>Very high serum androgens</li></ul></td></tr><tr><td style=\"width: 35%;\"><p align=\"center\"><strong>Cushing syndrome </strong></p></td><td style=\"width: 65%;\"><ul><li>Obesity (usually of the face, neck, trunk, abdomen)</li><li>Increased libido, virilization, irregular menses</li></ul></td></tr></tbody></table></div></p><p>Women normally produce a number of androgens, including testosterone (T), androstenedione (AS), dehydroepiandrosterone (DHEA), and <strong>dehydroepiandrosterone sulfate</strong> (DHEAS).&nbsp; AS, DHEA, and T are produced by both the ovaries and the adrenals.&nbsp; In contrast, DHEAS is produced predominantly in the <strong>adrenal glands</strong>.</p><p>This patient has an adrenal mass with rapidly progressive (ie, over weeks) <strong>hirsutism</strong> (excess terminal hair growth) and <strong>virilization</strong> (eg, clitoromegaly), suggesting very high androgen levels due to an androgen-producing neoplasm.&nbsp; Most androgen-producing adrenal tumors overproduce DHEAS.&nbsp; Although DHEA and DHEAS are used as diagnostic markers, they have negligible androgenic activity, and the clinical features are due to the conversion of DHEA and DHEAS to more potent androgens (ie, AS and T).&nbsp; Therefore, this patient would most likely have elevated DHEAS and T levels.&nbsp; LH would be low due to negative feedback by T.</p><p><strong>(Choice B)</strong>&nbsp; Low androgen with low LH levels would be seen in hypopituitarism with hypogonadotropic hypogonadism, which can cause amenorrhea but would have other manifestations of ovarian insufficiency (eg, hot flashes, vaginal dryness) rather than hirsutism and virilization.</p><p><strong>(Choice C)</strong>&nbsp; Virilizing ovarian tumors can release large amounts of T, leading to suppression of LH release.&nbsp; DHEAS would be normal as adrenal androgen secretion is regulated primarily by ACTH rather than LH.&nbsp; However, this patient&#39;s pelvic ultrasound does not reveal an ovarian tumor.</p><p><strong>(Choice D)</strong>&nbsp; Polycystic ovary syndrome (PCOS) can cause hyperandrogenism with ovulatory dysfunction.&nbsp; T and LH would be increased, and some patients have increased adrenal androgen production as well.&nbsp; However, this patient&#39;s ovaries have normal morphology, and rapidly progressive hirsutism with virilization would be unusual in PCOS.</p><p><strong>(Choice E)</strong>&nbsp; Patients with idiopathic hirsutism have normal androgen and LH levels.&nbsp; However, symptoms would be more slowly progressive, and menstrual cycles would be normal.</p><p><strong>Educational objective:</strong><br>Rapidly progressive hirsutism with virilization suggests very high androgen levels due to an androgen-producing neoplasm.&nbsp; Elevated dehydroepiandrosterone sulfate levels are seen in androgen-producing adrenal tumors.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 7232,
            "topic": "Hirsutism",
            "titleId": 7232,
            "title": "Hirsutism",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td align=\"center\" width=\"33%\">High</td><td align=\"center\" width=\"33%\">High</td><td align=\"center\" width=\"33%\">Low</td></tr></tbody></table>",
                    "choiceNumber": 1,
                    "correctTaken": 13256,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td align=\"center\" width=\"33%\">Low</td><td align=\"center\" width=\"33%\">Low</td><td align=\"center\" width=\"33%\">Low</td></tr></tbody></table>",
                    "choiceNumber": 2,
                    "correctTaken": 63,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td align=\"center\" width=\"33%\">Normal</td><td align=\"center\" width=\"33%\">High</td><td align=\"center\" width=\"33%\">Low</td></tr></tbody></table>",
                    "choiceNumber": 3,
                    "correctTaken": 2351,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td align=\"center\" width=\"33%\">Normal or high</td><td align=\"center\" width=\"33%\">High</td><td align=\"center\" width=\"33%\">High</td></tr></tbody></table>",
                    "choiceNumber": 4,
                    "correctTaken": 1759,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"500\"><tbody><tr><td align=\"center\" width=\"33%\">Normal</td><td align=\"center\" width=\"33%\">Normal</td><td align=\"center\" width=\"33%\">Normal</td></tr></tbody></table>",
                    "choiceNumber": 5,
                    "correctTaken": 31,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "855,992,true,-1,1*1282,1490,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 159,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 17460,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": "<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"550\"><tbody><tr><td align=\"center\" width=\"40%\">Dehydroepiandrosterone sulfate</td><td align=\"center\" width=\"27%\">Testosterone</td><td align=\"center\" width=\"33%\">Luteinizing hormone</td></tr></tbody></table>",
            "standards": null,
            "totalTimeSpentReview": 1189,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 3867,
            "questionIndex": 3867,
            "questionText": "<p>A 5-year-old girl is brought to the office for evaluation of pubic hair.&nbsp; Her mother noticed dark hair under the girl&#39;s arms and in her pubic area several days ago when helping her bathe.&nbsp; The patient has no headaches, visual changes, abdominal pain, or behavioral changes.&nbsp; She is obese and currently on a diet and exercise program.&nbsp; Several maternal relatives have type 2 diabetes mellitus.&nbsp; The patient&#39;s height has been tracking along the 50th percentile and weight at the 97th percentile.&nbsp; Physical examination shows a cooperative girl with mild facial acne.&nbsp; No breast buds are palpable.&nbsp; She has dark, coarse hair across the pubis and under both axillae.&nbsp; External genitalia appear normal.&nbsp; Bone age is normal.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"7168\" src=\"https://www.uworld.com/media/L17403.png\" ></p><p>Development of secondary sexual characteristics is premature (ie, precocious) in girls age &lt;8 and boys age &lt;9.&nbsp; <strong>Obese</strong> children are at high risk for precocious development as adiposity can trigger excess insulin production, which then stimulates the adrenal glands to produce sex hormones.</p><p>Isolated <strong>premature adrenarche</strong> is caused by early activation of <strong>adrenal androgens</strong>.&nbsp; Typical manifestations include body odor, oily skin, <strong>acne</strong>, and <strong>pubic and axillary hair</strong>.&nbsp; However, estrogen and testosterone levels remain normal; therefore, there are no other signs of premature puberty (eg, breast development, testicular enlargement) or virilization (eg, clitoromegaly).&nbsp; Mildly elevated dehydroepiandrosterone sulfate present in children with premature adrenarche is not sufficient to affect skeletal growth; therefore, <strong>bone age is normal</strong> in these patients.</p><p>Isolated premature adrenarche is generally benign but a risk factor for developing polycystic ovary syndrome, type 2 diabetes mellitus, and metabolic syndrome, especially in obese patients.</p><p><strong>(Choice A)</strong>&nbsp; Girls with classic congenital adrenal hyperplasia (CAH) present in infancy with salt-wasting and virilization.&nbsp; Due to partial 21-hydroxylase deficiency, nonclassic (late-onset) CAH manifests in childhood with premature pubarche/adrenarche (without virilization).&nbsp; However, significant elevations in androgen levels associated with CAH accelerate skeletal maturity, and an advanced bone age is expected.</p><p><strong>(Choice B)</strong>&nbsp; Granulosa cell estrogen/progesterone-secreting tumors typically present in middle-aged women with an ovarian mass and menstrual abnormalities.&nbsp; In rare cases, children with this tumor may have premature breast development and menses due to hyperestrogenism, but not isolated acne and pubic hair.</p><p><strong>(Choice C)</strong>&nbsp; Malignant testosterone-secreting hepatoblastomas are a rare cause of premature adrenarche and occur almost exclusively in boys.</p><p><strong>(Choices D, E, and G)</strong>&nbsp; Hypothalamic glioma, pituitary hamartoma, and idiopathic precocious puberty are causes of central precocious puberty, which is characterized by advanced bone age, elevated FSH and LH, and true precocious development (eg, breast development).</p><p><strong>(Choice F)</strong>&nbsp; McCune-Albright syndrome is characterized by peripheral precocious puberty, irregular caf&eacute;-au-lait macules, and fibrous dysplasia of the bone.&nbsp; Girls typically have premature vaginal bleeding and breast development, which are not seen in this child.</p><p><strong>Educational objective:</strong><br>Premature adrenarche is caused by early activation of adrenal androgens and is more common in obese children.&nbsp; Typical presentation includes precocious development of pubic and axillary hair, acne, and body odor in a child with a normal bone age.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 23716,
            "topic": "Precocious puberty",
            "titleId": 23716,
            "title": "Precocious puberty",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "8",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Congenital adrenal hyperplasia",
                    "choiceNumber": 1,
                    "correctTaken": 2694,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Granulosa cell tumor",
                    "choiceNumber": 2,
                    "correctTaken": 1100,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hepatoblastoma",
                    "choiceNumber": 3,
                    "correctTaken": 14,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothalamic glioma",
                    "choiceNumber": 4,
                    "correctTaken": 73,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Idiopathic precocious puberty",
                    "choiceNumber": 5,
                    "correctTaken": 2426,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "McCune-Albright syndrome",
                    "choiceNumber": 6,
                    "correctTaken": 571,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary hamartoma",
                    "choiceNumber": 7,
                    "correctTaken": 82,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Premature adrenarche",
                    "choiceNumber": 8,
                    "correctTaken": 9578,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1194,1346,true,-1,1*2210,2461,true,-1,1*143,319,true,-1,1*881,1070,true,-1,1*692,880,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "100",
                    "mediaDataId": 0,
                    "title": "Precocious puberty",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23355935",
                    "mediaDataId": 0,
                    "title": "Update on statural growth and pubertal development in obese children.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23355935",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19117864",
                    "mediaDataId": 0,
                    "title": "Thelarche, pubarche, and menarche attainment in children with normal and elevated body mass index.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19117864",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16538,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 58,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1898,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 14616,
            "questionIndex": 16030,
            "questionText": "<p>A 2-day-old infant is evaluated in the newborn nursery.&nbsp; The patient was born at term via spontaneous vaginal delivery to a 30-year-old woman.&nbsp; The pregnancy and delivery were uncomplicated.&nbsp; The mother had regular prenatal care, and her only medication was a daily prenatal vitamin.&nbsp; Family history is unremarkable.&nbsp; The patient&#39;s length at birth was at the 10th percentile.&nbsp; Weight and head circumference were at the 25th percentile.&nbsp; On initial examination after delivery, the patient was found to have ambiguous genitalia.&nbsp; The infant has been breastfeeding and has had appropriate urine and stool output.&nbsp; Examination shows an alert newborn with normal tone.&nbsp; The abdomen is soft with no palpable masses.&nbsp; Genitourinary examination reveals severe curvature of an underdeveloped phallus.&nbsp; The urethral meatus is at the base of the structure, flanked by labioscrotal folds; the gonads are not palpable.&nbsp; Examination of the mother shows no acne or hirsutism.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td colspan=\"2\">Serum chemistry</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Sodium</td><td>138 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Potassium</td><td>4.0 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Chloride</td><td>102 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Bicarbonate</td><td>24 mEq/L</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Blood urea nitrogen</td><td>11 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Creatinine</td><td>0.6 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Calcium</td><td>9.2 mg/dL</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Glucose</td><td>70 mg/dL</td></tr><tr><td colspan=\"2\" height=\"15\"></td></tr><tr><td colspan=\"2\">Endocrine</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Testosterone, serum</td><td>850 ng/dL (normal: 20-80)&nbsp;</td></tr><tr><td>&nbsp;&nbsp;&nbsp;&nbsp;Karyotype</td><td>46,XX</td></tr></tbody></table><p>Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t48644\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Classic congenital adrenal hyperplasia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Autosomal recessive</li><li>21-Hydroxylase deficiency &rarr; &darr; aldosterone, &darr; cortisol, &uarr; androgens</li></ul></td></tr><tr><td><p align=\"center\"><strong>Clinical presentation</strong></p></td><td><ul><li>Atypical (or ambiguous) genitalia (eg, clitoromegaly in 46,XX infant)</li><li>Adrenal crisis* (eg, vomiting, diarrhea, hypotension)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory findings</strong></p></td><td><ul><li>&darr; Sodium, &uarr; potassium &amp; &darr; glucose*</li><li>&uarr; 17-Hydroxyprogesterone</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Glucocorticoid &amp; mineralocorticoid replacement</li><li>Sodium chloride supplementation</li></ul></td></tr><tr><td colspan=\"2\"><p>*Adrenal crisis &amp; electrolyte abnormalities develop at age 1-3 weeks due to transient protective effects of maternal hormones at birth.</p></td></tr></tbody></table></div><p>This newborn with a 46,XX karyotype and <strong>ambiguous genitalia</strong> likely has <strong>congenital adrenal hyperplasia</strong> (CAH).&nbsp; The most common cause of CAH is <a href=\"678\">21-hydroxylase deficiency</a>, which results in decreased cortisol and aldosterone and <strong>increased 17-hydroxyprogesterone</strong> (17-OHP), the normal substrate for 21-hydroxylase.&nbsp; 17-OHP is then converted to <strong>testosterone</strong> in peripheral tissues.&nbsp; This excess androgen production leads to <strong>virilization</strong> (eg, clitoromegaly/underdeveloped phallus, nonpalpable gonads) in genotypically female <strong>(46,XX)</strong> infants, as seen in this patient.</p><p>Although most patients with classic CAH develop salt wasting (due to deficient aldosterone), <strong>electrolyte abnormalities</strong> (ie, hyponatremia, hyperkalemia) do not occur until <strong>age 1-2 weeks</strong>; in the first few days of life, serum electrolytes are normal due to the presence of maternal adrenal hormones.</p><p>Patients with suspected CAH require prompt treatment with glucocorticoids and mineralocorticoids to avoid a potentially fatal adrenal crisis (eg, hypotension, dehydration, vomiting).</p><p><strong>(Choice A)</strong>&nbsp; 5-Alpha reductase deficiency causes defective conversion of testosterone to dihydrotestosterone and classically presents in genotypically male (46,XY) newborns with female or undervirilized external genitalia.&nbsp; In addition, the testosterone level is normal.</p><p><strong>(Choice B)</strong>&nbsp; Androgen insensitivity syndrome is due to a defect in the androgen receptor and presents in genotypically male (46,XY) newborns with undervirilized, ambiguous, or female external genitalia.&nbsp; This infant has a 46,XX karyotype.</p><p><strong>(Choice D)</strong>&nbsp; Placental aromatase deficiency prevents the conversion of placental androgens into estrogens.&nbsp; Androgen excess causes virilization of the female fetus.&nbsp; The mother is also typically virilized, which is not seen in this patient&#39;s mother, due to the transplacental transfer of androgens.</p><p><strong>(Choice E)</strong>&nbsp; Sertoli-Leydig cell tumors produce androgens (eg, 17-OHP, testosterone) and cause virilization in female patients; however, presentation is typically in early adulthood, not the newborn period.</p><p><strong>Educational objective:</strong><br>Classic congenital adrenal hyperplasia occurs due to 21-hydroxylase deficiency, which leads to the buildup of 17-hydroxyprogesterone and testosterone.&nbsp; Genotypically female newborns (46,XX) have virilized genitalia (eg, underdeveloped phallus) and nonpalpable gonads.&nbsp; Electrolyte abnormalities do not develop until age 1-2 weeks.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 104,
            "subject": "Pediatrics",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 10495,
            "topic": "Congenital adrenal hyperplasia",
            "titleId": 10495,
            "title": "Congenital adrenal hyperplasia",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "3",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "5-Alpha reductase deficiency",
                    "choiceNumber": 1,
                    "correctTaken": 1864,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Androgen insensitivity syndrome",
                    "choiceNumber": 2,
                    "correctTaken": 1614,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Congenital adrenal hyperplasia",
                    "choiceNumber": 3,
                    "correctTaken": 7031,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Placental aromatase deficiency",
                    "choiceNumber": 4,
                    "correctTaken": 4330,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertoli-Leydig cell tumor",
                    "choiceNumber": 5,
                    "correctTaken": 1669,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "405,483,true,-1,1*485,619,true,-1,1*1273,1474,true,-1,1*2329,2463,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "571",
                    "mediaDataId": 0,
                    "title": "Congenital adrenal hyperplasia",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30291599",
                    "mediaDataId": 0,
                    "title": "Gender identity and sexual function in 46,XX patients with congenital adrenal hyperplasia raised as males.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30291599",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23624815",
                    "mediaDataId": 0,
                    "title": "An unexpected diagnosis in children with male phenotype and bilateral nonpalpable gonad: congenital adrenal hyperplasia with female genotype.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23624815",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 112,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 16508,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 43,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2370,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 3996,
            "questionIndex": 3996,
            "questionText": "<p>A 17-year-old girl comes to the office for evaluation of irregular menses.&nbsp; The patient reports irregular menses since menarche at age 13, and her menstrual cycle has become increasingly unpredictable.&nbsp; Over the past year, she has had 5 menstrual periods.&nbsp; Her most recent period was 6 weeks ago and it lasted 10 days, with heavy bleeding and large clots.&nbsp; The patient has also gained 10 kg (22 lb) over the last year and has been unable to lose weight despite changes in her diet.&nbsp; She has no medical problems and has had no surgeries.&nbsp; She does not use tobacco, alcohol, or recreational drugs.&nbsp; Blood pressure is 130/80 mm Hg and pulse is 76/min.&nbsp; BMI is 28 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; Physical examination shows coarse hair along the chin.&nbsp; There is no thyromegaly or palpable neck masses.&nbsp; The abdomen is soft and nontender, with no striae or palpable masses.&nbsp; Deep tendon reflexes of the extremities are normal, and no pedal edema is present.&nbsp; Hemoglobin is 10.2 g/dL.&nbsp; TSH and prolactin levels are normal.&nbsp; A urine pregnancy test is negative.&nbsp; Which of the following is the best next step for addressing this patient&#39;s irregular menses?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33552\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Polycystic ovary syndrome</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li><strong>Androgen excess</strong> (eg,&nbsp;acne, male pattern baldness, hirsutism)</li><li>Oligoovulation or anovulation (eg,&nbsp;<strong>menstrual irregularities</strong>)</li><li>Obesity</li><li><strong>Polycystic ovaries</strong> on ultrasonography</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathophysiology</strong></p></td><td><ul><li>&uarr;&nbsp;Testosterone levels</li><li>&uarr;&nbsp;Estrogen levels</li><li>LH/FSH imbalance</li></ul></td></tr><tr><td><p align=\"center\"><strong>Comorbidities</strong></p></td><td><ul><li>Metabolic syndrome (eg,&nbsp;diabetes mellitus, hypertension)</li><li>Obstructive sleep apnea</li><li>Metabolic dysfunction&ndash;associated steatohepatitis</li><li>Endometrial hyperplasia/cancer</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment<br />options</strong></p></td><td><ul><li>Weight loss (first line)</li><li>Oral contraceptive pills for menstrual regulation</li><li>Letrozole for ovulation induction</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>irregular menses</strong>, <strong>hirsutism</strong> (eg, coarse hair along chin), and weight gain are consistent with <strong>polycystic ovary syndrome (PCOS)</strong>.&nbsp; Patients with PCOS often have hyperandrogenism, diagnosed either clinically (eg, hirsutism, severe acne, androgenic alopecia) or biochemically (eg, elevated testosterone levels).&nbsp; Hyperandrogenism, and the subsequent hyperestrogenism (due to <a href=\"5388\">peripheral androgen conversion</a>), results in chronic anovulation.&nbsp; Anovulatory cycles cause irregular menses, decreased progesterone secretion, and <a href=\"5965\">uncontrolled endometrial proliferation</a> from unopposed estrogen.&nbsp; When menstrual periods do occur, they are often associated with heavy bleeding that may result in anemia.</p><p>The first-line therapy for menstrual regulation is a combination of weight loss and <strong>combined estrogen/progestin oral contraceptives</strong>.&nbsp; Combined oral contraceptives contain progesterone to stimulate endometrial differentiation (ie, limit continued proliferation) and estrogen to stabilize the uterine lining, which restores normal cycles.&nbsp; In addition, combined oral contraceptives reduce hirsutism by blocking adrenal androgen secretion and increasing production of sex hormone-binding globulin, which binds and decreases free testosterone.</p><p><strong>(Choice A)</strong>&nbsp; A CT scan of the adrenal gland can be used in the evaluation of adrenocortical tumors as causes of hyperandrogenism.&nbsp; Patients with adrenocortical tumors typically have virilization (eg, clitoromegaly, deepening voice), abdominal striae, and elevated dehydroepiandrosterone sulfate levels.</p><p><strong>(Choice C)</strong>&nbsp; <a href=\"44313\">Letrozole</a>, an aromatase inhibitor, is administered for ovulation induction in PCOS to treat infertility.&nbsp; It does not regulate menses.</p><p><strong>(Choice D)</strong>&nbsp; Leuprolide, a gonadotropin-releasing hormone agonist, is used in the treatment of endometriosis.&nbsp; Patients with endometriosis have dysmenorrhea, chronic pelvic pain, and no evidence of hyperandrogenism.</p><p><strong>(Choice E)</strong>&nbsp; Levothyroxine is used to treat hypothyroidism, which can cause irregular menses, but patients also have elevated TSH levels.&nbsp; This patient has a normal TSH level.</p><p><strong>(Choice F)</strong>&nbsp; Spironolactone, an androgen receptor antagonist, is indicated for treatment of hirsutism; it does not regulate menstrual cycles.</p><p><strong>Educational objective:</strong><br>Polycystic ovary syndrome may present with irregular menses and signs of hyperandrogenism (eg, hirsutism).&nbsp; Treatment involves weight loss and oral contraceptives containing estrogen and progestin to regulate menstrual cycles.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 8274,
            "topic": "Polycystic ovary disease",
            "titleId": 8274,
            "title": "Polycystic ovary disease",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Order CT scan of the adrenal gland",
                    "choiceNumber": 1,
                    "correctTaken": 916,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe combined oral contraceptives",
                    "choiceNumber": 2,
                    "correctTaken": 10156,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe letrozole",
                    "choiceNumber": 3,
                    "correctTaken": 430,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe leuprolide",
                    "choiceNumber": 4,
                    "correctTaken": 519,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe levothyroxine",
                    "choiceNumber": 5,
                    "correctTaken": 103,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe spironolactone",
                    "choiceNumber": 6,
                    "correctTaken": 659,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "258,296,true,-1,1*1454,1860,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "60",
                    "mediaDataId": 0,
                    "title": "Polycystic ovary syndrome",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "18252787",
                    "mediaDataId": 0,
                    "title": "Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/18252787",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19888063",
                    "mediaDataId": 0,
                    "title": "ACOG Practice Bulletin No. 108: polycystic ovary syndrome.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19888063",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23311996",
                    "mediaDataId": 0,
                    "title": "Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23311996",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24151290",
                    "mediaDataId": 0,
                    "title": "Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24151290",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 111,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 12783,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1059,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 15794,
            "questionIndex": 17231,
            "questionText": "<p>A 34-year-old man comes to the office due to lack of sexual desire and erectile dysfunction for 3 months.&nbsp; Medical history is significant for opioid use disorder, for which he has been taking methadone for 2 years.&nbsp; The patient has gained 4.5 kg (10 lb) over the past 6 months.&nbsp; Vital signs are normal.&nbsp; BMI is 24.5 kg/m<font size=\"2\"><sup>2</sup></font>.&nbsp; On examination, the testes are small and soft.&nbsp; There is no gynecomastia.&nbsp; Visual field and thyroid examination findings are normal.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Total testosterone</td><td style=\"vertical-align:middle;\">200 ng/dL (normal: 264-916)</td></tr><tr><td style=\"vertical-align:middle;\">LH</td><td style=\"vertical-align:middle;\">4 mU/mL</td></tr><tr><td style=\"vertical-align:middle;\">Prolactin</td><td style=\"vertical-align:middle;\">14 ng/mL</td></tr><tr><td style=\"vertical-align:middle;\">TSH</td><td style=\"vertical-align:middle;\">3.1 &micro;U/mL</td></tr></tbody></table><p>Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T59842\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Male secondary hypogonadism</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Fatigue, decreased libido</li><li>Testicular atrophy</li><li>Laboratory: low testosterone, low/normal LH</li></ul></td></tr><tr><td><p align=\"center\"><strong>Common causes</strong></p></td><td><ul><li>Pituitary tumors, hyperprolactinemia</li><li>Medications: opioids, glucocorticoids, exogenous androgens (withdrawal phase)</li><li>Infiltrative disease (eg, hemochromatosis)</li><li>Chronic/severe illness</li><li>Eating disorders, severe weight loss</li></ul></td></tr></tbody></table></div><p>This patient has <strong>secondary hypogonadism</strong> presenting with low libido, erectile dysfunction, and a <strong>low serum testosterone</strong> level.&nbsp; Secondary (ie, pituitary, hypothalamic) hypogonadism can be differentiated from primary hypogonadism by a <strong>low or inappropriately normal LH</strong>.&nbsp; In primary hypogonadism, the elevated gonadotropin (eg, LH) levels stimulate aromatization of estrogen precursors (eg, androstenedione) from the adrenal gland, leading to gynecomastia; in contrast, breast enlargement in secondary hypogonadism is less prominent.</p><p>Secondary hypogonadism is a common adverse effect of opioids.&nbsp; <strong>Opioids suppress GnRH and LH</strong> secretion, leading to reduced Leydig cell testosterone synthesis, decreased spermatogenesis, and testicular atrophy.&nbsp; Additional manifestations can include depression, hot flashes, and osteoporosis.&nbsp; In women, menstrual irregularities are common.</p><p><strong>(Choice A)</strong>&nbsp; Klinefelter syndrome (47,XXY) is a common chromosomal disorder that causes primary hypogonadism.&nbsp; It manifests with small, firm testes; low serum testosterone; and elevated LH levels.&nbsp; Gynecomastia is often present.</p><p><strong>(Choice C)</strong>&nbsp; Pituitary mass lesions can cause secondary hypogonadism due to disruption of the hypophyseal portal vessels or direct injury to the LH-secreting gonadotrophs.&nbsp; However, these disorders typically cause a mild to moderate elevation in prolactin (20-200 ng/mL) due to disruption of dopaminergic neurons in the pituitary stalk.</p><p><strong>(Choice D)</strong>&nbsp; Rapid or severe weight loss (eg, anorexia nervosa) can cause secondary hypogonadism due to the suppression of GnRH secretion.&nbsp; Although overweight and obese patients may have mildly low testosterone levels, moderate weight gain in a patient with a normal BMI would not cause symptomatic hypogonadism.</p><p><strong>Educational objective:</strong><br>Secondary hypogonadism in men presents with low libido, erectile dysfunction, a low serum testosterone level, and a low or inappropriately normal LH level.&nbsp; Secondary hypogonadism is a common adverse effect of opioids, which suppress GnRH and LH secretion, leading to reduced Leydig cell testosterone synthesis.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 4600,
            "topic": "Male sexual dysfunction",
            "titleId": 4600,
            "title": "Male sexual dysfunction",
            "topicAttributeId": 330665,
            "topicAttribute": "Reproductive endocrinology",
            "correctAnswer": "2",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Klinefelter syndrome",
                    "choiceNumber": 1,
                    "correctTaken": 1189,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effect",
                    "choiceNumber": 2,
                    "correctTaken": 7385,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Pituitary tumor",
                    "choiceNumber": 3,
                    "correctTaken": 2324,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Rapid weight gain",
                    "choiceNumber": 4,
                    "correctTaken": 2785,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "664,926,true,-1,1*1135,1265,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "481",
                    "mediaDataId": 0,
                    "title": "Sexual dysfunction",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30343356",
                    "mediaDataId": 0,
                    "title": "Testosterone deficiency in non-cancer opioid-treated patients.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30343356",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 47,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 13683,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 54,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 694,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 3490,
            "questionIndex": 3490,
            "questionText": "<p>A 45-year-old woman comes to the clinic due to fatigue, weakness, and diffuse bone pain.&nbsp; She was diagnosed with celiac disease 5 years ago but continues to consume gluten-containing foods on occasion.&nbsp; The patient takes over-the-counter folic acid and iron supplements.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Hemoglobin</td><td style=\"vertical-align:middle;\">12.2 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">9.0 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Phosphate</td><td style=\"vertical-align:middle;\">2.6 mg/dL (normal: 3-4.5)</td></tr><tr><td style=\"vertical-align:middle;\">Parathyroid hormone</td><td style=\"vertical-align:middle;\">122 pg/mL (normal: 10-65)</td></tr><tr><td style=\"vertical-align:middle;\">Alkaline phosphatase</td><td style=\"vertical-align:middle;\">234 U/L (normal: 36-92)</td></tr></tbody></table><p>Which of the following is directly responsible for this patient&#39;s bone pain?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t52397\"><table class=\"table-default-style table-header-footer-style\" style=\"width:531px\"><tbody><tr><td colspan=\"2\"><p align=\"center\" style=\"margin-left:.1in;\"><strong>Clinical features of osteomalacia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Malabsorption</li><li>Intestinal bypass surgery</li><li>Celiac disease</li><li>Chronic liver disease</li><li>Chronic kidney disease</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Symptoms/signs</strong></p></td><td><ul><li>May be asymptomatic</li><li>Bone pain &amp; muscle weakness</li><li>Muscle cramps</li><li>Difficulty walking, waddling gait</li></ul></td></tr><tr><td><p align=\"center\" style=\"margin-left:.1in;\"><strong>Diagnosis</strong></p></td><td><ul><li>&#8593; Alkaline phosphatase, &#8593; PTH</li><li>&#8595; Serum calcium &amp; phosphorus, &#8595; urinary calcium</li><li>&#8595; 25(OH)D levels</li><li>Imaging<ul style=\"list-style-type:circle;\"><li>Cortical thinning &amp; reduced bone density</li><li>Bilateral symmetric pseudofractures (Looser zones)</li></ul></li></ul></td></tr><tr><td colspan=\"2\"><p><strong>25(OH)D</strong> = 25-hydroxycholecalciferol; <strong>PTH</strong> = parathyroid hormone.</p></td></tr></tbody></table></div><p>This patient has <strong>osteomalacia</strong>, presenting with fatigue, <strong>bone pain</strong>, and <strong>hypophosphatemia</strong>.&nbsp; Osteomalacia is a potential complication of vitamin D deficiency and is frequently seen in patients with <strong>malabsorptive disorders</strong> (eg, celiac disease).&nbsp; In addition to bone pain, manifestations may include muscle weakness, a waddling gait, and increased risk of fracture.&nbsp; Bone density is typically decreased, and x-ray may reveal linear <a href=\"26250\">Looser zones</a>.</p><p><a href=\"2966\">1,25-dihydroxyvitamin D</a> is required for optimal intestinal absorption of calcium and phosphorus.&nbsp; In vitamin D deficiency, <a href=\"7937\">intestinal calcium absorption is impaired</a>, leading to a series of metabolic alterations:</p><ul><li><p>Secretion of <strong>parathyroid hormone</strong> (PTH) is increased (ie, secondary hyperparathyroidism) to maintain circulating calcium levels.</p></li><li><p>PTH causes release of calcium from bone stores, increases renal calcium reabsorption, and suppresses renal phosphate reabsorption.</p></li><li><p>As a result, circulating <strong>calcium</strong> levels can be restored to normal or near normal, but <strong>phosphate</strong> levels are reduced (as in this patient).</p></li></ul><p>During new <a href=\"15008\">bone formation and remodeling</a>, osteoclasts create a cavity at the bone surface that osteoblasts fill with organic matrix (osteoid).&nbsp; Calcium and inorganic phosphate then deposit in the matrix to mineralize the newly formed bone.&nbsp; However, calcium or phosphorus deficiency at the mineralization front will lead to <strong>reduced mineralization</strong> of the osteoid matrix.</p><p><strong>(Choice A)</strong>&nbsp; Paget disease of bone is characterized by accelerated focal bone remodeling.&nbsp; It starts with increased osteoclastic activity, followed by rapid and disorganized new bone formation.&nbsp; Alkaline phosphatase is elevated (indicating increased osteoblast activity).&nbsp; However, serum calcium, phosphorus, and PTH levels are typically normal.</p><p><strong>(Choice B)</strong>&nbsp; Osteogenesis imperfecta is due to defective formation of type 1 collagen, which is required for development of bone, tendons, ligaments, skin, teeth, and sclera.&nbsp; It typically presents in childhood with fragility fractures, and additional manifestations (eg, short stature, impaired hearing, blue sclera) are often present.</p><p><strong>(Choice D)</strong>&nbsp; Osteoporosis is characterized by low bone mass, but the bone usually has adequate mineralization.&nbsp; Laboratory evaluation shows normal serum calcium, phosphorus, PTH, and alkaline phosphatase.</p><p><strong>(Choice E)</strong>&nbsp; Lytic bone lesions are due to malignant cell infiltration by solid tumors (eg, breast, renal cell) or multiple myeloma, which induce activation of osteoclasts and local destruction of bone.&nbsp; Due to the release of bone mineral, hypercalcemia is common, and PTH will be suppressed.</p><p><strong>Educational objective:</strong><br>Osteomalacia is due to defective mineralization of bone matrix.&nbsp; It is most commonly due to vitamin D deficiency, which leads to decreased intestinal calcium and phosphorus absorption with resultant secondary hyperparathyroidism.&nbsp; Clinical features include bone pain, muscle weakness, hypophosphatemia, and increased risk of fracture.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 11552,
            "topic": "Vitamin D deficiency",
            "titleId": 11552,
            "title": "Vitamin D deficiency",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "3",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Accelerated focal bone remodeling",
                    "choiceNumber": 1,
                    "correctTaken": 4810,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Defective formation of collagen",
                    "choiceNumber": 2,
                    "correctTaken": 99,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Impaired osteoid matrix mineralization",
                    "choiceNumber": 3,
                    "correctTaken": 6551,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Low bone mass with normal mineralization",
                    "choiceNumber": 4,
                    "correctTaken": 1523,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lytic lesions due to malignant cell infiltration",
                    "choiceNumber": 5,
                    "correctTaken": 616,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "575",
                    "mediaDataId": 0,
                    "title": "Vitamin deficiencies and toxicities",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23565447",
                    "mediaDataId": 0,
                    "title": "Vitamin D deficiency presenting like hypophosphatemic osteomalacia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23565447",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20675513",
                    "mediaDataId": 0,
                    "title": "Vitamin D deficiency in adults: when to test and how to treat.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20675513",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 65,
            "notes": null,
            "peopleTaken": 13599,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 109,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 16870,
            "questionIndex": 18316,
            "questionText": "<p>A 68-year-old man comes to the office for follow-up.&nbsp; The patient has a 10-year history of end-stage renal disease due to diabetic and hypertensive nephropathy and receives intermittent hemodialysis.&nbsp; Current medications are losartan, metoprolol, amlodipine, short- and long-acting insulins, and epoetin alpha.&nbsp; His calcium acetate and calcitriol therapy were stopped 3 months ago due to an elevated serum calcium level.&nbsp; The patient is adherent with medications and dietary restrictions.&nbsp; Laboratory results are as follows:</p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\"><tbody><tr><td style=\"vertical-align:middle;\">Calcium</td><td style=\"vertical-align:middle;\">10.8 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Phosphorus</td><td style=\"vertical-align:middle;\">5.1 mg/dL</td></tr><tr><td style=\"vertical-align:middle;\">Albumin</td><td style=\"vertical-align:middle;\">3.8 g/dL</td></tr><tr><td style=\"vertical-align:middle;\">Parathyroid hormone, intact</td><td style=\"vertical-align:middle;\">760 pg/mL</td></tr></tbody></table><p>Which of the following is the most likely underlying cause of this patient&#39;s elevated serum calcium level?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T62242\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Tertiary hyperparathyroidism</strong></p></td></tr><tr><td><p align=\"center\"><strong>Risk factors</strong></p></td><td><ul><li>Longstanding chronic kidney disease/end-stage renal disease</li><li>Chronic hypocalcemia, hyperphosphatemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Pathogenesis</strong></p></td><td><ul><li>Parathyroid hyperplasia</li><li>Loss of feedback inhibition of PTH by calcium</li></ul></td></tr><tr><td><p align=\"center\"><strong>Laboratory diagnosis</strong></p></td><td><ul><li>Very high PTH</li><li>Mild/moderate hypercalcemia</li><li>Hyperphosphatemia</li></ul></td></tr><tr><td><p align=\"center\"><strong>Treatment</strong></p></td><td><ul><li>Usually refractory to medical therapy</li><li>Parathyroidectomy is often needed</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>PTH</strong> = parathyroid hormone.</p></td></tr></tbody></table></div><p><strong>Chronic kidney disease</strong> (CKD) is associated with hypocalcemia due to decreased renal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D (the more active form).&nbsp; Concurrently, decreased glomerular filtration leads to inadequate clearance of plasma phosphate.&nbsp; The resulting hypocalcemia and hyperphosphatemia stimulate secretion of parathyroid hormone (PTH), leading to high circulating PTH levels (ie, <a href=\"4299\">secondary hyperparathyroidism</a>).</p><p>In patients with long-standing CKD, especially those with <strong>end-stage renal disease</strong> (ESRD), <strong>chronic parathyroid stimulation</strong> can lead to <strong>parathyroid hyperplasia</strong>.&nbsp; This is associated with <strong>autonomous PTH secretion</strong> (ie, not suppressed by rising calcium levels) due to downregulation of calcium-sensing receptor and vitamin D receptor in the parathyroid glands.&nbsp; The net effect, termed <strong>tertiary hyperparathyroidism</strong>, is characterized by:</p><ul><li><strong>Extremely high serum PTH levels</strong></li><li><strong>Hypercalcemia</strong> due to mobilization from bone</li><li><strong>Hyperphosphatemia</strong> due to renal phosphate retention</li></ul><p>This patient has hypercalcemia despite discontinuation of calcium and calcitriol therapy.&nbsp; In the setting of ESRD, hyperphosphatemia, and a very high PTH level, this presentation is consistent with tertiary hyperparathyroidism.</p><p><strong>(Choice A)</strong>&nbsp; PTH is a peptide hormone that is metabolized primarily in the liver.&nbsp; Although a lesser amount is metabolized in the kidneys, intact renal function is not necessary for clearance of PTH.</p><p><strong>(Choice B)</strong>&nbsp; Humoral hypercalcemia of malignancy is characterized by ectopic production of PTH-related peptide and is a common cause of paraneoplastic hypercalcemia.&nbsp; Ectopic production of intact PTH is a very rare paraneoplastic syndrome and is not the cause of tertiary hyperparathyroidism in ESRD.</p><p><strong>(Choice D)</strong>&nbsp; Activation of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D is dependent on renal expression of 1-alpha-hydroxylase, which is decreased (not increased) in patients with CKD.&nbsp; Furthermore, excessive activation of vitamin D would suppress PTH production.</p><p><strong>(Choice E)</strong>&nbsp; Calcium circulates in a protein-bound fraction and a non&ndash;protein-bound ionized fraction.&nbsp; Pseudohypercalcemia refers to an elevated total serum calcium level due to excessive levels of serum proteins (eg, albumin, immunoglobulin) with a normal ionized calcium level.&nbsp; These patients are in a physiologically eucalcemic state with normal PTH levels.</p><p><strong>Educational objective:</strong><br>Patients with long-standing chronic kidney disease often have hypocalcemia and hyperphosphatemia, which can lead to chronic parathyroid stimulation.&nbsp; Over time, this can cause parathyroid hyperplasia and autonomous parathyroid hormone (PTH) secretion.&nbsp; The net effect, termed tertiary hyperparathyroidism, is characterized by hypercalcemia, hyperphosphatemia, and extremely high serum PTH levels.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 106,
            "subject": "Surgery",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 14203,
            "topic": "Hyperparathyroidism",
            "titleId": 14203,
            "title": "Hyperparathyroidism",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased clearance of parathyroid hormone",
                    "choiceNumber": 1,
                    "correctTaken": 4013,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ectopic production of parathyroid hormone",
                    "choiceNumber": 2,
                    "correctTaken": 1965,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperplasia of parathyroid glands",
                    "choiceNumber": 3,
                    "correctTaken": 8022,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased activation of vitamin D",
                    "choiceNumber": 4,
                    "correctTaken": 1593,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Plasma protein&ndash;mediated pseudohypercalcemia",
                    "choiceNumber": 5,
                    "correctTaken": 1049,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1071,1241,true,-1,1*346,417,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "490",
                    "mediaDataId": 0,
                    "title": "Parathyroid disorders: hyperparathyroidism and hypoparathyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31741895",
                    "mediaDataId": 0,
                    "title": "Secondary and tertiary hyperparathyroidism in chronic kidney disease: an endocrine and renal perspective.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31741895",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 64,
            "othersAvgTimeSpent": 84,
            "notes": null,
            "peopleTaken": 16642,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 48,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 679,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 40,
            "questionId": 4304,
            "questionIndex": 4304,
            "questionText": "<p>A 56-year-old woman comes to the office for a follow-up visit.&nbsp; She has chronic kidney disease due to systemic lupus erythematosus (SLE) and nonsteroidal anti-inflammatory drug use.&nbsp; Medical history is notable for recurrent kidney stones, and the patient experienced natural menopause at age 49.&nbsp; Her only current medication is hydroxychloroquine.&nbsp; The patient quit smoking 10 years ago when she was diagnosed with SLE.&nbsp; Family history is noncontributory.&nbsp; Laboratory results are as follows:</p><blockquote><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"400\"><tbody><tr><td>Calcium</td><td>10.8 mg/dL</td></tr><tr><td>Albumin</td><td>3.9 g/dL</td></tr><tr><td>Creatinine</td><td>1.6 mg/dL</td></tr><tr><td>Phosphorus</td><td>3.0 mg/dL</td></tr><tr><td>Parathyroid hormone</td><td>800 pg/mL</td></tr></tbody></table></blockquote><p>DXA bone densitometry scan shows a T score of -2.5 at the lumbar spine, which is consistent with osteoporosis.&nbsp; Which of the following is the most likely cause of this patient&#39;s hypercalcemia?</p>",
            "questionHeader": "",
            "explanationText": "<p><img draggable=\"false\" id=\"286\" src=\"https://www.uworld.com/media/L7026.png\" ></p><p>Causes of <strong>hypercalcemia</strong> can be categorized on the basis of parathyroid hormone (PTH) levels as PTH-dependent or PTH-independent:</p><ul><li><strong>PTH-independent</strong> hypercalcemia (suppressed PTH) is usually due to malignancy, vitamin D toxicity, or extrarenal conversion of 25-hydroxyvitamin D to 1,25-dihydroxyvitamin D in granulomatous diseases (eg, sarcoidosis) <strong>(Choices F and G)</strong>.</li><li><strong>PTH-dependent</strong> hypercalcemia (elevated or inappropriately normal PTH) is usually due to <strong>primary hyperparathyroidism</strong> (PHPT).</li></ul><p>This patient has hypercalcemia with an elevated PTH level, suggesting PHPT.&nbsp; Normally, elevated plasma calcium <a href=\"629\">suppresses PTH secretion</a>.&nbsp; However in PHPT, PTH secretion from autonomously functioning parathyroid adenomas or parathyroid hyperplasia is not suppressed.&nbsp; Most patients with PHPT present with mild, asymptomatic hypercalcemia, but potential clinical features include nephrolithiasis, osteoporosis, nausea, constipation, and neuropsychiatric symptoms (&#x22;stones, bones, abdominal moans, psychic groans&#x22;).&nbsp; Serum phosphorus is often normal but can be low in moderate-to-severe PHPT.</p><p><strong>(Choice A)</strong>&nbsp; Secondary hyperparathyroidism is characterized by increased secretion of PTH in response to hypocalcemia.&nbsp; It is a common finding in chronic kidney disease due to inadequate phosphate excretion and low 1,25-hydroxyvitamin D levels.&nbsp; Serum phosphorus will be high and calcium will be low or low-normal.&nbsp; Long-standing secondary hyperparathyroidism can lead to autonomous PTH secretion (tertiary hyperparathyroidism), but this is typically seen in patients with end-stage renal disease (eg, on hemodialysis) and would be very unusual with a creatinine of 1.6 mg/dL.&nbsp; It is associated with very high PTH levels.</p><p><strong>(Choice B)</strong>&nbsp; Hypercalcemia of malignancy is usually due to secretion of PTH-related protein and is characterized by severe hypercalcemia (typically &gt;14 mg/dL) and a suppressed PTH level.</p><p><strong>(Choice C)</strong>&nbsp; Milk-alkali syndrome is caused by excessive ingestion of calcium and absorbable alkali (eg, calcium-containing antacids).&nbsp; Calcium would be elevated, but PTH would be suppressed.</p><p><strong>(Choice D)</strong>&nbsp; Circulating levels of calcium and PTH are normal in primary osteoporosis.</p><p><strong>Educational objective:</strong><br>Primary hyperparathyroidism is characterized by autonomous secretion of parathyroid hormone from parathyroid adenomas or parathyroid hyperplasia.&nbsp; Most patients have mild, asymptomatic hypercalcemia, but potential clinical features include nephrolithiasis, osteoporosis, nausea, constipation, and neuropsychiatric symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 102,
            "subject": "Medicine",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 211,
            "system": "Endocrine, Diabetes & Metabolism",
            "topicId": 14203,
            "topic": "Hyperparathyroidism",
            "titleId": 14203,
            "title": "Hyperparathyroidism",
            "topicAttributeId": 330624,
            "topicAttribute": "Miscellaneous",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Chronic kidney disease",
                    "choiceNumber": 1,
                    "correctTaken": 10148,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypercalcemia of malignancy",
                    "choiceNumber": 2,
                    "correctTaken": 594,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Milk-alkali syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 248,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Osteoporosis",
                    "choiceNumber": 4,
                    "correctTaken": 965,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Primary hyperparathyroidism",
                    "choiceNumber": 5,
                    "correctTaken": 17920,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sarcoidosis",
                    "choiceNumber": 6,
                    "correctTaken": 214,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vitamin D toxicity",
                    "choiceNumber": 7,
                    "correctTaken": 175,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "490",
                    "mediaDataId": 0,
                    "title": "Parathyroid disorders: hyperparathyroidism and hypoparathyroidism",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22982802",
                    "mediaDataId": 0,
                    "title": "Primary hyperparathyroidism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22982802",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19494663",
                    "mediaDataId": 0,
                    "title": "A practical approach to problems of hypercalcaemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19494663",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 133,
            "othersAvgTimeSpent": 82,
            "notes": null,
            "peopleTaken": 30264,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": true,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 289,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}